Document:

License Agreement

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 EXHIBIT 10.5 
 LICENSE AGREEMENT 
 This License Agreement (this “Agreement”) is made and entered into as of
September 30th, 2001 (the “Effective Date”) by and between, as one party, DSP Group, Inc., a Delaware
corporation having a principal place of business at 3120 Scott Boulevard, Santa Clara, California 95054 and DSP Group, Ltd., an Israeli corporation having a principal place of business at 5 Shenkar Street, Herzelia Pituach 46120, Israel
(collectively, “DSPG”), and as the other party, Spreadtrum Communications, Inc. a Cayman Corporation, with a principal address of Ugland House, P.O. Box, George Town, Grand Cayman, Cayman Islands, British West Indies, on behalf of itself
and its wholly-owned subsidiaries, Speadtrum Communications, Corp., a California corporation having a principal place of business at 4701 Patrick Henry Drive, Building 1401, Santa Clara, California 95054, and Spreadtrum Communications Shanghai Corp,
a Chinese corporation having a principal place of business at
                                        
                                     (collectively,
“Licensee”). 
 Recitals 
  

	 	A.	DSPG has the right to license the technology described in Exhibit A. 

  

	 	B.	Licensee wishes to obtain certain rights from DSPG to use such technology. 

 THEREFORE, IN VIEW OF THE ABOVE PREMISES AND THE FOLLOWING PROMISES, DSPG and Licensee agree as follows: 
 Agreement 
  

	1.	DEFINITIONS 

 1.1 “Architecture
Specification” means the architecture specification for the Core described in Item 1.1 of Exhibit B. 
 1.2 “ASIC
Designer” means a third party integrated circuit designer engaged by Licensee to assist in the design and development of Core Products. 
 1.3 “Compliant” with respect to an implementation of the Core, means that such implementation (i) executes each and every instruction contained in the instruction set identified in the Architecture Specification and no
other additional instructions; (ii) implements the programming model as identified in the Architecture Specification; and (iii) is cycle by cycle compatible with the RTL model of the Core. 
 1.4 “Core” means the digital signal processing core described in Exhibit A. 
 1.5 “Core Product” means any integrated circuit device that combines one or more Compliant Cores with application-specific or
user-specific circuitry that adds a substantial and significant amount of value and functionality to such Compliant Core(s) and that is an Initial Product, a Designated Product, or is licensed under the Global Licensing Option pursuant to
Section 6.5. 
  

 1 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 1.6 “Core Technology” means the technology embodied or incorporated in the Core and Deliverables. 
 1.7
“Deliverables” means the Tools, Documentation and Design/Fabrication Materials. 
 1.8 “Designated Product”
means the Initial Products and other products that are designated as additional Designated Products pursuant to Section 6.4. 
 1.9
“Design/Fabrication Materials” means the materials set forth in Item 2 of Exhibit B. 
 1.10
“Documentation” means the materials set forth in Item 1 of Exhibit B. 
 1.11 “DSPG Marks” means the
trademarks, trade names and logos set forth in Exhibit D. 
 1.12 “Initial Products” means the [***] products which
incorporate a physical implementation of the Core that are designated in writing by Licensee and approved in writing by DSPG. 
 1.13
“Licensee Customer” means a third party that (a) is not a licensee of the Core and (b) engages Licensee to manufacture Core Products designed and/or developed by such third party for sale by Licensee to such third party.

 1.14 “Modification Guidelines” means the guidelines set forth in Exhibit E. 
 1.15 “Port” means a layout of the Core targeted for a specific fabrication process/technology. 
 1.16 “Subcontractor” means any of: (a) a third party software developer engaged by Licensee to write software applications that
utilize or otherwise interact with implementations of the Core on Core Products (“Software Subcontractor”); (b) a third party circuit board designer engaged by Licensee to design circuit boards that incorporate the Core
Products or development models thereof (“Hardware Subcontractor”); or (c) a third party semiconductor manufacturer engaged by Licensee to assist in the manufacturing of Core Products (“Fabrication
Subcontractor”). ASIC Designers shall not be deemed to be Subcontractors. 
 1.17 “Sublicense Agreement” means the
agreement attached hereto as Exhibit C, as may be amended by DSPG from time to time with notice to Licensee. 
 1.18 “Tools”
means the hardware tools set forth in Items 2.9 of Exhibit B (the “Hardware Tools”) and the software tools set forth in Item 2.8 of Exhibit B (the “Software Tools”). 
  

 2 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 1.19 “Trademark Usage Guidelines” means the guidelines set forth in Exhibit D, and any other guidelines regarding the use of the DSPG Marks that DSPG may communicate to Licensee from time to time. 
 1.20 “Translation” means a direct translation of the RTL for the Core into an alternative hardware description language at the same (or
higher) level of abstraction. 
  

	2.	DELIVERY 

 DSPG will use reasonable efforts to deliver the
Deliverables in accordance with the delivery schedule set forth in Item 3 of Exhibit B. 
  

	3.	LICENSE GRANT 

 3.1 Core Products. Subject to the
terms and conditions of this Agreement, DSPG hereby grants to Licensee a personal, nonexclusive, nontransferable license to: 
 (a) make
changes to the RTL for the Core, provided that the resulting Core is Compliant; 
 (b) incorporate the RTL for the Core, and any changes made
thereto pursuant to subsection (a) above, into Licensee’s designs for Core Products; 
 (c) import, manufacture and
have manufactured such Core Products; 
 (d) offer for sale, sell and otherwise distribute Core Products, provided that prior to selling or
distributing any Core Products, Licensee shall verify that each implementation of the Core contained in such Core Product is Compliant. 
 3.2 Tools and Documentation. Subject to the terms and conditions of this Agreement, DSPG hereby grants to Licensee a personal, nonexclusive, nontransferable license to: 
 (a) make copies of the Software Tools, provided that the total number of copies of the Software Tools, including any copies distributed to Subcontractors
but excluding copies for backup or archival purposes, does not exceed [***]. If Licensee wishes to use more than [***] copies of the Software Tools, Licensee may license from DSPG additional copies at DSPG’s then current listed price per copy
for the Windows 95/98/NT version or the Solaris OS version of the Software Tools; 
 (b) integrate the Tools with other development tools or
environments (in the case of Software Tools, solely by using the application programming interfaces thereof in the manner permitted by the applicable documentation); 
  

 3 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 (c) modify the Documentation, provided that such modifications are in conformance with the Modification Guidelines and the resulting documentation is in conformance with the Trademark Usage Guidelines; and 
 (d) use the Tools and Documentation internally for the sole purpose of designing, developing, having manufactured, and manufacturing Core Products.

 3.3 Design/Fabrication Materials. Subject to the terms and conditions of this Agreement, DSPG hereby grants to Licensee a personal,
nonexclusive, nontransferable license to use the Design/Fabrication Materials for the sole purpose of designing, developing, having manufactured and manufacturing Core Products. 
 3.4 Subcontractors and Licensee Customers. Subject to the terms and conditions of this Agreement, DSPG hereby grants to Licensee a personal,
nonexclusive, nontransferable license to distribute by sublicense (as set forth in Section 3.5): 
 (a) to Licensee Customers—the
Tools, the relevant Documentation (and any modifications thereto made in accordance with Section 3.2(b)); 
 (b) to Software
Subcontractors—the Tools and the relevant Documentation (and any modifications thereto made in accordance with Section 3.2(b)) solely for their use in writing software applications that utilize or otherwise interact with implementations of
the Core on Core Products; 
 (c) to Hardware Subcontractors—the Hardware Tools and the relevant Documentation (and any modifications
thereto made in accordance with Section 3.2(b)) solely for their use in designing circuit boards that incorporate the Core Products (or development models thereof); and 
 (d) to Fabrication Subcontractors—the masks for the Core Products solely for their use in manufacturing the Core Products. 
 3.5 Sublicense Agreements. Licensee shall not provide or otherwise distribute any Deliverables (or any portions thereof, modifications thereto or
derivative works thereof) to any Subcontractor or Licensee Customer that has not previously executed the Sublicense Agreement. Licensee shall provide DSPG with a copy of each such Sublicense Agreement promptly upon execution thereof. DSPG shall be
an intended third party beneficiary of each Sublicense Agreement and shall have the right to enforce any and all obligations of Subcontractors and Licensee Customers under their Sublicense Agreements. Licensee shall, at its own expense, use
commercially reasonable steps to monitor Subcontractors and Licensee Customers and investigate each report and indication of breach of any Sublicense Agreement, and Licensee shall promptly report to DSPG any breach discovered or learned of by
Licensee. Licensee will diligently enforce the terms and conditions of each Sublicense Agreement, including, without limitation, (a) pursuing all appropriate judicial and administrative action and relief in the event of any breach of the
Sublicense Agreement and (b) upon DSPG’s request, terminating the 

  

 4 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 
Sublicense Agreement upon a breach thereof if such breach is not capable of being cured or has not been cured within thirty (30) days. Notwithstanding
any of the foregoing, Licensee will be responsible and liable for any breach of any Sublicense Agreement by a Subcontractor or Licensee Customer. 
 3.6 ASIC Designers. Licensee shall not provide or otherwise distribute any Deliverables (or any portions thereof, modifications thereto or derivative works thereof) to any ASIC Designer unless Licensee first notifies DSPG in writing
of its desire to engage such ASIC Designer and DSPG notifies Licensee in writing that it has entered into a separate license agreement with such ASIC Designer specifically covering such Deliverables. In addition, Licensee will provide such
Deliverables to such ASIC Designer only as accompanied by written notice that such Deliverables are subject to the terms and conditions of such separate license agreement. DSPG will negotiate such license agreements with such ASIC Designers
promptly, in good faith and without additional charge to Licensee. Notwithstanding the foregoing, an ASIC Designer that is a wholly owned subsidiary of Licensee will not require a separate license agreement. 
 3.7 License Restrictions. Licensee may not (a) transfer, sublicense, distribute modify, translate, create derivative works of or reproduce
Deliverables or any other element of the Core or Core Technology, except as expressly set forth in Section 3, or (b) decompile, reverse engineer or disassemble the Deliverables or any other element of the Core or Core Technology. Licensee
will not remove, obscure or alter any DSPG Mark from any Deliverable, and Licensee will reproduce all DSPG Marks and proprietary rights and ownership notices on all copies and units of Deliverables made by or for Licensee. 
  

	4.	MARKETING 

 4.1 Licensee Commitment. Licensee will
use commercially reasonable efforts to develop, manufacture and bring to market Core Products within [***]. Licensee will actively promote, market, and sell Core Products as they become commercially available. 
 4.2 DSPG Collateral Materials. DSPG may from time to time provide Licensee with datasheets and other marketing and technical documentation and
materials regarding the Core (“DSPG Collateral Materials”). Subject to the terms and conditions of this Agreement, DSPG hereby grants to Licensee a personal, nonexclusive, nontransferable license to (a) modify DSPG Collateral
Materials, provided that such modifications are in conformance with the Modification Guidelines and the resulting materials are in conformance with the Trademark Usage Guidelines, and (b) use, copy and distribute such DSPG Collateral Materials
(and any such modifications thereto) solely in connection with the marketing and sale of Core Products. 
 4.3 Trademark License.
Subject to the terms and conditions of this Agreement (including, without limitation, the provisions of Section 4.4), DSPG grants Licensee the right to use the DSPG Marks on press releases, data sheets and other documentation and 

  

 5 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 
materials for Core Products (“Licensee Collateral Materials”). All Licensee Collateral Materials shall be in conformance with the Trademark Usage
Guidelines. Furthermore, any Licensee Collateral Materials mentioning the Core or Core Technology will prominently (a) identify the Core as the “TeakLite®” and (b) state that DSP Group, Inc. has developed and owns certain
right, title and interest in and to the Core Technology, the associated intellectual property rights and the DSPG Marks. 
 4.4 Trademark
Usage Guidelines. All use of the DSPG Marks by Licensee will be in conformance with the Trademark Usage Guidelines. Upon DSPG’s request, Licensee will provide DSPG with copies and samples of any Tools, Documentation, Design/Fabrication
Materials, DSPG Collateral Materials, and Licensee Collateral Materials that are provided or otherwise distributed to any third parties, and will promptly remedy any failure of such materials to conform with the Trademark Usage Guidelines or
Modification Guidelines, as applicable, that are communicated to Licensee by DSPG. 
 4.5 Licensee Marks. Licensee hereby grants to
DSPG a non-exclusive, nontransferable right and license to use Licensee’s trademarks, trade names and logos (“Licensee Marks”) on its brochures, displays and marketing materials for the Core. DSPG will provide Licensee with samples of
any such materials upon Licensee’s request, and shall promptly remedy any failure of such materials to conform with the reasonable trademark usage guidelines of Licensee. In using any of the Licensee Marks as provided herein, DSPG will annotate
such Licensee Marks with the “TM” or “®” symbols, as may be applicable, and footnote Licensee’s ownership of the Licensee Marks. 
  

	5.	TECHNICAL SUPPORT AND ADDITIONAL SERVICES 

 5.1 For a
period of twenty-four (24) months commencing on DSPG’s delivery of the RTL for the Core (the “Initial Support Term”), DSPG will provide technical support to Licensee for the Core at no additional charge during the Initial Support
Term. Licensee may receive technical support for additional twenty-four (24) month periods (each an “Extended Support Term”) subject to the payment of fees set forth in Section 6.3 if it gives written notice to DSPG at least
thirty (30) days prior to the expiration of the Initial Support Term or any Extended Support Term. Such technical support will consist of providing: 
 (a) any bug fixes to the Design/Fabrication Materials that DSPG may make available generally to licensees of the Core at no additional charge; 
 (b) any bug fixes to the Tools that DSPG may make available generally to licensees of the Core at no additional charge; 
 (c) any Core-related peripheral blocks that DSPG may make available generally to licensees of the Core at no additional charge; and 
 (d) up to ten (10) man-days of engineering technical support during DSPG’s normal business hours at no additional charge during the Initial
Support Term. 

  

 6 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 
DSPG shall have no obligation to provide any technical support to (i) any Subcontractors, ASIC Designers or any other party other than Licensee or
(ii) to Licensee regarding any non-Compliant Cores. 
 5.2 Training Class. DSPG will conduct a five (5) day training class
for up to ten (10) Licensee personnel at the Santa Clara or Shanghai offices of either DSPG or Licensee, on a mutually agreeable date, but no later than three (3) months after the Effective Date. Licensee will be responsible for all
reasonable expenses (including, without limitation, transportation, food, lodging and other out-of-pocket expenses) incurred by its and DSPG personnel in connection with the training. 
 5.3 Additional Services. Upon Licensee’s request, DSPG will provide additional technical support under terms, conditions and fees mutually
agreed upon by the parties in writing. If Licensee requests any other services not covered by this Agreement (including, without limitation, engineering support in excess of ten man-days or other support and maintenance not required under
Section 5.1 or 5.2), the requested services shall be provided upon the prior written agreement of the parties, at DSPG’s standard rates then in effect. 
  

	6.	PAYMENTS 

 6.1 License Fee. Licensee will pay DSPG a
non-refundable license fee of [ *** ] for the licenses for the [ *** ] Initial Products granted to Licensee in this Agreement. Such license fee will be payable as follows: 
  

					
	a.	  	 [ *** ]
	  	
			
	b.	  	 [ *** ]
	  	
			
	c.	  	 [ *** ]
	  	
		  		  	 
		  		  	

 6.2 Royalties. In addition to the fee set forth in Section 6.1, Licensee will pay DSPG
a non-refundable royalty for each implementation of the Core on each unit of each Core Product shipped, sold, transferred or otherwise distributed by or for Licensee, or put to productive internal use by Licensee, at the following rates: 

 

	 	•	 	 [ *** ] 

  

	 	•	 	 [ *** ] 

  

	 	•	 	 [ *** ] 

  

	 	•	 	 [ *** ] 

  

	 	•	 	 [ *** ] 

  

 7 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 6.2.1 Notwithstanding the foregoing, the royalty for each unit of Core Product that performs any functions of a PSTN-based phone, integrated with a telephone answering device (TAD), speakerphone, caller ID, or other telephony feature, will
be [ *** ] and no additional royalties will be due on such Core Products. 
 6.2.2 Licensee shall pay royalties to DSPG on a
quarterly basis, with the royalties for each calendar quarter to be paid within thirty (30) days of the end of such quarter. 
 6.2.3 No
royalties will be due for samples provided that the quantity of such implementations on which royalties are not due shall not exceed [ *** ] implementations per year. 
 6.2.4 No royalties will be due for replacements of defective units. 
 6.3 Support Fees for Extended Support Terms. For support in addition to the Initial Support Term described in Section 5.1, Licensee will pay DSPG a non-refundable support fee of [ *** ]. Such
installments will be payable on the 1st, 90th, 180th, 270th, 360th, 450th, 540th, and 630th days of an Extended Support Term. 
 6.4
Additional Designated Applications. Licensee may designate additional single physical implementations of the Core on single end products beyond the [***] Products as Designated Products, provided that (a) each such additional product is
approved in writing by DSPG, such approval not to be unreasonably withheld or delayed, and (b) Licensee pays to DSPG an additional designation fee of [ *** ] for each such additional product. 
 6.5 Global Licensing Option. Licensee will have the option to license the Core for all Core Products of Licensee (the “Global Licensing
Option”) in accordance with the terms of this Section. If Licensee exercises the Global Licensing Option, the definition of Core Product shall be modified as set forth in Section 1.5. The Global Licensing Option will be exercisable by
Licensee solely by paying DSPG (a) a license fee equal to [ *** ] less amounts paid by Licensee to DSPG under Sections 6.1 and 6.4 of this Agreement (i.e., less license fees and fees for additional Designated Products). The Global
Licensing Option shall terminate and be of no further force or effect on the three (3) year anniversary of the Effective Date if Licensee does not exercise the Global Licensing Option prior to such date. 
 6.6 Payment Terms. All payments to DSPG will be made by wire transfer to a bank account designated by DSPG. All monetary amounts set forth in this
Agreement refer to U.S. dollars. If any amount payable under this Agreement is not paid by the applicable due date, then, in addition to any other remedies DSPG may have, Licensee will pay interest on such amount at a per annum rate of eighteen
percent (18%) (or, if less, the maximum rate permitted by applicable law) for the period between the due date and the date DSPG receives payment of such amount. 
  

 8 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	7.	REPORTS; AUDIT; TAXES 

 7.1 Reports. While this
Agreement is in effect, within thirty (30) days of the close of each calendar quarter, Licensee will deliver to DSPG a written report setting forth (a) the number of units of each Core Product shipped, sold, transferred or otherwise
distributed by or for Licensee, or put to productive internal use by Licensee, during such quarter, (b) the number of implementations of the Core on each such unit, (c) the amount of royalties payable to DSPG for such implementations,
(d) an itemized list of the Tools, Documentation and Design/Fabrication Materials provided or otherwise distributed to each Subcontractor and Licensee Customer during such quarter, and (e) an itemized list of each product tape-out that
incorporates the Core or Core Technology. Licensee will begin delivering such reports to DSPG six (6) months after the Effective Date or when the Licensee distributes or puts to productive internal use Core Products, whichever is earlier.

 7.2 Audit. While this Agreement is in effect, and for three (3) years after its expiration or earlier termination, Licensee
will maintain at its principal offices such books and records as sufficient to confirm Licensee’s compliance with this Agreement for at least three years following the time of sale of particular Core Product units. Licensee will permit
DSPG’s representative, which must be an independent public accounting firm of DSPG’s choice that is reasonably acceptable to Licensee and that enters into an appropriate confidentiality agreement with Licensee, to audit such books and
records upon at least 30 days prior written notice. If any such audit reveals that Licensee has underpaid the royalties owed to DSPG for the audited period by more than five percent (5%), Licensee will reimburse DSPG for all expenses reasonably
incurred by DSPG in connection with such audit. Unless such an underpayment is revealed, Licensee will not be required to submit to an audit more than once during any calendar year. Any audit must be performed during Licensee’s normal business
hours and without interference with Licensee’s normal business operations. 
 7.3 Taxes. In addition to the fees, royalties and
other charges set forth in this Agreement, Licensee shall pay all taxes, duties and levies imposed by all foreign, federal, state and local authorities (including, without limitation, export, sales, use, excise, and value-added taxes) based on the
transactions or payments under this Agreement, other than taxes imposed or based on DSPG’s net income. All amounts payable by Licensee hereunder shall be paid without deduction or withholding for or on account of any present or future tax,
levy, impost, fee, assessment, deduction or charge by any taxing authority 
  

	8.	PROPRIETARY OWNERSHIP RIGHTS 

 8.1 Core Technology and
Deliverables. Except for the rights and licenses expressly granted to Licensee in this Agreement, DSPG shall reserve and retain all right, 

  

 9 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 
title and interest (including, without limitation, all intellectual property rights) in and to the DSPG Marks and the Core, Core Technology, Deliverables,
all copies thereof, and all revisions, modifications, Translations, updates, and upgrades provided to Licensee by DSPG of any of the foregoing. Subject to DSPG’s underlying rights, Licensee will own all modifications and derivative works of the
Core, Core Technology and Deliverables created by or on behalf of Licensee pursuant to this Agreement. Nothing contained in this Agreement shall be construed as conferring upon Licensee or any third party (by implication, operation of law, estoppel
or otherwise) any license or right not expressly granted by DSPG in this Agreement. Any goodwill arising out of or relating to Licensee’s use of the DSPG Marks shall inure to the sole benefit of DSPG. 
 8.2 Translations and Ports. DSPG may request from time to time that Licensee notify DSPG in writing of any Translations, Ports or changes made by
or for Licensee to the Design/Fabrication Materials, and Licensee shall promptly comply with such requests. To the extent that any Translations or Ports are created by or for Licensee, Licensee shall promptly provide such Translations and Ports to
DSPG, and Licensee hereby grants and agrees to grant to DSPG an irrevocable, nonexclusive, royalty-free, paid-up, worldwide license (with right to sublicense) to use, modify, have modified, make, have made, reproduce, sublicense, sell and otherwise
distribute such Translations and Ports. 
 8.3 No Registration. Licensee will not (and Licensee will ensure that its subsidiaries and
affiliates will not) at any time directly or indirectly attempt to register in any country the DSPG Marks, any other DSPG name or mark, or any name or mark substantially similar thereto. 
  

	9.	REPRESENTATIONS AND WARRANTIES 

 9.1 Authority. Each
party represents and warrants that it possesses the right and capacity to enter into this Agreement. 
 9.2 Deliverables. DSPG
represents and warrants that, for a period of ninety (90) days commencing on the delivery of the Deliverables, the Deliverables will be sufficient for a competent semiconductor manufacturer to produce Compliant implementations of the Core.
DSPG’s entire liability and obligation and Licensee’s sole and exclusive remedy for a breach of the foregoing warranty shall be to use commercially reasonable efforts to modify or replace the relevant Deliverables to remedy any such
insufficiency reported to DSPG during such ninety (90) day period. 
 9.3 Noninfringement. DSPG represents and warrants that, to
its knowledge, the Deliverables, as of the Effective Date, in the form delivered to Licensee, do not infringe any U.S. patents or copyrights of any third party. 
 9.4 Warranty Disclaimers. EXCEPT AS EXPRESSLY PROVIDED IN SECTIONS 9.2 and 9.3, DSPG MAKES NO WARRANTY OF ANY KIND WITH 

  

 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 
RESPECT TO THE DSPG MARKS OR THE CORE, CORE TECHNOLOGY OR DELIVERABLES. DSPG EXPRESSLY DISCLAIMS ANY OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY
IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT, WHETHER ARISING IN LAW, CUSTOM, CONDUCT OR OTHERWISE. 
  

	10.	INDEMNIFICATION 

 10.1 Indemnification. DSPG will
(a) defend Licensee against any claim by a third party that the Core, Core Technology or Deliverables infringe any U.S., Japanese, or European Union patents or copyrights or misappropriate any U.S., Japanese, or European Union trade secret of
any third party, and (b) pay any damages (including costs and attorneys’ fees) finally awarded against Licensee by a court of competent jurisdiction based on such claim (or pay any settlement of such claim agreed to by DSPG). DSPG will be
relieved of the foregoing obligations unless Licensee (i) promptly notifies DSPG of the claim (in any event, within ten (10) days after Licensee becomes aware of the claim), (ii) authorizes and allows DSPG to have sole control of the
defense and settlement of the claim, and (iii) provides any information and cooperation reasonably requested by DSPG at DSPG’s expense. 
 10.2 Options. If a claim of the type described in Section 10.1 arises or is reasonably likely to arise, DSPG will have the right, at its own expense and option, to (a) procure for Licensee the right to continue using the
Core, Core Technology or Deliverable that is the subject of such claim, (b) modify or replace such Core, Core Technology or Deliverable to make it (or increase the likelihood it will be) noninfringing, or (c) refund to Licensee the amount
of any license fees paid with respect to such Core, Core Technology or Deliverable, in which case Licensee’s rights and licenses with respect thereto will terminate. This Section 10 sets forth DSPG’s entire liability and obligation
and Licensee’s sole and exclusive remedy with respect to any infringement or claim of infringement of any intellectual property right in connection with the Core, Core Technology or Deliverables. 
 10.3 Exclusions. DSPG will have no liability for, and the obligations of DSPG in Section 10.1 will not apply to, any claim based on or
related to (i) modification or adaptation of any Deliverable by any person other than DSPG if the infringement claim would have been avoided but for such modification, (ii) combination or operation of any Deliverable with any software,
hardware, data, or other materials or products not supplied by DSPG if the infringement claim would have been avoided but for such combination, (iii) use of any Deliverable after DSPG has provided Licensee with a modified version of or
replacement for such Deliverable if the infringement claim would have been avoided by use of such modified or replacement version, or (iv) use of any Deliverable other than as expressly authorized by this Agreement. Licensee will
(a) defend DSPG against any such claim brought by a third party, and (b) pay any damages (including costs and attorneys’ fees) finally awarded against DSPG by a court of competent jurisdiction based 

  

 11 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 
on such claim (or pay any settlement of such claim agreed to by Licensee). Licensee will be relieved of the foregoing obligations unless DSPG
(i) promptly notifies Licensee of the claim (in any event, within ten (10) days after DSPG becomes aware of the claim), (ii) authorizes and allows Licensee to have sole control of the defense and settlement of the claim, and
(iii) provides any information and cooperation reasonably requested by Licensee at Licensee’s expense. 
  

	11.	LIMITATION OF LIABILITY 

 IN NO EVENT WILL EITHER PARTY BE
ENTITLED TO RECOVER FROM THE OTHER PARTY ANY INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR SPECIAL DAMAGES, OR ANY DAMAGES FOR LOSS OF DATA, PROFITS, REVENUE, BUSINESS OR GOODWILL, EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH
DAMAGES. IN NO EVENT WILL DSPG’S AGGREGATE LIABILITY IN CONNECTION WITH THIS AGREEMENT EXCEED THE AMOUNTS PAID BY LICENSEE TO DSPG HEREUNDER. 
  

	12.	CONFIDENTIALITY 

 12.1 Definition of Confidential
Information. “Confidential Information,” with respect to either party, means all trade secrets, know-how, ideas, inventions (whether patentable or not), processes, techniques, algorithms, computer programs (source and object code),
designs, schematics, drawings, formulas, data, product development plans, strategies, forecasts and other technical, engineering, manufacturing, product, marketing, servicing, financial, and personnel information and materials of such party or any
of its employees, consultants, investors, affiliates, customers, clients, vendors, suppliers or business; provided, however, that in order to be deemed “Confidential Information,” any of the foregoing (a) if disclosed in writing, must
be marked as confidential at the time of disclosure, and (b) if disclosed orally or in other intangible form, must be identified and treated as confidential at time of disclosure and reduced to writing and marked confidential within thirty
(30) days of disclosure. Notwithstanding the foregoing, the Deliverables, the terms and conditions of this Agreement, and any other information or materials relating to the Core or Core Technology will constitute “Confidential
Information” of DSPG regardless of whether the procedures described in (a) and (b) above are followed with respect thereto. 
 12.2 Recipient Obligations. Each party (“Recipient”) will maintain the Confidential Information of the other party (“Discloser”) in strict confidence and will not disclose such Confidential Information to any
third party without Discloser’s prior written consent except as provided in this Agreement. Recipient may disclose Discloser’s Confidential Information only to Recipient’s employees and agents who have a need to know such Confidential
Information .and who have entered into written agreements with Recipient requiring them to comply with the obligations set forth in this Section 12. Recipient will not use any Confidential Information of Discloser except as necessary to 

  

 12 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 
exercise its rights and fulfill its obligations under this Agreement. Recipient will protect the confidentiality and avoid the unauthorized use, disclosure,
publication, and dissemination of Discloser’s Confidential Information with the same degree of care that Recipient uses to protect its own confidential and proprietary information of similar nature and like importance, and in no event with less
than reasonable care. 
 12.3 Remedies. Licensee acknowledges and agrees that due to the unique nature of the Confidential
Information, a breach of its obligations under Section 12 would cause DSPG irreparable harm and damage for which there can be no adequate remedy at law. Therefore, upon any such breach or threatened breach by Licensee, DSPG will be entitled to
seek an immediate injunction, restraining order and/or other appropriate equitable relief, in addition to whatever remedies it may have under applicable law. 
 12.4 Unauthorized Disclosures. Licensee will notify DSPG of any actual or suspected unauthorized use or disclosure of Confidential Information or infringement of any of Confidential Information of which
Licensee has knowledge. Licensee will reasonably cooperate with DSPG, at DSPG’s expense, in the investigation and prosecution of such unauthorized use, disclosure or infringement. 
  

	13.	TERM AND TERMINATION 

 13.1 Term. This Agreement
will be in effect for a [***] term commencing on the Effective Date. Thereafter, this Agreement will renew automatically for additional one (1) year terms unless either party delivers to the other party written notice of its intention not to
renew at least thirty (30) days prior to the end of the initial or any renewal term. 
 13.2 Termination for Cause. Either party
may terminate this Agreement if: 
 (a) the other party breaches any material provision of this Agreement and fails to remedy such breach
within thirty (30) days of non-breaching party’s written notice of such breach (or, if such breach cannot be remedied in that time, fails to commence remedial procedures reasonably satisfactory to the non-breaching party), provided that
any material breach of Section 12 will be grounds for immediate termination of this Agreement; 
 (b) the other party dissolves, becomes
insolvent or makes a general assignment for the benefit of its creditors; 
 (c) a voluntary or involuntary petition or proceeding is
commenced by or against the other party under the Federal Bankruptcy Act or any other statute of any state or country relating to insolvency or the protection of the rights of creditors, or any other insolvency or bankruptcy proceeding or other
similar proceeding for the settlement of the other party’s debt is instituted; or 
  

 13 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 (d) A receiver of all or substantially all of the property of the other party is appointed. 
 Except as expressly limited by this Agreement,
termination of this Agreement under this Section 13.2 will be without prejudice to any other remedy which may be available to a party under applicable law. 
 13.3 Effect of Termination. Upon any expiration or earlier termination of this Agreement: 
 (a) all
rights and licenses granted to Licensee, Licensee Customers and Subcontractors will terminate, and Licensee shall cease to design, develop, modify, translate, manufacture, use, market, sell, sublicense and otherwise distribute any Deliverables (or
any changes thereto or Translations thereof), DSPG Collateral Materials or DSPG Marks; except that if this Agreement is terminated by Licensee pursuant to Section 13.2, Licensee may provide to DSPG within fifteen (15) days following such
termination a written list of the Core Products currently in development and those for which development has been completed (collectively, the “Developed Products”), in which case the rights and licenses granted to Licensee under
Section 3 shall continue with respect to such Developed Products as long as Licensee continues to pay royalties pursuant to Section 6 and otherwise abides by the terms and conditions of this Agreement; 
 (b) Licensee will promptly return to DSPG all Deliverables (and changes thereto and Translations and Ports thereof), all other Confidential Information,
and all copies of any of the foregoing (including, without limitation, those copies distributed by Licensee to third parties); and 
 (c) the
due date of any royalties and other payments that accrued prior to such expiration or earlier termination will be accelerated and such royalties and other payments will become immediately due and payable. 
 13.4 Survival. The parties’ rights and obligations under Sections 7, 8, 10, 11, 12, 13.3 and 13.4 and the relevant portions of
Section 14 will survive any expiration or earlier termination of this Agreement. 
  

	14.	MISCELLANEOUS 

 14.1 Relationship. The relationship
between the parties will be that of independent contractors. Nothing contained herein will be construed to imply a joint venture, principal or agent relationship, or other joint relationship, and neither party will have the right, power or authority
to bind or create any obligation, express or implied, on behalf of the other party. 
 14.2 Governing Law. This Agreement is to be
construed in accordance with and governed by the internal laws of the State of California (as permitted by Section 

  

 14 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 
1646.5 of the California Civil Code or any similar successor provision) without giving effect to any choice of law rule that would cause the application of
the laws of any jurisdiction other than the internal laws of the State of California to the rights and duties of the parties. Each party hereby irrevocably consents to the jurisdiction and venue of the courts of Santa Clara County, California and
the United States District Court for the Northern District of California in connection with any claim, action, suit, or proceeding relating to this Agreement. Neither party will commence or prosecute any claim, action, suit, or proceeding relating
to this Agreement other than in the courts set forth in the preceding sentence, except either party may seek injunctive, equitable or similar relief from any court of competent jurisdiction. The provisions of the United Nations Convention on the
International Sales of Goods are hereby disclaimed and excluded. 
 14.3 Waiver. Failure by any party to enforce any of its rights
under this Agreement will not be deemed a waiver of any right which that party has under this Agreement. 
 14.4 Severability. If any
provision of this Agreement is held to be invalid or unenforceable by an arbitration panel or court of competent jurisdiction, then (a) the validity and enforceability of the remainder of this Agreement shall in no way be affected or impaired
thereby and (b) such provision shall be enforced to the maximum extent possible so as to effect the intent of the parties and shall be reformed without further action by the parties to the extent necessary to make such provision valid and
enforceable. 
 14.5 Assignment. Licensee may not assign or delegate this Agreement or any of its rights or obligations hereunder
(whether voluntarily, by operation of law or otherwise) without the prior written consent of DSPG. If Licensee wishes to assign this Agreement to a party that is a successor-in-interest of Licensee as a result of any merger or reorganization of
Licensee or the sale by Licensee of all or substantially all of Licensee’s assets or equity, and such party is not a competitor to DSPG, in it’s technology licensing business, in DSPG’s reasonable judgment, then Licensee may provide
to DSPG a written list of Core Products that are generally commercially available prior to such merger, reorganization, or sale (collectively, “Pre-Existing Products”), in which case this Agreement may then be assigned in connection
with such merger, reorganization, or sale, and the assignee may exercise the rights and licenses granted under Section 3 solely with respect to such Pre-Existing Products as long as the assignee continues to pay royalties pursuant to
Section 6 and otherwise abides by the terms and conditions of this Agreement. Subject to the foregoing, the rights and liabilities of the parties hereto will bind, and inure to the benefit of, their respective successors and assigns. Any
attempted assignment or delegation in violation of this Section 14.5 shall be null and void. 
 14.6 Notices. All notices,
reports, requests, approvals, consents and other communications hereunder will be in writing and will only be effective: when delivered personally; when sent by facsimile with written verification of receipt; or three (3) days after deposit with a
reputable international commercial courier such as DHL or Federal Express specifying immediate delivery and with written verification of receipt. All such 

  

 15 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 
written communications will be sent to the parties at their respective addresses as set forth below, subject to the right of either party to change its
address by delivering written notice to the other in the manner set forth herein. 
  

							
	 For DSPG:
	 	 	  	 For Licensee:

	Attention:	 	Issachar Ohana	 		  	Attention: Renyong Fan, VP
	Address:	 	5 Shenkar Street	 		  	Operations
		 	Herzelia Pituach 46120	 		  	Address: 4701 Patrick Henry Drive,
		 	Israel	 		  	1401. Santa Clara, California 95054
	Tel:     972-9-9529618	 		  	Tel: 408 919 2809 x 102
	Fax:     972-9-9541234	 		  	Fax: 408 919 2810

 14.7 Publicity. The parties will issue a mutually agreeable press release to the general
public regarding the parties’ relationship under this Agreement at a time to be mutually determined, but in any event within ninety (90) days of the Effective Date. 
 14.8 Export Compliance. Licensee will comply with any and all U.S. export regulations and rules now in effect or as may be issued from time to
time, including without limitation, (a) all regulations and rules of the Bureau of Export Administration of the U.S. Department of Commerce and any other federal governmental authority that has jurisdiction relating to the export of technology
from the U.S., and (b) all export/reexport requirements of the U.S. Export Administration Regulations. Without limiting the generality of the foregoing, Licensee will not export, directly or indirectly, any Deliverables, Core Technology or Core
Products, in any form, to any country for which United States laws or regulations (i) require an export license or other governmental approval, without first obtaining such license or approval, or (ii) prohibit such export. Licensee hereby
agrees to indemnify and hold DSPG harmless from and against any losses, damages, penalties or causes of action resulting from Licensee’s breach of this Section 14.8. 
 14.9 Expert Advice. Each party acknowledges that it has consulted such legal, financial, technical, and other experts as it deems necessary or
desirable prior to entering into this Agreement. Each party represents and warrants that it has read, knows, understands, and agrees with the terms and conditions of this Agreement. Neither party has relied upon any oral representation of the other
party in entering into this Agreement. All discussions, estimates or projections developed by a party during the course of negotiation the terms and conditions of this Agreement are by way of illustration only and, unless specifically contained in
this Agreement or one of its Exhibits, are not binding or enforceable against the other party in law or in equity. 
 14.10 Force
Majeure. Except for payment of moneys due under this Agreement, neither party will be responsible for its failure to perform due to circumstances or causes beyond its reasonable control, including, without limitation, acts of God, wars, riots,
embargoes, acts of civil or military authorities, fires, floods, earthquakes, accidents, strikes, failure of suppliers or shortages of transportation, facilities, fuel or energy. 
  

 16 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 14.11 Counterparts. This Agreement may be executed in one or more counterparts, each of which shall constitute an original, but all of which together shall constitute one instrument. 
 14.12 Entire Agreement: Amendment. This Agreement constitutes the complete understanding and agreement of the parties and supersedes all prior and
contemporaneous negotiations, understandings and agreements with respect to the subject matter of this Agreement. Any modification or amendment of any provision of this Agreement will be effective only if in writing and signed by an authorized
representative of both parties. 
 [THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK] 
  

 17 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 IN WITNESS WHEREOF, the parties have executed this Agreement by their duly authorized representatives. 
  

							
	“DSPG”:	 	DSP GROUP, INC.	 	
				
		 	By:	 	 

	 	
		 	Printed Name:	 	EREZ AVIV	 	
		 	Title:	 	C.O.O	 	
			
		 	DSP GROUP, LTD.	 	
				
		 	By:	 	 

	 	
		 	Printed Name:	 	ISSACHAR OHAMA	 	
		 	Title:	 	V.P. Sales, Tech. Licensg Div	 	
			
	“Licensee”:	 	  	 	
				
		 	By:	 	 

	 	
		 	Printed Name:	 	PING WU	 	
		 	Title:	 	President	 	

  

 18 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 EXHIBIT A 
 Description of Core 
 TeakLite® is a high-performance, low
power, sub-micron, fully synthesizable (Soft Core) Digital Signal Processor (DSP) core designed for use in DSP based Application Specific ICs. TeakLite is targeted for the cellular communication market, Multimedia, as well as for speech/audio
applications. 
 TeakLite has been designed for an ASIC design environment (e.g. single-edge clocking, scan methodology, process and library independent,
etc.) TeakLite also has special proprietary mechanisms to reduce power consumption, and other micro-architecture modifications. 
  

 19 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 EXHIBIT B 
 Deliverables and Delivery Schedule 
 [***] 
  

 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	3.	Delivery Schedule 

 Item 1, 2.2 -2.4, 2.7-2.9 of this Exhibit B
will be delivered within 10 days of the Effective Date. 
 Item 2.1 of this Exhibit B and a preliminary version of Item 2.5 of this Exhibit B
reflecting DSPG’s available implementation will be delivered within 20 days of the Effective Date. 
 A preliminary version of Item 2.6 of this
Exhibit B will be delivered within 30 days of the completion of the statement of work by DSPG. 
 Final versions of Item 2.5 and 2.6 of this Exhibit B
will be delivered within 60 days of the completion of the statement of work by DSPG. 
  

 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 EXHIBIT C 
 Sublicense Agreement 
 This Sublicense Agreement (the “Agreement”) is made and entered into as of                     ,
             (the “Effective Date”) by and between,
                            , a
                                        
corporation having its principal place of business at ______________ 
 ________________________ (“Sublicensee”), and
                                        
                , a                      corporation having
a principal place of business at
                                        
                     (“Licensee”). 
 Recitals 
 A. Licensee has entered into with DSP Group, a Delaware corporation and DSP Group Ltd., an Israeli corporation
(collectively “DSPG”) that certain License Agreement dated as of                     ,
             (“the License Agreement”), whereby DSPG granted to Licensee a limited right to license the materials relating to DSPG’s digital signal processing core
named                     , (the “Core”) set forth in Attachment 1 (the “Deliverables”) to approved third parties.

 [Licensee Customers:] 
 B. Sublicensee
wishes to purchase from Licensee the integrated circuit device described in Attachment 2, which combines one or more implementations of the Core with application specific or user specific circuitry and which will be manufactured by Licensee (the
“Core Product”). 
 C. Sublicensee wishes to use the Deliverables for the purpose of designing and/or developing the Core Product
(the “Work”). 
 [Subcontractors:] 
 B. Licensee has developed or is developing the integrated circuit device described in Attachment 2, which combines one or more implementations of the Core with application specific or user specific circuitry (the “Core Product”),
and Licensee wishes to engage Sublicensee to 
 [Software Subcontractors:] write software applications for Licensee that utilize or
otherwise interact with implementations of the Core on the Core Product (the “Work”). 
 [Hardware Subcontractors:] design
circuit boards for Licensee that incorporate the Core Product or development models thereof (the “Work”). 
  

 22 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 [Fabrication Subcontractors:] manufacture the Core Product for Licensee (the “Work”). 
 C. Sublicensee wishes to
use the Deliverables in the performance of the Work. 
 NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter
contained and other valuable consideration the receipt and adequacy of which is hereby acknowledged, Licensee and Sublicensee agree as follows: 
 Agreement 
 1. Sublicense Grant. Subject to the terms and conditions of this Agreement, Licensee hereby grants to
Sublicensee the limited, nonexclusive, nontransferable, personal right to use the Deliverables for the sole purpose of performing the Work. 
 2. Sublicense Restrictions. Sublicensee will not (a) transfer, sublicense, translate, create derivative works of or otherwise modify, copy or reproduce any Deliverable or any other element of the Core, except as expressly set
forth in Section 1, (b) decompile, reverse engineer or disassemble any Deliverable or any other element of the Core, or (c) remove, obscure or alter any trademarks or proprietary rights or ownership notices from any Deliverable.

 3. Proprietary Information. “Proprietary Information” means the Deliverables and all information that is either
(a) disclosed by Licensee to Sublicensee, whether in oral, written, graphic, electronic or other form or (b) learned by Sublicensee in connection with the Deliverables or the Work. Without limiting the generality of the foregoing,
Proprietary Information will be deemed to include without limitation, any trade secret, know-how, idea, invention (whether patentable or not), process, technique, algorithm, computer program (source and object code), design, schematic, drawing,
formula, data, product development plan, strategy, forecast and other technical, engineering, manufacturing, product, marketing, servicing, financial, personnel and other information and materials relating to the Core, DSPG or any of its employees,
consultants, investors, affiliates, customers, clients, vendors or suppliers. 
 4. Disclosure and Use. Sublicensee will maintain all
Proprietary Information in the strictest confidence for the sole benefit of Licensee and DSPG and will not disclose Proprietary Information to any third party. Proprietary Information may only be disclosed to the employees of Sublicensee who
(a) have a need to know and (b) have signed an agreement with Sublicensee binding them to all of the obligations of Sublicensee set forth in this Agreement. Sublicensee will protect the Proprietary Information with at least the same degree
of care as it uses for its own confidential and proprietary information, but in no case with any less than reasonable care. Sublicensee agrees not to use Proprietary Information other than as necessary to perform the Work. 
  

 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 5. Return of Proprietary Information. Upon termination of the Work, or upon Licensee’s or DSPG’s request, Sublicensee will promptly return to Licensee all Deliverables and other Proprietary Information, including copies and
extracts thereof. 
 6. Term and Termination. This Agreement will commence on the Effective Date and continue in effect until (a)
             (         ) months [ *** ] have elapsed, (b) the Work is completed or (c) the License Agreement
expires or is terminated, whichever occurs first. Either party may terminate this Agreement immediately if the other party defaults in the performance of any material provision of this Agreement and such defaulting party fails to cure such default
within fifteen (15) days of receiving written notice of such default. Upon the expiration or earlier termination of this Agreement, all rights and licenses granted to Sublicensee will terminate. The rights and obligations of the parties under
Sections 3-11 will survive any expiration or earlier termination of this Agreement. Termination of this Agreement will be without prejudice to any other remedy which may be available to a party due to default of this Agreement. 
 7. Ownership. Except for the rights and licenses expressly granted to Sublicensee in this Agreement, Licensee and DSPG, as applicable, will
reserve and retain all right, title and interest (including, without limitation, all intellectual property rights) in and to the Core, the Deliverables and the other Proprietary Information. Nothing contained in this Agreement will be construed as
conferring upon Sublicensee or any third party (by implication, operation of law, estoppel or otherwise) any license or right not expressly granted by Licensee in this Agreement. 
 8. Remedies. Sublicensee acknowledges and agrees that due to the unique nature of the Proprietary Information, there can be no adequate remedy at
law for any breach of their obligations under this Agreement, that any such breach may allow Sublicensee or third parties to unfairly compete with Licensee or DSPG resulting in irreparable harm and significant injury to Licensee or DSPG, which may
be difficult to ascertain, and therefore, that upon any such breach or any threatened breach thereof, Licensee will be entitled to seek from any appropriate court or tribunal in any appropriate jurisdiction an immediate injunction, temporary
restraining order and/or other appropriate equitable relief, in addition to whatever remedies it might have at law. Sublicensee will notify Licensee and DSPG in writing immediately upon the occurrence of any such unauthorized release or other
breach. 
 9. Disclaimer of Warranties. LICENSEE MAKES NO WARRANTY TO SUBLICENSEE OF ANY KIND WITH REGARD THE CORE, THE DELIVERABLES
OR ANY OTHER PROPRIETARY INFORMATION. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, LICENSEE EXPRESSLY DISCLAIMS ANY OTHER WARRANTIES, EXPRESS, STATUTORY OR IMPLIED, INCLUDING BUT NOT LIMITED TO ANY WARRANTIES OF NON-INFRINGEMENT OF THIRD PARTY
RIGHTS, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, WHETHER ARISING OUT OF LAW, CUSTOM, CONDUCT, OR 

  

 24 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 
OTHERWISE. Sublicensee acknowledges that nothing in this Agreement shall impose on DSPG or create for DSPG any liability of any kind (whether express,
implied, statutory, or other) to Sublicensee or any other person. 
 10. Third Party Beneficiary. Licensee and Sublicensee acknowledge
and agree that DSPG is an intended third party beneficiary of Sublicensee’s obligations under this Agreement, and that DSPG will have the right, to the same extent as Licensee, to take legal action against any breach by Sublicensee of such
obligations and to otherwise enforce such obligations. 
 11. General Provisions. This Agreement represents the entire agreement
between Licensee and Sublicensee and supersedes all prior agreements and understandings, whether written or oral, with respect to all matters covered in this Agreement. This Agreement will not be altered, modified, or amended in any respect except
by a writing signed by each party. This Agreement is to be construed in accordance with and governed by the internal laws of the State of California (as permitted by Section 1646.5 of the California Civil Code or any similar successor
provision) without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of California to the rights and duties of the parties. Nothing in this Agreement is
intended or will be construed to give any person (other than Licensee, Sublicensee and DSPG) any legal or equitable right, remedy or claim under this Agreement or any provision hereof. Sublicensee may not assign this Agreement or any of its rights
or obligations hereunder, whether voluntarily, by operation of law or otherwise. Failure by either party to enforce at any time or for any period of time the provisions of this Agreement will not be construed as a waiver of such provisions, and will
in no way affect such party’s right to later enforce such provisions. If any part of this Agreement is determined by any court of competent jurisdiction to be unenforceable for any reason, such unenforceability will not affect the balance of
this Agreement, and the unenforceable provision will be changed and interpreted so as to best accomplish the objectives of such provision within the limits of applicable law. 
 IN WITNESS WHEREOF, the parties have executed this Agreement by their duly authorized representatives. 
  

									
	SUBLICENSEE:	 		  	LICENSEE:
	  	 		  	  
					
	Signature:	 	  	 		  	Signature:	  	  

									
	Name:	 	  	 		  	Name:	  	  

									
	Title:	 	  	 		  	Title:	  	  

  

 25 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 ATTACHMENT 1 
 Deliverables 
 [Licensee Customers:] 
 Hardware Tools: 
 Software Tools: 
 Documentation: 
 Other: encrypted RTL for the Core 
 [Software Subcontractors:] 
 Hardware Tools: 
 Software Tools: 
 Documentation: 
 [Hardware Subcontractors:] 
 Hardware Tools: 
 Documentation: 
 [Fabrication Subcontractors:] 
 Masks: 
 ATTACHMENT 2 
 Core Product 
  

 26 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 EXHIBIT D 
 DSPG Marks and Trademark Usage Guidelines 
 DSPG Marks 
 Teak® 
 TeakDSPCore® 
 TeakLite® 
 PalmDSPCore® 
 OakDSPCore® 

OCEM® 
 SmartCoresTM 
 Trademark Usage Guidelines 
 1. With respect to any
document or other material on which Licensee uses any DSPG Mark, Licensee must place the “TM” or “®” symbol, as may be applicable, directly after the first prominent use (e.g., in a title, headline, tagline, paragraph
heading, etc.) of the DSPG Mark and directly after its first use in the text or body copy. 
 2. With respect to any document or other
material on which Licensee uses any DSPG Marks, Licensee will provide notice that the DSPG Marks are the trademarks of DSP Group, Inc. Such notice shall be in the following format: “[DSPG Mark] is a [registered] trademark of DSP Group,
Inc.” 
 3. No Documentation, DSPG Collateral Materials or Licensee Collateral Materials shall confuse or misrepresent the fact that DSP
Group, Inc. and DSP Group, Ltd. have developed and own certain right, title and interest in and to the Core Technology, the associated intellectual property rights and the DSPG Marks. 
 4. No Documentation, DSPG Collateral Materials or Licensee Collateral Materials shall state or imply that the Core Products are warranted or otherwise
sponsored or endorsed by DSP Group, Inc. or DSP Group, Ltd. 
 5. Licensee will label all Core Products in a reasonably prominent manner with
the appropriate DSPG Mark indicating the Core(s) that the Core Product implements. 
  

 27 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 6. DSPG may amend these guidelines as necessary or desirable to protect the rights of DSPG in and to the Core Technology, the associated intellectual property rights and the DSPG Marks. 
  

 28 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 EXHIBIT E 
 Modification Guidelines 
 1. All modifications made by Licensee to the Documentation and DSPG Collateral Materials pursuant to this Agreement must be factually and technically accurate. If the content of any Documentation or DSPG Collateral
Materials is modified in any way from its original form as delivered to Licensee by DSPG, Licensee will prominently state in such materials that neither DSP Group, Inc. nor DSP Group, Ltd. makes any representations or warranties with respect to the
accuracy, validity, content or completeness of such materials. 
 2. Licensee will duplicate and apply DSPG’s patent and other
proprietary rights and ownership notices that DSPG may provide to Licensee from time to time on all Documentation and DSPG Collateral Materials. 
 3. Subject to the foregoing, Licensee may substitute references to the name of DSPG in the DSPG Collateral Materials with the name of Licensee to identify Licensee as the manufacturer of the Core Products described in such DSPG Collateral
Materials. 
 4. DSPG may amend these guidelines as necessary or desirable to protect the rights of DSPG in and to the Core Technology, the
associated intellectual property rights and the DSPG Marks. 
  

 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 AMENDMENT TO LICENSE AGREEMENT 
 This Amendment (this “Amendment”) is made effective as of June 12, 2003 (the
“Amendment Effective Date”) by and between, as one party, ParthusCeva Technologies Inc., a Delaware corporation having a place of business at: 2033 Gateway Place, Suite 150, San Jose, CA 95110 and ParthusCeva Ltd. an Israeli corporation
having a place of business at 5 Shenkar Street, Herzelia Pituach 46120, Israel (collectively, “ParthusCeva”), and Spreadtrum Communications, Inc. a Cayman Corporation, with a principal address of Ugland House, P.O. Box, George Town, Grand
Cayman, Cayman Islands, British West Indies, on behalf of itself and its wholly-owned subsidiaries, Spreadtrum Communications, Corp., a California corporation having a principal place of business at 810 East Arques Ave., Sunnyvale, California 94085,
and Spreadtrum Communications Shanghai Corp, a Chinese corporation having a principal place of business at 439 Chunxiao Road, Building No. 2, Zhangjiang Hi-Tech Park, Pudong, Shanghai, China 201203 (collectively, “Licensee”).

 RECITALS 
 A. Licensee
and DSP Group Inc. and DSP Group Ltd. (collectively, “DSPG”) entered into a License Agreement dated October 5, 2001 (the “License Agreement”), pursuant to which DSPG has licensed to Licensee rights in the TeakLite core and
related technology. 
 B. ParthusCeva, the successor to DSPG’s core licensing business, has the right to license the digital signal
processing cores known as the Teak. 
 C. The parties wish to amend the License Agreement to grant to Licensee a license to rights in the
Teak under terms and conditions that are comparable to Licensee’s license to the TeakLite and to grant to Licensee an option to license the XpertTeak under terms and conditions that are comparable to Licensee’s license to the TeakLite.

 NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, the parties hereto, intending to be legally
bound, hereby agree as follows: 
 AGREEMENT 
  

	1.	Continuation of Provisions 

 Except as expressly set
forth herein, all other terms and conditions of the License Agreement shall remain in full force and effect. In tfie event of any inconsistency or conflict between this Amendment and the License Agreement, the terms, conditions and provisions of
this Amendment shall supercede the License Agreement and shall govern and control. 
  

 1 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	2.	Additional Definitions 

 2.1. “Architecture
Specification” shall mean: with respect to TeakLite, the architecture specification for the Core described in Item 1.1 of Exhibit B to the License Agreement, with respect to the Teak, the architecture specification for the Core
described in Item 1.1 of Exhibit A to this Amendment, and if the [***] Option has been exercised, with respect to the [***], the architecture specification for the Core described in Item 1.1 of Exhibit B to this Amendment. 
 2.2. “Core” means each and any of the Teak or TeakLite digital signal processing cores, and only if the [***] Option is exercised, the
[***]. 
 2.3. “Design/Fabrication Materials” means each and any of the materials set forth in Item 2 of Exhibit B to
the License Agreement, the items described in Item 2 of Exhibit A to this Amendment, and if the [***] Option has been exercised, the items described in Item 2 of Exhibit B to this Amendment. 
 2.4. “Documentation” means each and any of the materials set forth in Item 1 of Exhibit B to the License Agreement, the items
described in Item 1.1 of Exhibit A to this Amendment, and if the [***] Option has been exercised, the items described in Item 1.1 of Exhibit B to this Amendment. 
 2.5. “Initial Product” means two end products which incorporate a physical implementation of the TeakLite (or the Teak if the Initial
Product has been upgraded pursuant to Section 4.2(d) or the [***], if Initial Product has been upgraded pursuant to Section 4.2(d) and the [***] Option has been exercised by Licensee) that are designated in writing by Licensee and approved
in writing by ParthusCeva. 
 2.6. “Initial Teak Products” means two end products which incorporate a physical
implementation of the Teak (or the [***] if the [***] Product has been upgraded pursuant to Section 4.2(e) and the [***] Option has been exercised by Licensee) that are designated in writing by Licensee and approved in writing by ParthusCeva.

 2.7. “Teak” means the Teak®, a high performance, low power, sub-micron, fully synthesizable digital signal processing
core. Teak is a dual MAC machine with additional architecture enhancements. Teak has been designed for an ASIC design environment (single-edge clocking, scan methodology, fully synthesizable, etc.). 
 2.8. “TeakLite” means the digital signal processing core described in Exhibit A to the License Agreement. 
  

 2 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 2.9. “Teak Technology” means the technology incorporated or embodied in the Teak and the deliverables listed in Exhibit A to this Amendment. 
 2.10. “[***]” means the [***], a highly integrated, low power, general purpose DSP platform based on the Teak. In addition to the Teak DSP core, the [***] consists of a DMA controller, buffered serial
port, parallel host interface, general purpose I/O, on-chip emulator, memory interface unit, and power down unit. 
 2.11. “[***]
Option” shall have the meaning set forth in Section 6 of this Amendment. 
 2.12. “[***] Technology” means the
technology incorporated or embodied in the [***] and the deliverables listed in Exhibit B to this Amendment. 
 2.13. Other Terms.
Except as expressly defined or otherwise modified herein, all capitalized terms in this Agreement have the same meanings as set forth in the License Agreement. 
  

	3.	Amendment 

 3.1. Section 6.4 of the License
Agreement shall be replaced in its entirety with the following: 
 6.4. Additional
Designated Applications. Licensee may designate additional single physical implementations of the TeakLite, Teak or [***] (if Licensee has exercised the [***] Option described in Section 5 of the Amendment) on single end products beyond the
Initial Products or Initial Teak Products as Designated Products, provided that (a) each additional product is
approved in writing by ParthusCeva, such approval not to be unreasonably withheld or delayed, and (b) Licensee pays to ParthusCeva an additional fee of: [ *** ] if the Core implemented is the TeakLite, [ *** ] if the Core
implemented is the Teak, or [ *** ] if the Core implemented is the [***]. If Licensee chooses to implement multiple Cores on a single end product, then Licensee shall pay an additional fee equal to the highest fee for a Core implemented on
the end product, but no fees for the other Cores implemented (e.g., if Licensee implements both the TeakLite and the [***] on a single end product, then the total fee would be [ *** ]). 
  

	4.	Additional Terms 

 4.1. Extension of Terms.
The terms and conditions of the License Agreement, excluding Sections 2, 5, 6.1, 6.3, and 6.5 (collectively, the “Excluded Sections”) will be deemed to apply to Teak (and [***] if and when Licensee exercises the [***] Option) to the same
extent as they apply to TeakLite, and to the Teak Technology (and [***] Technology if and when Licensee exercises the [***] Option) to the 

  

 3 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 
same extent as they apply to the Core Technology. Without limiting the generality of the foregoing, the terms, “Core” and “Core
Technology” wherever used in the License Agreement (except the Excluded Sections) or this Amendment, will be deemed to include Teak and Teak Technology, respectively (and the [***] and [***] Technology, respectively, if and when Licensee
exercises the [***] Option). 
 4.2. Additional Terms for Teak and XpertTeak. 
 (a) Delivery. Within ten (10) days of the Amendment Effective Date, ParthusCeva will deliver to Licensee the Teak deliverables listed in
Exhibit A. If Licensee exercises the [***] Option, ParthusCeva will deliver to Licensee the [***] deliverables listed in Exhibit B within tea (10) days of such exercise. 
 (b) Teak and TeakLite (“TeakDSPCore”) Support. ParthusCeva will provide Licensee with support for the TeakDSPCore as set forth in
Sections 5.1 (a)-(c) of the License Agreement as such terms apply to support for the TeakLite. Starting on the Amendment Effective Date, ParthusCeva will provide such support for an initial term of twenty four (24) months. Thereafter,
Licensee may renew such support for additional twelve (12) month terms if Licensee provides ParthusCeva with written notice of renewal at least thirty (30) days prior to the end of the initial or any renewal support term. Licensee will pay
for such TeakDSPCore support at a rate of [ *** ] for such support, provided that the first twelve (12) months of support shall be free of charge. Such support payments are payable in quarterly installments, and will start on the
Amendment Effective Date. 
 (c) [***] Support. If and when Licensee exercises the [***] Option, ParthusCeva will provide Licensee with
support for the [***] as set forth in Sections 5.1 (a)-(c) of the License Agreement as such terms apply to support for the TeakLite. Starting on the date the [***] Option is exercised, ParthusCeva will provide such support for an initial term
of twelve (12) months. Thereafter, such support will automatically renew for additional twelve (12) month terms unless Licensee provides ParthusCeva with written notice of non-renewal at least thirty (30) days prior to the end of the
initial or any renewal support term. Licensee will pay for such [***] support at a rate of [ *** ]. Such support payments are payable in quarterly installments, and will start on the first date of exercise of the [***] Option. 

 

 4 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 (d) Initial Product Upgrade. Licensee represents to ParthusCeva that is has developed only one of the two Initial Products permitted to Licensee under the License Agreement. Licensee may implement either the Teak or the [***] (if
Licensee has exercised the [***] Option) in its remaining Initial Product rather than the TeakLite. Should Licensee choose to do so, Licensee will designate the Initial Product for the upgrade, subject to ParthusCeva’s approval (not to be
unreasonably withheld or delayed), and pay an upgrade fee of [ *** ] in the case of Teak or [ *** ] in the case of [***]. 
 (e) Initial Teak Product Upgrade. Licensee may implement the [***] (if Licensee has exercised the [***] Option) in either or both of the Initial Teak Products rather than the Teak. Should Licensee choose to do so, Licensee will
designate the Initial Teak Product for the upgrade, subject to ParthusCeva’s approval (not to be unreasonably withheld or delayed), and pay an upgrade fee of [ *** ] for each such Initial Teak Product that Licensee chooses to upgrade
to the [***]. 
 (f) Royalty Modifications. Licensee shall pay royalties for each implementation of Teak and [***] (if Licensee
exercises the [***] Option) as set forth in Section 6.2 of the Agreement. The Teak and [***] shall be considered separate and distinct Cores for the purposes of royalties and royalty scale in Section 6.2 shall apply separately to each of
the TeakLite, Teak and [***]. If, after the Amendment Effective Date, Licensee develops and manufactures a Core Product that implements multiple Cores on such single end product, then Licensee shall pay royalties for each implementation of a Core as
set forth in Section 6.2 of the Agreement, provided that the royalty for the second implementation on a unit will be equal to [ *** ] of the amount set forth in Section 6.2 of the Agreement (e.g., if the royalty rate were
[ *** ] per implementation and a Core Product has two implementations of the Core, then the royalties would be [ *** ]). 
  

	5.	Payment 

 5.1. License Fee for Teak. Licensee
will pay ParthusCeva a total license fee of [ *** ] for [ *** ] Initial Teak Products, payable as follows: 
  

	 	(a)	[ *** ] 

  

 5 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	 	(b)	[ *** ] 

  

	6.	[***] Option 

 Licensee will have the option to
license the [***] (the “[***] Option”) in accordance with the terms of this Section 6. The [***] Option will be exercisable by Licensee by either (a) opting to upgrade the Initial Product or an Initial Teak Product pursuant to
Sections 4.2(d) or 4.2(e) and paying ParthusCeva the upgrade fees set forth in those sections or (b) licensing the [***] for use in a Designated Product as set forth in Section 6.4 of the License Agreement and paying the designation fee, as
amended. 
  

	7.	General 

 7.1. Authorization. Each party
represents and warrants that it possesses the right and capacity to enter into this Amendment. Each party represents and warrants to the other party that this Amendment has been duly authorized, executed and delivered by it and constitutes its valid
and legally binding agreement with respect to the subject matter contained herein. 
 7.2. Entire Agreement. The License Agreement, as
amended by this Amendment, constitutes the complete and exclusive statement of the agreement between the parties and supersedes all prior and contemporaneous proposals and understandings, oral and written, relating to the subject matter contained
therein. 
 IN WITNESS THEREOF, the parties have executed this Amendment by their duly authorized representatives. 
  

									
	 Spreadtrum Communications, Inc.
	 		 	ParthusCeva Technologies, Inc.
			
	 

	 		 	 

			
	 PING WU
	 		 	 ISSACHAR OHAMA

	 Printed Name
	 		 	Printed Name
	 Title
	 	President	 		 	Title	 	VP Sales

  

 6 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

					
	Date 6/12/2003	 	Date June 12, 2003
		
		 	ParthusCeva Ltd.
		
		 	 

		
		 	 Chet Silvestri

		 	Printed Name
		 	Title	 	President/CEO
		 	Date	 	6/13/2003

  

 7 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Exhibit A 
 [***] 
  

 8 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Exhibits B 
 [***] 
  

 9 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

					
		 		 	 ParthusCeva Technologies Inc.
 2033 Gateway Place,
Suite 150
 San Jose, CA 95110 USA

			
		 		 	 ParthusCeva Ltd.
 5 Shenkar Street
 Herzelia Pituach 46120 Israel

 Spreadtrum Communications, Inc. 
 810 East Arques Ave. 
 Sunnyvale, CA 94085 
 Dear Ping Wu, 
 This letter is in regard to certain
payments to be made under the amendment dated 6/12/2003 (the “Amendment”) to the license agreement (the
“License Agreement”) dated October 5, 2001 between Spreadtrum Communications, Inc., on behalf of itself and its wholly-owned subsidiaries, Spreadtrum Communications, Corp., and Spreadtrum Communications Shanghai Ltd (collectively,
“Spreadtrum”) and ParthusCeva Technologies Inc and ParthusCeva Ltd. (collectively, “ParthusCeva”). Any capitalized terms used in this letter shall have the same definitions as in Amendment and the License Agreement. 

Under Section 5.1 of the Amendment, Spreadtrum is to make certain payments to ParthusCeva as a license fee for the use of the Teak. Spreadtrum
and ParthusCeva agree to the following: 
  

	 	•	 	 If Spreadtrum, one year after the Amendment Effective Date, has not conducted any development or design activities (for commercial tape-out, shuttle, or otherwise)
for any Core Product (including the Initial Teak Product) during such one-year period, then the fees paid under Section 5.1 of the Amendment shall be deemed prepaid royalties creditable against Spreadtrum’s royalty obligations under
Section 6.2 of the License Agreement. 

  

	 	•	 	 If Spreadtrum, one year after the Amendment Effective Date, has conducted development or design activities during such one-year period (for commercial tape-out,
shuttle, or otherwise) for a Core Product that implements TeakLite but not for an Initial Teak Product, then [ *** ] of the fee paid under Section 5.1 of the Amendment shall be deemed prepaid royalties creditable against
Spreadtrum’s royalty obligations under Section 6.2 of the License Agreement. 

 The Amendment, License Agreement,
and this letter serve to document the entire understanding relating to the subject matter hereof, and terminates, supersedes, and replaces any prior or contemporaneous agreements, negotiations or understandings (whether oral or written), relating to
the same subject matter. No amendment or modification to any of the terms hereof will be valid or binding unless made in writing and signed by duly authorized representatives of the parties. 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 If this letter agreement is consistent with your understanding and intent, please so indicate by signing in the space provided below. 
  

			
	Sincerely,
	
	ParthusCeva Technologies Inc.
		
	By:	 	 

	Title:	 	VP Sales
	
	ParthusCeva Limited
		
	By:	 	 

	Title:	 	President / CEO

  

			
	AGREED TO AND ACCEPTED BY:
	
	Spreadtrum Communications, Inc.
		
	By:	 	 

	Title:	 	President
	Date:	 	6/12/2003

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

					
		 		 	 ParthusCeva Technologies Inc.
 2033 Gateway Place,
Suite 150
 San Jose, CA 95110 USA

			
		 		 	 ParthusCeva Ltd.
 5 Shenker Street
 Herzelia Pituach 46120 Israel

 Spreadtrum Communications, Inc. 
 810 East Arques Ave. 
 Sunnyvale, CA 94085 
 Dear Ping Wu, 
 This letter serves to document the understanding and agreement between the parties to revoke the letter dated
June 12, 2003 (the “Side Letter”), in regard to certain payments to be made under the amendment dated June 12, 2003 (the “Amendment”) to the license agreement dated October 5, 2001 (the “License
Agreement”) between Spreadtrum Communications, Inc., on behalf of itself and its wholly-owned subsidiaries, Spreadtrum Communications, Corp., and Spreadtrum Communications Shanghai Ltd (collectively, “Spreadtrum”) and ParthusCeva
Technologies Inc. and ParthusCeva Ltd. (collectively, “ParthusCeva”). A copy of the Side Letter is attached hereto 
 Therefore, as of the date
hereof, the Side letter shall be no longer valid and shall be considered null and void. It is acknowledged that in view of the revocation of the Side Letter the License Agreement and the Amendment reflect the entire understanding between the parties
relating to the subject matter hereof. 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 If this
letter agreement is consistent with your understanding and intent, please so indicate by signing in the space provided below. 
  

									
	 Sincerely,
	 		 		 		 	
				
	

	 		 		 	
				
	ParthusCeva Technologies Inc.	 		 		 	
					
		 		 		 	By:	 	 

		 		 		 	Title:	 	 PRESIDENT & CEO

					
	ParthusCeva Limited	 		 		 		 	
					
		 		 		 	By:	 	  

		 		 		 	Title:	 	  

  

			
	AGREED TO AND ACCEPTED BY:
	
	Spreadtrum Communications, Inc.
		
	By:	 	 Ping Wu                

	Title:	 	President
	Date:	 	1st October, 2003

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 FOURTH AMENDMENT TO LICENSE AGREEMENT 
 This Fourth Amendment to License Agreement (“Fourth Amendment”) is made effective
as of September 30, 2005 (the “Fourth Amendment Effective Date”) by and between, as one party, Ceva Technologies Inc., having a place of business at 2033 Gateway Place, Suite 150, San Jose, CA 95110 and Ceva DSP Ltd.,
having a place of business 2 Maskit Street, P.O.B. 2068, Herzelia 46120, Israel (collectively, “Ceva”) and Spreadtrum Communications, Inc., having a place of business at Ugland House, P.O.Box, Georgetown, Grand Cayman, Cayman
Islands, British West Indies, on behalf of itself and its wholly-owned subsidiaries, Spreadtrum Communications Corp., having a place of business at 810 East Arques Ave., Sunnyvale, California 94085, and Spreadtrum Communications (Shanghai)
Co., Ltd., having a place of business at 696 Songiao Road, 3-5F, Zhangjiang Hi-Tech Park, Pudong, Shanghai, China 201203 (collectively, “Licensee”). 
 RECITALS 
 Licensee and DSP Group Inc. and DSP Group Ltd. (collectively, “DSPG”) entered into a
License Agreement dated October 5, 2001 (“License Agreement”), pursuant to which DSPG has licensed to Licensee rights in the TeakLite core and related technology. 
 Licensee and ParthusCeva (now known as Ceva), the successor to DSPG’s core licensing business, amended the License Agreement by Amendment to License
Agreement dated June 12, 2003 (the “First Amendment”) to include the license to the Teak core to Licensee, and an option to the [***] Core, by the Letter Amendment dated June 12, 2003 (the “Second Amendment”) to include
additional terms regarding Section 5.1 of the First Amendment, and by the Letter Amendment dated October 1, 2003 (the “Third Amendment”) to cancel the Second Amendment. 
 Licensee and Ceva wish to amend the License Agreement and its amendments, to grant to Licensee an additional license rights in the Ceva-X1620 Core and in
the related Ceva-XS1200 Sub-system under the same terms and conditions of the License Agreement unless otherwise expressly provided under this Fourth Amendment, all as set forth in this Fourth Amendment. 
 NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth hereunder, the parties hereby agree as follows: 
 AGREEMENT 
  

	I.	Continuation of Non- contradicting Provisions of License Agreement 

  

	1.1.	 Except as expressly set forth hereunder, all other terms and conditions of the License Agreement and its amendments, shall remain in force and effect. In the

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	 	 
event of any inconsistency or conflict between this Fourth Amendment and the License Agreement and its amendments, the terms and conditions of the Fourth
Amendment shall govern and control. 

  

	2.	Additional/Amended Definitions 

  

	2.1.	The terms “Core”, “Core Product”, “Architecture Specification”, “Core Technology”, “Deliverables”, “Design/Fabrication
Materials” and “Documentation”, as defined in Section 1.1 of the License Agreement (and in Section 2 of the First Amendment, shall also include, when applicable, the Ceva-XI620 Core and the related Ceva-XS1200
Sub-system licensed to Licensee under this Fourth Amendment and the related deliverables, as set forth in the attached Exhibit A. 

  

	2.2.	“Ceva-X1620 Core” the core as defined in the architecture specification of the CEVA-X 1620 as listed in Exhibit A. 

  

	2.3.	“Ceva-XS1200 Sub-system” (“Sub-system”): shall mean a set of peripherals for the Ceva-X1620 Core as described in the attached Exhibit Al.

  

	2.4.	“Initial Ceva-X1620 Products” shall mean the first two end products which incorporate a physical implementation of the Ceva-X1620 Core and the Sub-system that are
designated in writing by Licensee and approved in writing by Ceva, the first of such two end products shall be a replacement of the second Initial Teak Product ( the “First Ceva-X1620 Product”). 

  

	2.5.	Section 6.4 of the License Agreement shall be replaced in its entirety with the following: 

 “Additional Designated Applications. Licensee may designate additional single physical
implementations of the TeakLite, Teak, [***] (if Licensee has exercised the [***] Option described in Section 5 of the Second Amendment) or the Ceva-X1620 Core and Sub-system on single end products beyond the Initial Products or Initial Teak
Products or Initial Ceva-X1620 Products, as Designated Products, provided that (a) each additional product is approved in writing by Ceva, such approval not to be unreasonably withheld or delayed, and (b) Licensee pays to Ceva an
additional fee of: [ *** ] if the Core implemented is the TeakLite, [ *** ] if the Core implemented is the Teak, [ *** ] if the Core implemented is the [***] and [ *** ] if the Core implemented is the
Ceva-Xl620 Core. If Licensee chooses to implement multiple Cores on a single end product, then Licensee shall pay an additional fee equal to the highest fee for a Core implemented on the end product, but no fees for the other Cores implemented
(e.g., if Licensee implements both the TeakLite and the [***] on a single end product, then the total fee would be [ *** ]). Except as expressly defined or otherwise modified herein, all capitalized terms in this Agreement have the same
meanings as set forth in the License Agreement.” 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	3.	Amendment 

  

	3.1.	Extension and Exclusion of Terms. The terms and conditions of the License Agreement, excluding Sections 2 (Delivery), 5 (Technical Support), 6.1 (License Fee), 6.2
(Royalties), 6.3 (Support Fees) and 6.5 (Global Licensing Option) (collectively, the “Excluded Sections”), will be deemed to apply to Ceva-X1620 Core and Sub-system to the same extent as they apply to the other Cores (i.e. TeakLite, Teak
or [***]). 

  

	3.2.	Initial Teak Products Upgrade. Licensee represents to Ceva that it has developed only one of the two Initial Teak Products permitted to Licensee under the License Agreement.
As a partial consideration to obtaining the license of the Ceva-X1620 Core and Sub-system, Licensee agrees to waive the right to development or design activity with respect to the second Initial Teak Products immediately, and subject to the payment
of the License Fee for the Ceva-X1620 Core and Sub-system set below in Section 4.1, to implement the Ceva-X1620 and Sub-system in its remaining Initial Teak Product rather than the Teak to create the First Initial Ceva-X1620 Product.

  

	3.3.	Delivery. Within ten (10) days of this Fourth Amendment Effective Date, Ceva will deliver to Licensee the Ceva-X1620 Core deliverables and the Sub-system Deliverables
listed in Exhibit A and Al respectively of this Fourth Amendment. 

  

	 3.4.
	 Ceva-X1620 Core and Sub-system Support. Ceva will provide Licensee with technical support for the Ceva-X1620 Core
and Sub-system and Deliverables as set forth in Sections 5.1 (a)-(c) of the License Agreement as such terms apply to support for the Ceva-X1620 Core and Sub-system. Notwithstanding the foregoing, as part of the support services for the
Ceva-X1620 Core and Sub-system, Ceva shall provide Licensee with reasonable support in connection with Licensee’s efforts to port its existing software from the Teak or TeakLite Core to the Ceva-X1620 and Sub-system (“Porting
Support”). Such Porting Support shall be provided via email and telephone, and quarterly management meetings in Shanghai or California when such are necessary to review the Ceva-X1620 Core Product design and to define the necessary support
needs. Commencing on the delivery of the RTL for the Ceva-X1620 Core and Sub-system, Ceva will provide such support for an initial term of twenty four (24) months. Thereafter, Licensee may renew such support for additional twelve
(12) month terms if Licensee provides Ceva with written notice of renewal at least thirty (30) days prior to the end of the initial or any renewal support term. Licensee will pay for such Ceva-X1620 Core and Sub-system support at a rate of
[***] for such support. Such support payments are payable in quarterly installments, and will start on the Fourth Amendment Effective Date. 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	4.	Payment for the Ceva-X1620 Core and Sub-system and for Royalty Waiver 

  

	4.1.	License Fee for the Ceva-X1620 Core and Sub-system and for the Royalty Waiver. Licensee will pay Ceva a total non-refundable license fee and Royalty Waiver Fee as described
below in Section 4.2, of [***]. Such fees shall be made for the initial Ceva-X1620 Products (namely, for the First Ceva-X1620 Product, which is a substitute to the second Teak Product, as specified above, and the second Ceva-X1620 Product), and
for the said Royalty Waiver, due and payable as following: 

  

			
	 [***
	  	]
		
	 [***
	  	]

	 	

	 	*	For avoidance of doubt such payment includes all the Royalty Waiver Fees 

  

	4.2.	Royalty Modification - Royalty Waiver and New Rate for Core Products including for Ceva-X1620 Products. 

  

	1)	As of the Fourth Amendment Effective Date and subject to the payment of the License Fees for the Ceva-X1620 Core and Sub-system and the Royalty Waiver Fees as specified above,
Section 6.2 of the License Agreement shall be replaced in its entirety with the following Section 6.2 and the royalty rates for Core Products shall be amended as follows: 

 “6.2 As of the Fourth Amendment Effective Date and in addition to the License Fee for the Ceva-X1620 and Sub-system as set above, Licensee shall pay
non-refundable royalties for each implementation of the Core, as defined in the License Agreement and its amendments and this Fourth Amendment (i.e. TeakLite/Teak/[***] or Ceva-X1620 and Sub-system, as applicable) on each unit of Core Product (as
defined in the License Agreement, its amendments and this Fourth Amendment) (it being understood that a single unit of a Core Product may include one or more implementation of the Core(s) shipped or sold by or for Licensee(”Sold”) after
the Third Amendment Effective Date (except for such non commercial samples as specified in Section 6.2.3 of the original License Agreement). The royalty for each unit shall be calculated based on the NSP of the unit as follows: 
  

	 	•	 	 [***] 

 Notwithstanding the foregoing,
Licensee shall have no obligation to pay royalties for the first [***] implementations on Core Products that are Sold after the Fourth Amendment Effective date (Royalty Waiver). 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 For clarification purposes and for avoidance of doubt, the royalty obligations and rates for Core Products that were Sold before the Fourth Amendment Effective Date shall continue to be governed by the terms of the License Agreement (i.e.
Section 6.2 as amended by Section 4.2 of the First Amendment). 
 “NSP,” with respect to a unit of Core Product shipped
sold, or transferred by a unit, division, group, subsidiary or affiliate of Licensee (“Licensee Affiliate”), means the greater of (a) the transfer price of such unit and (b) the fair market value for such unit if purchased in an
arms-length transaction by an unrelated, unaffiliated party. “NSP,” with respect to a unit of Core Product shipped, sold, transferred, disposed of or otherwise distributed to a customer that is not a Licensee Affiliate, means the net sales
price of such unit exclusive of taxes, duties and commissions actually paid or credited. 
 Royalties will accrue on the date on which each
unit of the Core Product is shipped, sold, transferred, disposed of, or otherwise distributed by or for Licensee, or put to productive internal use by Licensee. Licensee shall pay the royalties to Ceva on a quarterly basis, with the royalties for
each calendar quarter to be paid within thirty (30) days of the end of such quarter. Licensee will submit, with the payment of the royalties, the report described in Section 7.1 of the License Agreement.” 
  

	5.	General 

  

	5.1.	The notice information provided in Section 14.6 of the License Agreement for Ceva shall be replaced with the following notice information: 

 For Ceva: 
 Attention: Sales Administration

 Address:2 Maskit Street, P.O.B. 2068 
 Herzelia Pituach 46120, Israel 
 Tel: +972-9-9613790 
 Fax: +972-9-9613890 
 Copy to: Legal Department 
 Tel: +972- 9- 9613 9752 
 FAX: +972-9-9613852

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	5.2.	Authorization. Each party represents and warrants that it possesses the right and capacity to enter into this Amendment. Each party represents and warrants to the other party
that this third Amendment has been duly authorized, executed and delivered by it and constituted its valid and legally binding agreement with respect to the subject matter constituted herein. 

  

	5.3.	The License Agreement and its Amendments, as amended by this Fourth Amendment constitutes the complete and exclusive statement of the agreement between the parties and supersedes
all prior and contemporaneous proposals and understandings, oral and written, relating to the subject matter contained therein. 

 IN WITNESS THEREOF, the parties have executed this Fourth Amendment by their duly authorized representatives. 
  

											
	Spreadtrum Communications, Inc.	 		 		 	Ceva Technologies, Inc.
				
	 

	 		 		 	 

	Name	 	Ping Wu	 		 		 	Name	 	Issachar Ohama
	Title	 	CEO/President	 		 		 	Title	 	VP. WW Sales
					
		 		 		 		 	Ceva DSP Ltd.
					
		 		 		 		 	 

		 		 		 		 	Name	 	
		 		 		 		 	Title	 	CEO

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Exhibit A 
 [***] 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 2.
Design Materials 
 [***] 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 EXHIBIT A1 
 [***] 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 FIFTH AMENDMENT TO LICENSE AGREEMENT 
 This Fifth Amendment to License Agreement (“Fifth Amendment”) is made effective as
of February 1st, 2006 (the “Fifth Amendment Effective Date”) by and between, as one party, Ceva Technologies Inc., having a place of business at 2033 Gateway Place, Suite 150, San Jose, CA 95110 and Ceva DSP Ltd., having
a place of business 2 Maskit Street, P.O.B. 2068, Herzelia 46120, Israel (collectively, “Ceva”) and Spreadtrum Communications, Inc., having a place of business at Ugland House, P.O.Box, Georgetown, Grand Cayman, Cayman Islands,
British West Indies, on behalf of itself and its wholly-owned subsidiaries, Spreadtrum Communications Corp., having a place of business at 810 East Arques Ave., Sunnyvale, California 94085, and Spreadtrum Communications (Shanghai) Co.,
Ltd., having a place of business at 696 Songtao Road, 3-5F, Zhangjiang Hi-Tech Park, Pudong, Shanghai, China 201203 (collectively, “Licensee”). 
 RECITALS 
 Licensee and DSP Group Inc. and DSP Group Ltd. (collectively, “DSPG”) entered into a
License Agreement dated October 5, 2001 (“License Agreement”), pursuant to which DSPG has licensed to Licensee rights in the TeakLite core and related technology. 
 Licensee and Ceva (under its former name, ParthusCeva), the successor to DSPG’s core licensing business, amended the License Agreement by Amendment
to License Agreement dated June 12, 2003 (the “First Amendment”) to include the license to the Teak core to Licensee, and an option to the [***] Core, by the Letter Amendment dated June 12, 2003 (the “Second Amendment”)
to include additional terms regarding Section 5.1 of the First Amendment, and by the Letter Amendment dated October 1, 2003 (the “Third Amendment”) to cancel the Second Amendment. 
 Licensee and Ceva amended the License Agreement by another Amendment to the License Agreement dated September 30, 2005 (the “Fourth
Amendment”) to grant to Licensee license rights in the Ceva-X1620 Core and in the related Ceva-XS1200 Subsystem, under the terms set forth in the said Fourth Amendment. 
 Licensee and Ceva wish to further amend the License Agreement and its amendments, to grant to Licensee license rights in the new [***] in replacement to
(and instead of) the rights granted to Licensee under the Forth Amendment regarding the Ceva-X1620 Core, such rights in the new [***] shall be provided under the same terms and conditions granted to Licensee regarding the Ceva-X1620 Core in the
Fourth Amendment, unless otherwise expressly provided under this Fifth Amendment, all as set forth in this Fifth Amendment. 
 NOW,
THEREFORE, in consideration of the mutual covenants and agreements set forth hereunder, the parties hereby agree as follows: 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 AGREEMENT 
 1. Continuation of Non- contradicting Provisions of License Agreement 
  

	1.1.	Except as expressly set forthhereunder, all other terms and conditions of the License Agreement and its amendments, shall remain in force and effect. In the event of any
inconsistency or conflict between this Fifth Amendment and the License Agreement and its amendments, the terms and conditions of the Fourth Amendment shall govern and control. 

 2. Additional/Amended Definitions 
  

	2.1.	The terms “Core”, “Core Product”, “Architecture Specification”, “Core Technology”,
“Deliverables”, “Design/Fabrication Materials” and “Documentation”, as defined in Section 1.1 of the License Agreement (and in Section 2 of the First Amendment, shall also include, when
applicable, the [ *** ] licensed to Licensee under this Fifth Amendment and the related deliverables, as set forth in the attached Exhibit A, and shall not include the Ceva-X1620 Core and related deliverables. 

  

	2.2.	“[ *** ]” the core as defined in the architecture specification of the [ *** ] as listed in Exhibit A. 

 3. Amendment 
  

	3.1.	Replacement of the Ceva-X1620 Core with the [ *** ]. As of this Amendment Effective date the term Ceva-X1620 wherever it appears in the Fourth Amendment shall be replaced
by the term [ *** ], and all terms and conditions that relate to the Ceva-X1620 (including the royalty terms as specified in Section 4.2 of the Fourth Amendment and the fees specified in Section 6.4 of the License Agreement
regarding Additional Designated Applications, as restated in Section 2.5 of the Fourth Amendment) shall be deemed to apply to the [ *** ] and to the [ *** ], as applicable, in stead of to the Ceva-X1620 and the Ceva-X1620
Deliverables. 

  

	3.2.	Following the execution of this Fifth Amendment, Licensee shall receive the [ *** ] set forth in the attached Exhibit A of this Fifth Amendment, according to the schedule
for delivery that will be mutually agreed by the parties. Licensee agrees that upon execution of this Amendment, the licenses granted to Licensee under the Fourth Amendment regarding the Ceva-X1620 core shall terminate forthwith and Licensee will
promptly return to Ceva all the Ceva-X1620 Deliverables (as defined in the Fourth Agreement), and all Confidential Information regarding the Ceva-X1620 Core and its related deliverables. 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 4.
General 
  

	4.1.	Authorization. Each party represents and warrants that it possesses the right and “capacity to enter into this Fifth Amendment. Each party represents and warrants to the
other party that this Fifth Amendment has been duly authorized, executed and delivered by it and constitutes its valid and legally binding agreement with respect to the subject matter contained herein. 

  

	4.2.	The License Agreement and its amendments, as amended by this Fifth Amendment constitutes the complete and exclusive statement of the agreement between the parties and supersedes all
prior and contemporaneous proposals and understandings, oral and written, relating to the subject matter contained therein. 

 IN WITNESS THEREOF, the parties have executed this Fifth Amendment by their duly authorized representatives. 
  

									
	Spreadtrum Communications, Inc.	 		 	Ceva Technologies, Inc.
			
	 

	 		 	 

	Name	 	Harry Qin	 		 	Name	 	
	Title	 	VP, Global BD	 		 	Title	 	CEO
				
		 		 		 	Ceva DSP Ltd.
				
		 		 		 	 Yaniv Aneli

		 		 		 	Name	 	
				
		 		 		 	 CEO

		 		 		 	Title	 	

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Exhibit A 
 [ *** ] 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SIXTH AMENDMENT TO LICENSE AGREEMENT 
 This Sixth Amendment to License Agreement (“Sixth Amendment”) is made effective as
of September 27, 2006 (the “Sixth Amendment Effective Date”) by and between, as one party, Ceva Technologies Inc., having a place of business at 2033 Gateway Place, Suite 150, San Jose, CA 95110 and Ceva DSP Ltd., having
a place of business 2 Maskit Street, P.O.B. 2068, Herzelia 46120, Israel (collectively, “Ceva”) and Spreadtrum Communications, Inc., having a place of business at Ugland House, P.O.Box, Georgetown, Grand Cayman, Cayman Islands,
British West Indies, on behalf of itself and its wholly-owned subsidiaries, Spreadtrum Communications Inc., having a place of business at 810 East Arques Ave., Sunnyvale, California 94085, and Spreadtrum Communications (Shanghai) Co Ltd.,
having a place of business at 696 Songtao Road, 3-5F, Zhangjiang Hi-Tech Park, Pudong, Shanghai, China 201203 (collectively, “Licensee”). 
 RECITALS 
 Licensee and DSP Group Inc. and DSP Group Ltd. (collectively, “DSPG”) entered into a
License Agreement dated October 5, 2001 (“License Agreement”), pursuant to which DSPG has licensed to Licensee rights in the TeakLite core (hard macro version) and related technology for certain single uses. 
 Licensee and Ceva, the successor to DSPG’s core licensing business, amended the License Agreement by Amendment to License Agreement dated
June 12, 2003 (the “First Amendment”) to include the license to the Teak core (now named Ceva-TeakTM) to Licensee, and an option to the [***] Core, by the Letter Amendment dated June 12, 2003 (the “Second
Amendment”) to include additional terms regarding Section 5.1 of the First Amendment, and by the Letter Amendment dated October 1, 2003 (the “Third Amendment”) to cancel the Second Amendment. 
 Licensee and Ceva amended the License Agreement by another Amendment to the License Agreement dated September 30, 2005 (the “Fourth
Amendment”) to grant to Licensee rights in the Ceva-X1620 core and in the related Ceva-XS1200 subsystem, under the terms set forth thereunder, and further amended by another Amendment to the License Agreement dated February 1, 2006 (the
“Fifth Amendment”) to grant to Licensee rights in the [ *** ] in replacement to the rights granted for the Ceva-X1620 core. 
 Licensee and Ceva wish to further amend the License Agreement and its amendments, to grant to Licensee an additional license rights in the Ceva-TeakLiteTM core, the [ *** ] and the Ceva-TeakTM core (all in Ceva RTL soft
versions) for [***] under the terms and conditions of the License Agreement and amendments and this Sixth Amendment. 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth hereunder, the parties hereby agree as follows: 
 AGREEMENT 
  

	1.	Continuation of Provisions of License Agreement 

  

	1.1.	Except as expressly set forth hereunder, all other terms and conditions of the License Agreement and its amendments, shall remain in force and effect. In the event of any
inconsistency or conflict between this Sixth Amendment and the License Agreement and its amendments, the terms and conditions of the Sixth Amendment shall govern and control. 

  

	2.	Additional/Amended Definitions 

  

	2.1.	The terms “Core”, “Core Product”, “Architecture Specification”, “Core Technology”,
“Deliverables”, “Design/Fabrication Materials” and “Documentation”, as defined in the License Agreement and in the amendments shall include when applicable, the Ceva-TeakTM Core and
Ceva-TeakLiteTM Core and [ *** ] (in Ceva [***] soft versions) licensed to Licensee under this Sixth Amendment, as set forth in the attached Exhibit A. 

  

	2.2.	“Ceva-TeakLiteTM Core Product” means any integrated circuit device designed, manufactured or marketed by or for Licensee that (a) combines one or more
Compliant Ceva-TeakLiteTM Core(s) with application-specific or user-specific circuitry that adds a substantial and significant amount of value and functionality to such Compliant Ceva-TeakLiteTM Core(s). 

  

	2.3.	[ *** ] Product” means any integrated circuit device designed, manufactured or marketed by or for Licensee that (a) combines one or more Compliant
[ *** ] with application-specific or user-specific circuitry that adds a substantial and significant amount of value and functionality to such Compliant [ *** ]. 

  

	2.4.	“Ceva-TeakTM Core Product” means any integrated circuit device designed, manufactured or marketed by or for Licensee that (a) combines one or more
Compliant Ceva-TeakTM Core(s) with application-specific or user-specific circuitry that adds a substantial and significant amount of value and functionality to such Compliant Ceva-TeakTM Core(s). 

  

	2.5.	[ *** ] Software Development Tools” means the development tools for the [ *** ] as defined in Exhibit A-4. 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 3.
Amendment 
  

	3.1.	License Grant for the Ceva-TeakLiteTM Core, the [ *** ] and the Ceva-TeakTM Core. Subject to the terms and conditions of the License Agreement and the Sixth
Amendment, Ceva hereby grants to Licensee a personal, nonexclusive, nontransferable, [***] term license to: 

  

	 	(a)	make changes to the [***] for the Ceva-TeakLiteTM Core the [ *** ] and the Ceva-TeakTM Core, provided that the resulting core is Compliant (as defined in the
License Agreement); 

  

	 	(b)	incorporate the [***] for the Ceva-TeakLiteTM Core, the [ *** ] and the Ceva-TeakTM Core and any changes made thereto pursuant to subsection (a) above, into
Licensee’s designs for Ceva-TeakLiteTM Core Products or [ *** ] or Ceva-TeakTMCore Products; 

  

	 	(c)	import, manufacture in different foundries and have manufactured such Ceva-Tektite Core Products and [ *** ] Core and Ceva-TeakTM Core Products;

  

	 	(d)	offer for sale, sell and otherwise distribute Ceva-TeakLiteTM Core Products and [ *** ] and Ceva-TeakTM Core Products, provided that prior to selling or
distributing any such Core Products, Licensee shall verify that each implementation of the Core contained in such Core Product is Compliant (as defined in the License Agreement). 

  

	3.2.	Ceva [***] Soft Version Security Measures. The Ceva [***] soft version of the Core(s) and all non-public information relating thereto, including without limitation the techniques,
algorithms, and processes contained in the Ceva [***] and in any part thereof, constitute trade secrets of Ceva and may be used by Licensee only in accordance with the terms of this Agreement. The Ceva [***] shall be treated by Licensee under the
highest confidentiality protection measures, at least in the same manner it uses to protect its own source code technologies, but in no event shall Licensee use less than reasonable care in protecting such [***]. Notwithstanding anything to the
contrary in this Agreement, Licensee shall be authorized to use the Ceva [***] only in the Licensee premises, unless Ceva authorizes otherwise in writing. Licensee shall not cause or authorize the unauthorized use, dissemination, or publication of
the Ceva [***], and shall take prompt and appropriate action to prevent any unauthorized use or disclosure of the Ceva [***] by Licensee’s employees. Licensee shall take all reasonable measures to prevent unauthorized access to the Ceva [***],
and shall instruct its employees not to copy the Ceva [***] on their own, and not to disclose the Ceva [***] to anyone not authorized to receive it and Licensee will promptly notify Ceva of any lost, or unauthorized use of the [***] and take all
reasonable steps to remedy such failures. 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	 3.3.
	 Delivery. Within ten (10) days of this Sixth Amendment Effective Date, Ceva will deliver to Licensee the
Ceva-TeakLiteTM Core (soft version) deliverables listed in Exhibit A-l of this Sixth Amendment and the [***] (soft version) deliverables listed in Exhibit A-2 of this Sixth Amendment and the Ceva-TeakTM Core (soft version) deliverables
listed in Exhibit A-3 of this Sixth Amendment. 

  

	3.4.	[***] Software Development Tools. Following the execution of this Sixth Amendment and subject to the terms of the License Agreement and the following amendments including
this Sixth Amendment, Licensee shall receive a license to use the [***] Software Development Tools listed in Exhibit A-4 at no additional charge. 

  

	 3.5.
	 License Fee for the Ceva-TeakLiteTM Core, the [***] and the Ceva-TeakTM Core. Licensee will pay
Ceva a non-refundable license fee of [***] for the licenses granted to Licensee in this Sixth Amendment with respect to the Ceva-TeakLiteTM Core, [***] and the Ceva-TeakTM Core. Such license fee is due immediately and payable as follows:

 [***] 
 [***]

  

	 3.6.
	 Royalty Rate Modification—New Royalty Rate for Core Products As of the Sixth Amendment Effective Date and
subject to the payment of the License Fees for the Ceva-TeakLiteTM Core, the [***] and the Ceva-TeakTM Core,
as specified above, Section 6.2 of the License Agreement shall be replaced in its entirety with the following Section 6.2 and the royalty rates for (all) Core Products shall be amended as follows: 

 “6.2. As of the Sixth Amendment Effective Date and in addition to the License Fee for the
Core(s), Licensee shall pay Ceva a non-refundable royalty for each implementation of the Core (i.e., Ceva-TeakLiteTM Core, [***], Ceva-TeakTM Core, and/or [***], as applicable), on each unit of a Core Product shipped, sold, transferred, disposed of, or otherwise distributed by or for Licensee, or put to productive internal use by Licensee
(“Sold”) after the Sixth Amendment Effective Date (except for such non commercial samples as specified in Section 6.2.3 of the original License Agreement). The royalty for each unit of the applicable Core Product ([***] Product/
Ceva-TeakTM Core Product and [***] Product shall be calculated as follows: 
  

	 	•	 	 [***] 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 [ *** ] 
 Notwithstanding the foregoing and for avoidance of doubt, the above terms are subject to the Royalty Waiver of
the Forth Amendment and Licensee shall have no obligations to pay royalties for the first [ *** ] implementations on Core Products that are Sold after the Forth Amendment Effective Date. 
 Royalties will accrue on the date on which each unit of each Core Product is shipped, sold, transferred, disposed of, or otherwise distributed by or for
Licensee, or put to productive internal use by Licensee. Licensee shall pay the royalties to Ceva on a quarterly basis, with the royalties for each calendar quarter to be paid within thirty (30) days of the end of such quarter. Licensee will
submit, with the payment of the royalties, the report described in Section 7.1 of the License Agreement.” 
  

	3.7.	Term. Notwithstanding any of the terms under the License Agreement and amendments, the term of this Sixth Amendment and the licenses granted to Licensee under this Sixth Amendment,
will be in effect for [***] commencing on the Sixth Amendment Effective Date, unless terminated earlier in accordance with Section 13 of the License Agreement. 

  

	3.8.	Authorization. Each party represents and warrants that it possesses the right and capacity to enter into this Amendment. Each party represents and warrants to the other party
that this Sixth Amendment has been duly authorized, executed and delivered by it and constitutes its valid and legally binding agreement with respect to the subject matter contained herein. 

  

	3.9.	Complete Agreement. The License Agreement and its amendments, as amended by this Sixth Amendment constitutes the complete and exclusive statement of the agreement between the
parties and supersedes all prior and contemporaneous proposals and understandings, oral and written, relating to the subject matter contained therein. 

 IN WITNESS THEREOF, the parties have executed this Sixth Amendment by their duly authorized representatives. 
  

									
	Spreadtrum Communications, Inc.	 		 	Ceva Technologies, Inc.
			
	 

	 		 	 

	Name	 	HARRY QIN	 		 	Name	 	Issachar Oham
	Title	 	UP. BD	 		 	Title	 	EVP WW Sales

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

			
	Ceva DSP Ltd.
	
	 

	Name	 	Gideon Wertheizer
	Title	 	CEO

 

 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Exhibit A-l 
 [***] 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 2.
Design Materials 
 [***] 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 4.
Implementation 
 [***] 
 5. Delivery Schedule

 All items in this Exhibit A-1 will be delivered within ten (10) days after the Sixth Amendment Effective Date. 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Exhibit A-2 
 [***] 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 3.
Verification and Integration 
 [***] 
 5. Delivery
Schedule 
 All items in this Exhibit A-2 will be delivered within ten (10) days after the Sixth Amendment Effective Date. 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Exhibit A-3 
 [***] 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 2.
Design Materials 
 [***] 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Exhibit A-4 
 [***]Design License Agreement

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Exhibit 10.6 
  
 This design license agreement
(“Agreement”) is made as of the 15th day of October 2001 (“Effective Date”) 
 BETWEEN, 
 ARM LIMITED whose registered office is situated at 110 Fulbourn Road, Cambridge CB1 9NJ, England (“ARM”) 
 and 
 SPREADTRUM COMMUNICATIONS, INC. whose principal place of
business is situated at Ugland House, P.O. Box 309, George Town, Grand Cayman Islands, British West Indies (“LICENSEE”). 
 WHEREAS

 LICENSEE has requested and ARM has agreed to license LICENSEE, on the following terms and conditions, to use certain specified third party
manufacturers (each an “Authorised Foundry” (defined below)) to manufacture certain specified ARM Compliant Products (defined below) developed by or for and solely for distribution by LICENSEE. 
  

	1.	Definition 

  

	1.1	“ADC Program Member” means any third party design entity that has entered into and enjoys the benefit of an agreement with ARM making such third party a member of
the “ARM Approved Design Centre Program” a list of which are published by ARM in accordance with the provisions of Clause 4.2. An entity shall only be an ADC Program Member whilst it continues to enjoy the benefit of such agreement.

  

	1.2	“ARM Compliant Product” means any integrated circuit designed by or for LICENSEE and which incorporates at a minimum; (i) a Qualified ARM Core; and
(ii) LICENSEE or LICENSEE’s customer’s circuitry which adds significant additional functionality. 

  

	1.3	“ARM MicroPack” means together; (i) the AMBA Specification; (ii) the Documentation; (iii) the EASY Models; (iv) the EASY Test Vectors;
(v) the Software Examples; (vi) the Test Infrastructure; (vii) the AMBA Module Test Benches; (viii) the EASY Module Test; and (ix) the CPU AHB Wrappers, together with any Updates thereto delivered to LICENSEE by ARM from
time to time. 

  

	1.4	“AMBA Module Test Benches” means the test benches for the APB and ASB and identified in Schedule 7 Section 2 Part E. 

  

	1.5	“AMBA Specification” means the bus specification identified in Schedule 7 Section 1 Part A. 

  

	1.6	“ARM7TDMI Core” means the ARM7TDMI core as described and identified in the relevant technical reference manual in Schedule 1 Section 1.

  

	1.7	“ARM9 Core” means either the ARM922T Core or the ARM946E Core. 

  

	1.8	“ARM922T Core” means the ARM922T core as described and identified in the relevant technical reference manual in Schedule 1 Section 1. 

 

	1.9	“ARM946E Core” means the ARM946E core as described and identified in the relevant technical reference manual in Schedule 1 Section 1. 

 

	1.10	“Authorised Design(s)” means for each Design Fee (defined in Clause 8.1) paid to ARM by LICENSEE, up to one thousand (1000) units in aggregate of any
designs for ARM Compliant Products in respect of which ARM has issued a Design ID. 

  

	1.11	“Authorised Foundry” means for each Authorised Design or Authorised Product, the semiconductor manufacturer mutually agreed by ARM and LICENSEE and identified in
the relevant Section 2 Part C of Schedule 1. 

  

	1.12	“Authorised Product(s)” means for each Design Fee (defined in Clause 8.1) paid to ARM by LICENSEE; 

  

	 	(i)	an unlimited number of units of a single design for an ARM Compliant Product in respect of which ARM has issued a Design ID; 

  

	 	(ii)	an unlimited number of units of any derivatives of the ARM Compliant Products referred to in Clause 1.12(i), provided that; 

  

 Page 1 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	 	(a)	such derivatives result only from any or all of the following modifications; (1) a change to the size or type of the on-chip memory or change to the code on the on-chip memory
of such ARM Compliant Products; (2) the implementation by LICENSEE of an Update delivered by ARM to some or all of the Transfer Materials; and (3) the correction of errors in such ARM Compliant Products to achieve conformance with the
original specification for such design; 

  

	 	(b)	except as provided below, no more than one such derivative for the ARM Compliant Product referred to in Clause 1.12(i) is being manufactured for LICENSEE at any time. LICENSEE shall
be permitted to concurrently manufacture the derivative and the design from which such derivative was derived for a period of twelve (12) months from the date of first manufacture of the new derivative; and 

  

	 	(c)	in respect of any such derivative ARM has issued a Design ID. 

  

	1.13	“Claim” means a written notice of Intellectual Property infringement received by ARM from a third party demanding that ARM ceases and desists from such alleged
Intellectual Property infringement. 

  

	1.14	“CPU AHB Wrappers” means such of the wrappers identified in Schedule 7 Section 2 Part F as are delivered to LICENSEE from time to time by ARM pursuant to a
request from LICENSEE in accordance with the provisions of Clause 10.2. 

  

	1.15	“Confidential Information” means; (i) any trade secrets relating to the Transfer Materials and Design Sign-Off Models; (ii) any information designated in
writing by either party, by appropriate legend, as confidential; (iii) any information which is first disclosed verbally but designated as confidential at the time of disclosure and is thereafter reduced to writing for confirmation and sent to
the other party within thirty (30) days after its oral disclosure and designated, by appropriate legend, as confidential; and (iv) the terms and conditions of this Agreement. 

  

	1.16	“Design ID” means the unique design number issued by ARM to LICENSEE in respect of an Authorised Design or Authorised Product in accordance with the provisions of
Clause 4.1. 

  

	1.17	“Design Sign-Off Model” means; (i) the object code and such source code of the programs identified in Schedule 2 Part B Section 1 as may be necessary to
allow the support of multiple releases of the specified simulator; and (ii) subject to the payment by LICENSEE of the fee(s) in accordance with the provisions of Clause 8.4 the object code and such source code of the programs identified in
Schedule 2 Part B Section 2 as may be necessary to allow the support of multiple releases of the specified simulator, together with such Updates thereto delivered to LICENSEE by ARM from time to time. 

  

	1.18	“Documentation” means the documentation identified in Schedule 2 Part A Section 1 and Schedule 7 Section 1 Part B. 

  

	1.19	“EASY Models” means the VHDL models identified in Schedule 7 Section 2 Part G. 

  

	1.20	“EASY Module Test” means the example modifications to the AMBA Module Test Benches required to test the EASY Models and identified in Schedule 7 Section 2 Part
D. 

  

	1.21	“EASY Test Vectors” means the data files identified in Schedule 7 Section 2 Part A. 

  

	1.22	“End User License” means a license agreement substantially in the form set out in Schedule 6. 

  

	1.20	“Functional Test Vectors” means the functional test vectors identified in Schedule 2 Part A Section 3. 

  

	1.23	“Intellectual Property” means any patents, patent rights, trade marks, service marks, registered designs, topography or semiconductor maskwork rights, applications
for any of the foregoing, copyright, know-how, unregistered design right, trade secrets and know-how and any other similar protected rights in any country. 

  

	1.24	“Layout Design Data” means the technical materials identified in Schedule 2 Part A Section 2. 

  

	1.25	“Program Design Rules” means for each Authorised Design or Authorised Product, the nominated set of design rules identified in the relevant Section 2 Part A of
Schedule 1 and any modifications thereto made by the relevant Authorised Foundry from time to time. 

  

	1.26	“Qualified ARM Core” means an implementation of the microprocessor core identified in the relevant Sections 1 of Schedule 1 and which is manufactured by an
Authorised Foundry under licence from ARM. 

  

	1.27	“Quarter” means each calendar quarter ending the 31st March, 30th June, 30th September and 31st December. 

  

	1.28	“Software Examples” means the source code and object code of the programs described in Schedule 7 Section 2 Part B. 

  

 Page 2 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	1.29	“Subsidiary” means any company the majority of whose voting shares is now or hereafter owned or controlled, directly or indirectly, by a party hereto or any company
a majority of whose voting shares is now or hereafter owned or controlled, directly or indirectly, by any of the aforementioned entities. A company shall be considered a Subsidiary only so long as such control exists. 

  

	1.30	“Subsidiary’s Undertaking” means an undertaking in the form set out in Schedule 8. 

  

	1.31	“Test Infrastructure” means the programs identified in Schedule 7 Section 2 Part C. 

  

	1.32	“Trademarks” means the trademarks, service marks and logos set out in Schedule 4. 

  

	1.33	“Transfer Materials” means together; (i) the Layout Design Data; (ii) the Functional Test Vectors; (iii) ARM MicroPack; (iv) the Documentation;
and (v) the ARM Developers Kit identified in Schedule 2 Part A Section 4, for each Qualified ARM Core, together with any Updates thereto delivered to LICENSEE by ARM from time to time. 

  

	1.34	“Updates” means any enhancements and modifications including but not limited to any error corrections to any deliverable including any documentation associated
therewith, designed by, or for ARM, the incorporation of which ARM, in its absolute discretion, decides does not cause to be created a new product together with any Intellectual Property embodied therein. 

  

	2.	Licence to LICENSEE 

 Transfer Materials Licence 

 

	2.1	For each Design Fee (defined in Clause 8.1) paid to ARM by LICENSEE, ARM hereby grants to LICENSEE, a non-transferable (subject to Clause 20.2), non-exclusive, world-wide licence;

  

	 	(i)	to use and copy; (a) the Layout Design Data; and (b) the SDK Models (solely in conjunction with the EASY Models), only for the purposes of designing, having designed
(subject to the provisions of Clause 2.2) ARM Compliant Products; 

  

	 	(ii)	to use, copy and modify (solely to the extent necessary to run the following deliverables on LICENSEE’s or LICENSEE’s agent’s tester or simulator) the Functional Test
Vectors only for the purposes of designing, having designed (subject to the provisions of Clause 2.2) testing and having tested (subject to the provisions of Clause 2.5), ARM Compliant Products; 

  

	 	(iii)	use, copy and modify; (a) the Software Examples; (b) the EASY Test Vectors; (c) the EASY Models; (d) the Test Infrastructure; (e) the AMBA Module Test
Benches; (f) the EASY Module Test; and (g) the CPU AHB Wrappers, only for the purposes of designing, having designed (subject to the provisions of Clause 2.2) ARM Compliant Products; 

  

	 	(iv)	use and copy the AMBA Specification only for the purposes of designing, having designed, manufacturing, having manufactured, offering to sell, selling, importing, supplying or
otherwise distributing products incorporating a bus which is compliant with the AMBA Specification; 

  

	 	(v)	subject to the provisions of Clauses 2.3, 2.7 and 3.1, to have manufactured only by an Authorised Foundry, the Authorised Designs and Authorised Products created under the
licences granted in Clauses 2.1(i) to 2.1(iv) inclusive; 

  

	 	(vi)	subject to the provisions of Clause 2.4, to have packaged, the Authorised Designs and Authorised Products manufactured under the licences granted in Clause 2.1(v);

  

	 	(vii)	to sell, supply and distribute Authorised Designs and Authorised Products manufactured for LICENSEE under the licences granted in Clause 2.1(v); and 

  

	 	(viii)	to use, copy, modify (solely to the extent necessary to reflect any permitted modifications in accordance with the provisions of this Clause 2.1 or for incorporation into
LICENSEE’s documentation), distribute and have distributed the Documentation. 

 ARM shall supply LICENSEE with [***]
[Schedule 2 Part A Section 4]. The [***] are delivered subject to respective shrinkwrap licence terms. 
  

 Page 3 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Have
Designed Rights 
  

	2.2	LICENSEE may exercise its right to have Authorised Designs and Authorised Products designed in accordance with the provisions of Clause 2.1(i), (ii), (iii) and (iv) only
by an ADC Program Member and provided that LICENSEE; (i) notifies ARM of the identity of the ADC Program Member within thirty (30) days of delivery of any Transfer Materials to such ADC Program Member;
(ii) ensures that such ADC Program Member agrees; (a) to be bound by obligations of confidentiality in respect of any delivered Transfer Materials no less restrictive than those contained in this Agreement; and
(b) to supply the design for the Authorised Design or Authorised Product solely to LICENSEE; and (iii) ensures that the ADC Program Member either returns to LICENSEE or destroys any Confidential Information and Transfer Materials
delivered to it upon completion of the Authorised Design or Authorised Product or, if earlier, termination of this Agreement. 

 If any ADC Program Member breaches the provisions referred to in this Clause 2.2, LICENSEE agrees to take all reasonable actions to cure such breach. If LICENSEE is unable to cure such breach within thirty (30) days, then LICENSEE
shall terminate the right of such ADC Program Member to design ARM Compliant Products for LICENSEE and shall ensure that the ADC Program Member either destroys or returns to LICENSEE any Confidential Information and Transfer Materials in ADC Program
Member’s possession. 
 Notwithstanding the foregoing, LICENSEE may have Authorised Designs and Authorised Products designed in
accordance with the provisions of Clause 2.1(i), (ii), (iii) and (iv) by ARM. 
 Have Manufactured Rights 
  

	2.3	LICENSEE may exercise its right to have Authorised Designs and Authorised Products manufactured by an Authorised Foundry in accordance with the provisions of Clause 2.1(v) provided
that LICENSEE; (i) ensures that the Authorised Foundry agrees; (a) to be bound by obligations of confidentiality in respect of any Transfer Materials delivered to the Authorised Foundry which are no less restrictive
than those contained in this Agreement; and (b) to supply the Authorised Designs and Authorised Products solely to LICENSEE or as directed by LICENSEE to a Test House (defined in Clause 2.5) or Packaging House (defined in Clause 2.4); and
(ii) ensures that the Authorised Foundry either returns to LICENSEE or destroys any Confidential Information and Transfer Materials delivered to it upon completion of the Authorised Design or Authorised Product or, if earlier,
termination of this Agreement. 

 If any Authorised Manufacturer breaches the provisions referred to in this Clause 2.3,
LICENSEE agrees to take all reasonable actions to cure such breach. If LICENSEE is unable to cure such breach within thirty (30) days, then LICENSEE shall terminate the right of such Authorised Foundry to manufacture Authorised Designs and
Authorised Products for LICENSEE and shall ensure that the Authorised Manufacturer either destroys or returns to LICENSEE any Confidential Information and Transfer Materials in the Authorised Foundry’s possession. 
 Have Packaged Rights 
  

	2.4	LICENSEE may exercise its right to have Authorised Designs and Authorised Products packaged and tested by a packaging house (“Packaging House”) in accordance with
the provisions of Clause 2.1(vi) provided that LICENSEE; (i) notifies ARM of the identity of the Packaging House within thirty (30) days of delivery of any unpackaged silicon to such Packaging House; and
(ii) ensures that such Packaging House agrees; (a) to be bound by obligations of confidentiality in respect of any Transfer Materials delivered to the Packaging House which are no less restrictive than those contained in this
Agreement; (b) to provide in the agreement between LICENSEE and the Packaging House the right for ARM, as a third party beneficiary, to enforce the obligations of confidentiality directly against the Packaging House; and (c) to supply the
Authorised Designs and Authorised Products solely to LICENSEE or as directed by LICENSEE to a Test House (defined in Clause 2.5); and (iii) ensures that the Packaging House either returns to LICENSEE or destroys any Confidential
Information and Transfer Materials delivered to it upon completion of the packaging of the Authorised Design or Authorised Product or, if earlier, termination of this Agreement. 

 If any Packaging House breaches the provisions referred to in this Clause 2.4, LICENSEE agrees to take all reasonable actions to cure such breach. If
LICENSEE is unable to cure such breach within thirty (30) days, then LICENSEE shall terminate the right of such Packaging House to test ARM Compliant Products for LICENSEE and shall ensure that the Packaging House either destroys or returns to
LICENSEE any Confidential Information and Transfer Materials in the Packaging House’s possession. LICENSEE shall hold harmless and indemnify ARM against all and any loss, liability, costs, damages, reasonable expenses (including the reasonable
fees of lawyers and other professionals), suffered, incurred or sustained as a result of or in relation to any such breach. 
  

 Page 4 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Have
Tested Rights 
  

	2.5	LICENSEE may exercise its right to have Authorised Designs and Authorised Products tested by a test house (“Test House”) in accordance with the provisions of Clause
2.1(ii) provided that LICENSEE; (i) notifies ARM of the identity of the Test House within thirty (30) days of delivery of any Transfer Materials to such Test House; and (ii) ensures that such Test House agrees
(a) to be bound by obligations of confidentiality in respect of any Transfer Materials delivered to the Packaging House which are no less restrictive than those contained in this Agreement; (b) to provide in the agreement between LICENSEE
and the Packaging House the right for ARM, as a third party beneficiary, to enforce the obligations of confidentiality directly against the Packaging House; and (c) to supply the Authorised Designs and Authorised Products solely to LICENSEE or
as directed by LICENSEE to a Packaging House (defined in Clause 2.4); and (iii) LICENSEE ensures that the Test House either returns to LICENSEE or destroys any Confidential Information and Transfer Materials delivered to it upon
completion of the testing of the Authorised Design or Authorised Product or, if earlier, termination of this Agreement. 

 If
any Test House breaches the provisions referred to in this Clause 2.5, LICENSEE agrees to use all reasonable action to cure such breach. If LICENSEE is unable to cure such breach within thirty (30) days, then LICENSEE shall terminate the right
of such Test House to test ARM Compliant Products for LICENSEE and shall ensure that the Test House either destroys or returns to LICENSEE any Confidential Information and Transfer Materials in the Test House’s possession. LICENSEE shall hold
harmless and indemnify ARM against all and any loss, liability, costs, damages, reasonable expenses (including the reasonable fees of lawyers and other professionals), suffered, incurred or sustained as a result of or in relation to any such breach.

 Second Source Option 
  

	2.6	For each Authorised Product, LICENSEE may, upon payment of a Second Source Fee (defined in Clause 8.3), elect to amend Schedule 1 to include either or both an additional set of
nominated Program Design Rules and an additional nominated Authorised Foundry. As soon as is reasonably possible after LICENSEE’s exercise of the option referred to in this Clause 2.6, and subject to payment of the Second Source Fee, ARM shall
use reasonable efforts to deliver such additional Transfer Materials as may be necessary to enable LICENSEE to have the Authorised Product manufactured to the additional Program Design Rules and, as appropriate, by the additional Authorised Foundry.

 For each Authorised Design, LICENSEE may, upon payment of a Process Migration Fee (defined in Clause 8.6), elect to amend
Schedule 1 to include a new set of Program Design Rules for the existing Authorised Foundry. As soon as is reasonably possible after LICENSEE’s exercise of the option referred to in this Clause 2.6, and subject to payment of the Process
Migration Fee, ARM shall use reasonable efforts to deliver such additional Transfer Materials as may be necessary to enable LICENSEE to have the Authorised Design manufactured to the additional Program Design Rules by the Authorised Foundry.

 Authorised Designs and Authorised Products 
  

	2.7	Under this Agreement LICENSEE shall be permitted to have manufactured and ARM shall only be obliged to issue Design ID(s) in respect of Authorised Designs and [***] Authorised
Products. The first Authorised Product shall be based on the ARM7TDMI Core identified in Section 1 of Schedule 1. The second Authorised Product shall be based on the Qualified ARM Core that LICENSEE elects under Clause 2.8. For the avoidance of
doubt, LICENSEE shall be required to pay [***] Design Fees (as defined in Clause 8.1). 

  

	2.8	LICENSEE shall elect to base the second Authorised Product on either the ARM7TDMI Core or on an ARM9 Core by giving written notice to ARM in accordance with this Clause 2.8 before
December 31, 2003. In the event that LICENSEE elects to base the second Authorised Product on the ARM7TDMI Core, such notice shall be in the form of a Design ID request as set out in Schedule 1 Section 1. Upon receipt of such notice in
accordance with the provisions of this Clause 2.8, ARM shall invoice LICENSEE for the relevant Design Fee (defined in Clause 8.1). In the event that LICENSEE elects to base the second Authorised Product on an ARM9 Core, such notice shall be a
separate notification of an ARM9 Core election. Upon receipt of such ARM9 Core election, ARM shall deliver the relevant Transfer Materials for the ARM9 Core under separate amendment to this Agreement and invoice LICENSEE for the first payment of the
relevant Design Fee (defined in Clause 8.1). Subsequent to delivery of the Transfer Materials for the ARM9 Core, LICENSEE shall submit a Design ID request as set out in Schedule 1 Section 1. 

  

	2.9	Except as expressly provided under the provisions of Clause 2.1, no right is granted to LICENSEE under this Agreement to sub-license the rights licensed to LICENSEE under the
provisions of Clause 2.1. 

  

 Page 5 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	2.10	Except as expressly licensed under Clause 2.1, LICENSEE acquires no right, title or interest to the Qualified ARM Core, the Transfer Materials or any Intellectual Property embodied
therein. In no event shall the license grant set out in Clause 2.1 be construed as granting LICENSEE, expressly or by implication, estoppel or otherwise, a license to use any ARM technology except the Transfer Materials. 

  

	2.11	LICENSEE shall reproduce and not remove or obscure any notice incorporated in the Transfer Materials or related documentation by ARM to protect ARM’s Intellectual Property or
to acknowledge the copyright and/or contribution of any third party developer. LICENSEE shall incorporate corresponding notices and/or such other markings and notifications as ARM may reasonably require on all copies of the Transfer Materials and
related documentation and related documentation used by LICENSEE. 

  

	2.12	During the term of this Agreement, LICENSEE may exercise the right to include any Subsidiary as a licensee of ARM under the terms of this Agreement provided that:

  

	 	(i)	such Subsidiary agrees in writing, as set forth in Schedule 8, to be bound by the obligations of LICENSEE and to comply with all the terms and conditions of this Agreement. LICENSEE
shall deliver to ARM a copy of the Subsidiary’s Undertaking within thirty (30) days of the execution of such undertaking; 

  

	 	(ii)	any breach of the terms and conditions of this Agreement by a Subsidiary shall constitute a breach of this Agreement by LICENSEE; 

  

	 	(iii)	any termination of this Agreement as provided by Clause 18 shall be effective in respect of all Subsidiaries; 

  

	 	(iv)	any license, granted in accordance with the provisions of this Clause 2.12, shall automatically terminate, in respect of a Subsidiary upon such Subsidiary ceasing to be a
Subsidiary. 

  

	3.	LICENSEE’s Obligations 

  

	3.1	In respect of each ARM Compliant Product developed under the licences granted in Clauses 2.1(i) to 2.1(iv) which LICENSEE wishes to have manufactured under the licence granted in
Clause 2.1(v), LICENSEE shall, at least ten (10) days prior to delivery of the layout database for the ARM Compliant Product to the Authorised Foundry submit, to ARM, a written notice (in duplicate) in the form set out in Schedule 1
(“Design ID Request”) for the Authorised Design or Authorised Product. 

 Upon receipt of a Design ID Request
and payment in accordance with the provisions of this Clause 3.1 such Design ID Request shall be incorporated in to Schedule 1 and form part of this Agreement. 
 LICENSEE acknowledges that the Authorised Foundry shall not be permitted to manufacture any ARM Compliant Product for LICENSEE without LICENSEE producing, to the Authorised Foundry, a Design ID in respect of such ARM
Compliant Product. 
  

	3.2	LICENSEE shall only deliver the layout database for any Authorised Product to the Authorised Foundry in GDSII format. 

  

	4.	LICENSOR’S Obligations 

  

	4.1	Subject to the provisions of Clauses 2.7 and 2.8 and subject to receipt by ARM of the appropriate Design Fees, upon receipt of a Design ID Request (defined in Clause 3.1) from
LICENSEE in accordance with the provisions of Clause 3.1, ARM shall issue a Design ID to LICENSEE for the ARM Compliant Product in respect of which the Design ID Request has been submitted and return a completed copy of the Design ID Request to
LICENSEE. 

  

	4.2	Through the “Partner Programs” site on ARM’S website [www.arm.com] ARM shall publish and maintain a current list of ADC Program Members. 

  

 Page 6 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	5.	Program Design Rules Changes 

  

	5.1	As soon as reasonably possible after ARM has received notice from an Authorised Foundry of a change to any Program Design Rules, ARM shall provide notice to LICENSEE that the
Transfer Materials are subject to review to assess whether the changes to the Program Design Rules requires any changes to the Transfer Materials. 

  

	5.2	If any change to any of the Transfer Materials are required as a result of any change to the Program Design Rules, ARM shall deliver Updates to the Transfer Materials to LICENSEE as
soon as reasonably possible after receipt by ARM of the changes to the Program Design Rules from the Authorised Foundry. 

  

	5.3	If ARM delivers any Updates to the Layout Design Data pursuant to the provisions of Clause 5.2, LICENSEE; 

  

	 	(i)	shall cease use of the old Layout Design Data and use the new Layout Design Data for the development of any designs for ARM Compliant Products commenced after the date of receipt of
such Updates; 

  

	 	(ii)	may continue to have ARM Compliant Products, the designs for which have already been commenced as at the date of receipt of such Updates, manufactured by the Authorised Foundry
subject to the Authorised Foundry continuing to support manufacture of designs under the superseded Program Design Rules. 

 ARM
shall not be liable for any failure by an Authorised Foundry to offer continued manufacturing support under any superseded Program Design Rules but ARM represents that for the continuance of any agreements between ARM and any Authorised Foundry
nothing in any such agreement shall restrict such Authorised Foundry from continuing to manufacture Authorised Designs and Authorised Products using a process which is compatible with the nominated set of Program Design Rules. 
  

	6.	Design Sign-Off Models License 

  

	6.1	ARM hereby grants to LICENSEE a non-transferable (subject to Clause 20.2), non-exclusive, world-wide licence, solely for the purpose of developing ARM Compliant Products for
distribution by LICENSEE, to; 

  

	 	(i)	use, copy, distribute, and sub-license (solely to an ADC Program Member and subject to the terms of an End User Licence) the use of the Design Sign-Off Models; and

  

	 	(ii)	use, copy, modify, and distribute (including any modified versions thereof) the documentation related to the Design Sign-Off Models. 

  

	6.2	For the period of [***] months after the Effective Date, LICENSEE may extend the licenses contained in Clause 6.1 so as to include further Design Sign-Off Models by giving written
notice to ARM, referring to this Clause 6.2, together with payment, to ARM, of the Design Sign-Off Model Option Fee in accordance with Clause 8.4. 

  

	6.3	In no event shall the license grants set out in Clause 6.1 be construed as granting LICENSEE, expressly or by implication, estoppel or otherwise, a licence under any ARM technology
other than the Design Sign-Off Models, and related documentation. 

  

	6.4	Except as licensed to LICENSEE in Clause 6.1 all right, title and interest in the Design Sign-Off Models and related documentation shall remain vested in ARM.

  

	7.	Trademark License and Promotional Obligations 

  

	7.1	ARM hereby grants to LICENSEE a non-transferable (subject to Clause 20.2), non-exclusive, royalty-free, worldwide right and license to use the Trademarks in the promotion and sale
of Authorised Products. 

  

	7.2	LICENSEE shall use the Trademarks, in accordance with ARM’s guidelines set out in Schedule 4 (“Guidelines”). ARM shall have the right to revise Schedule 4 and
the Guidelines (including the right to add further trademarks or modify the Trademarks). Any such revisions shall be effective upon printed materials and products to be produced or manufactured after ninety (90) days from receipt of ARM’s
written notice to LICENSEE. 

  

	7.3	In the event that any documentation, packaging, promotional or advertising material fails to comply with the Guidelines, ARM shall notify LICENSEE and LICENSEE shall rectify such
documentation, packaging, and promotional or advertising materials so as to comply with the Guidelines and cease using any such non-compliant materials within thirty (30) days of the date of ARM’s notice. 

  

 Page 7 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	7.4	Except as provided by the terms of this Agreement, LICENSEE shall not use or register any trademark, service mark, device or logo, any of the Trademarks or any word or mark
confusingly similar to any of the Trademarks, in any jurisdiction. 

  

	7.5	Within six (6) months after the Effective Date, LICENSEE and ARM shall mutually agree a press release relating to the commercial relationship established under this Agreement.

  

	7.6	Except where LICENSEE’s customer requests otherwise, ARM and LICENSEE shall mutually agree a press release; (i) for release on or around the commencement of the
development of any Authorised Product; and (ii) for release on or around the launch of any product incorporating an Authorised Product. LICENSEE shall use commercially reasonable efforts to obtain permission for its customers to make
such press releases. 

  

	7.7	In each twelve (12) month period after the Effective Date in which LICENSEE distributes a new Authorised Product, LICENSEE shall use commercially reasonable efforts to submit
at least one article relating to such Authorised Product in at least two (2) major industry publications (where major industry publication shall mean; any publication with a targeted market segment directly relevant to the product being
promoted and with a circulation of at least fifty thousand (50,000). 

  

	7.8	Subject to LICENSEE having made a public announcement with respect to an Authorised Product or product incorporating an Authorised Product, ARM shall have the right to independently
announce and reference such Authorised Product or product. 

  

	7.9	ARM and LICENSEE shall each appoint and maintain a marketing contact and a technical contact for the other party. Any changes to such contacts from time to time shall be notified to
the other party as soon as reasonably possible. 

  

	7.10	ARM and LICENSEE shall use reasonable efforts to generate sales materials targeted at application areas mutually agreed by the parties. 

  

	8.	Fees and Royalties 

  

	8.1	In consideration for the licences granted under Clause 2.1, the Maintenance (defined in Clause 11.1), the Support (defined in Clause 12.1) and the Training (defined in Clause 13,
LICENSEE shall pay the relevant fees (each a “Design Fee”) as set out in and in accordance with, the provisions of Schedule 5 Part A. The Design Fee for the first Authorised Product must be paid in full by September 30, 2002.
The Design Fee for the second Authorised Design must be paid in full by October 31, 2003. 

  

	8.2	LICENSEE shall pay fees (each a “Maintenance Update Fee”) as set out in and in accordance with the provisions of Schedule 5 Part B for each Update, requested by
LICENSEE in accordance with the provisions of Clause 11.2, for any Qualified ARM Core translated to a nominated set of Program Design Rules. 

  

	8.3	If LICENSEE elects to have Authorised Designs or Authorised Products manufactured by a second source in accordance with the provisions of Clause 2.6, then LICENSEE shall, in respect
of each such Approved Design, pay a fee (“Second Source Fee”) as set out in and in accordance with the provisions of Schedule 5 Part C. 

  

	8.4	Upon exercise of the option granted in Clause 6.2, for each Design Sign-Off Model Option delivered to LICENSEE, LICENSEE shall pay, to ARM, a fee (“Design Sign-Off Model
Option Fee”) as set out in and in accordance with Schedule 5 Part D. 

  

	8.5	If ARM is required to provide Additional Support to LICENSEE in accordance with the provisions of Clause 12.5, then LICENSEE shall pay fees (“Additional Support
Fees”) as set out in and in accordance with, the provisions of Schedule 5 Part E. 

  

	8.6	If LICENSEE elects to have Authorised Designs [***] with an existing Authorised Foundry in accordance with the provisions of Clause 2.6, then LICENSEE shall, in respect of each such
Authorised Design, pay a fee (“Process Migration Fee”) as set out in and in accordance with the provisions of Schedule 5 Part F. 

  

 Page 8 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	8.7	For each unit of an Authorised Product distributed by LICENSEE (excluding samples marked as such and replacements for defective units), LICENSEE shall pay a royalty
(“Royalty”) determined by reference to; (i) the number of Qualified ARM Cores in the Authorised Product; and (ii) the total number of units of such Authorised Product distributed by LICENSEE in accordance
with the tables set out in Schedule 3 Part B. 

  

	8.8	Within thirty (30) days after the end of each Quarter, LICENSEE shall deliver, to ARM, a completed report in the form set out in Schedule 3 Exhibit 1. Royalties due to ARM
under this Agreement shall be paid in accordance with the terms in Schedule 3. 

  

	8.9	In no event shall a Design Fee or a Second Source Fee be construed as being an advance payment of Royalties, by LICENSEE and no right of set off of either (i) fees due under
the terms of any other agreement against any fees due under the terms of this Agreement; or (ii) fees due under the terms of this Agreement against any fees due under the terms of any other agreement, shall exist. 

  

	8.10	All sums stated under this Agreement do not include taxes. All applicable taxes shall be payable by LICENSEE in accordance with relevant legislation in force at the relevant tax
point date. 

  

	8.11	LICENSEE shall pay all fees due to ARM under the terms of this Agreement within thirty (30) days of receipt of ARM’s invoice therefor (“Due Date”).

  

	8.12	If any sum under this Agreement is not paid by the Due Date (as defined in Clause 8.10), then (without prejudice to ARM’s other rights and remedies) ARM reserves the right to
charge interest on such sum on a day to day basis (as well after as before any judgement) from the Due Date to the date of payment at the rate of two and a half (2.5%) per cent per annum above the base rate of National Westminster Bank PLC from
time to time in force. 

  

	9.	Record Keeping and Auditing 

  

	9.1	LICENSEE shall keep all such records as are necessary to demonstrate compliance with its obligations under Clauses 2, 3, 8 and 14 for a period of [***] from the date of creation of
such records of account. 

  

	9.2	ARM shall have the right for representatives of a firm of independent Chartered Accountants (“Auditors”) to which LICENSEE shall not unreasonably object, to make an
examination and audit, by prior appointment during normal business hours, of all records and accounts which contain information bearing upon; (i) the number of units of Authorised Designs and Authorised Products manufactured for LICENSEE
under the licences granted in this Agreement; (ii) the number of Authorised Designs and Authorised Products developed by LICENSEE under the licences granted in this Agreement; (iii) the number of ARM Compliant Products
distributed by LICENSEE under this Agreement; and (iv) the amounts of Royalties payable to ARM by LICENSEE. LICENSEE shall be supplied with a copy of or sufficient extracts from any report prepared by the Auditors. The Auditors must
enter into an appropriate confidentiality agreement with LICENSEE prior to the audit. The Auditors’ report shall (in the absence of clerical or manifest error) be final and binding on the parties. Such audit shall be at ARM’s expense
unless it reveals an underpayment by LICENSEE of the fees and royalties identified in Clause 8 of more than 5% over the audited period in which case LICENSEE shall reimburse ARM for the costs of such audit. In the event that an audit of Clauses
2, 3, and 14 of this Agreement reveals a failure on LICENSEE’s part to comply with Clauses 2, 3, or 14, then LICENSEE shall only be responsible for reimbursing ARM for the costs associated with the portion of the audit that LICENSEE has
failed. 

  

	10.	Delivery and Acceptance 

  

	10.1	The Transfer Materials in respect of each Qualified ARM Core delivered to LICENSEE shall conform to the nominated Program Design Rules identified in the relevant Section 2 Part
A of Schedule 1. Except as provided in Clause 2.8, ARM shall deliver the Transfer Materials and the Design Sign-Off Models to LICENSEE within twenty (20) working days after the payment to ARM of the first instalment of the relevant Design Fee.
ARM shall deliver Updates for the Transfer Materials and the Design Sign-Off Models requested in accordance with the provisions of Clause 11.2 to LICENSEE within twenty (20) working days of receipt of such request from LICENSEE.

  

 Page 9 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	10.2	For the continuance of this Agreement, LICENSEE may request the delivery of any CPU AHB Wrapper from ARM and, subject to availability, ARM shall use reasonable efforts to deliver
the CPU AHB Wrappers to LICENSEE within thirty (30) days of receipt of any such request. 

  

	10.3	Unless LICENSEE rejects the Transfer Materials within thirty (30) days of receipt from ARM, then the Transfer Materials shall be deemed accepted by LICENSEE.

  

	11.	Maintenance 

  

	11.1	For the period of [***] from the date of payment to ARM of a Design Fee (“Maintenance Period”), ARM shall provide to LICENSEE, in respect of the Transfer Materials,
the Design Sign-Off Models, and any information or deliverable provided under this Agreement and relating to the Authorised Product in respect of which the Design Fee has been paid, the following maintenance services
(“Maintenance”); 

  

	 	(i)	the correction, to the extent reasonably possible, of any defects in the Transfer Materials which prevents; (a) LICENSEE from designing an integrated circuit with a physical
interface that will completely and accurately interface to the layout for the relevant Qualified ARM Core translated to the nominated Program Design Rules; or (b) MicroPack from operating in accordance with the functionality described in the
relevant Documentation. If ARM determines that such defects are due to errors in such description, ARM shall promptly issue corrections to the datasheet and shall not be required to correct the Transfer Materials or MicroPack provided that LICENSEE
is not thereby prevented from commercially exploiting any Authorised Product or MicroPack; 

  

	 	(ii)	the correction, to the extent reasonably possible, of any defects in the Design Sign-Off Models which cause the Design Sign-Off Models not to operate in accordance with the
functionality described in the relevant documentation. If ARM determines that such defects are due to errors in such description, ARM shall promptly issue corrections to the datasheet and shall not be required to correct the Design Sign-Off Models
provided that LICENSEE is not thereby prevented from commercially exploiting the Design Sign-Off Models; and 

  

	 	(iii)	any Updates to the Transfer Materials, created by ARM. 

  

	11.2	For the period of [***] after the expiry of the Maintenance Period, LICENSEE may request Updates to the Transfer Materials and Design Sign-Off Models Update for any Qualified ARM
Core translated to a nominated set of Program Design Rules by giving written notice to ARM, referring to this Clause 11.2, together with payment, to ARM, of the Maintenance Update Fee in accordance with Clause 8.2. 

  

	11.3	The Maintenance Services shall be provided at ARM’S premises in Cambridge, England. Nevertheless, ARM will use reasonable efforts to provide Maintenance Services to LICENSEE,
at LICENSEE premises, subject to LICENSEE meeting all reasonable travelling, accommodation and sustenance expenses. 

  

	11.4	For the avoidance of doubt, ARM’s obligation under this Clause 11 is limited expressly to the provision of the Maintenance Services to LICENSEE. 

  

	12.	Support 

  

	12.1	ARM shall provide to LICENSEE, in respect of the Transfer Materials and the Design Sign-Off Models relating to each Authorised Design or Authorised Product, for the period of
[***] from the date of payment to ARM of the Design Fee for such Authorised Designs or Authorised Product (“Support Period”), reasonable telephone and written consultation relating to the operation and application of such Transfer
Materials and Design Sign-Off Models (“Support”). 

  

	12.2	The Support shall be provided from ARM’s premises in Cambridge, England. 

  

	12.3	ARM’s obligation under this Clause 12 shall be limited to the provision of the Support solely to LICENSEE in respect of the Transfer Materials translated to the relevant
Program Design Rules. 

  

	12.4	Except as provided under Clause 12.5, the Support provided under this Clause 12 shall be limited to ten (10) person days in the Support Period. 

  

 Page 10 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	12.5	For the period of [***] after the date of payment to ARM of the Design Fee relating to an Authorised Design or Authorised Product, LICENSEE may, by giving written notice to ARM
referring to this Clause 12.5, request additional support in blocks often (10) days (“Additional Support”) in respect of the Transfer Materials and Design Sign-Off Models for such Authorised Design or Authorised Product. Upon
receipt of such request ARM shall provide such Additional Support to LICENSEE. Any support required by LICENSEE after the third anniversary of the Effective Date shall be provided at ARM’s discretion and shall be subject to the agreement by the
parties of appropriate fees in respect thereof. 

  

	13.	Training 

  

	13.1	In the period of twelve (12) months after the payment of the first Design Fee, in consideration for the payment of such Design Fee, LICENSEE may request and ARM shall provide
places for a maximum of three (3) of LICENSEE’S personnel on one of ARM’s standard ARM open training courses (“Training”). 

  

	14.	Confidentiality 

  

	14.1	Except as provided by Clauses 14.3, 14.4 and 14.5, each party shall maintain in confidence the Confidential Information disclosed by the other party and apply security measures no
less stringent than the measures that such party applies to protect its own like information, but not less than a reasonable degree of care, to prevent unauthorised disclosure and use of the Confidential Information. The period of confidentiality
shall be indefinite with respect to each party’s Confidential Information. 

  

	14.2	LICENSEE agrees that it shall not use any of ARM’s Confidential Information other than for the purposes of designing, having designed, manufacturing, having manufactured,
marketing and distributing ARM Compliant Products. ARM agrees that it shall only use LICENSEE’S Confidential Information for LICENSEE’S purposes. 

  

	14.3	Notwithstanding the foregoing; LICENSEE shall have the right to disclose the Transfer Materials marked “M” in Schedule 2 to the Authorised Foundry pursuant to the
exercise of the have manufactured rights granted in Clause 2.1 under an NDA with substantially similar terms to this Clause 14, except that the confidentiality period for each deliverable shall be at a minimum of five (5) years from the date of
disclosure. 

  

	14.4	Notwithstanding the foregoing; LICENSEE shall have the right to disclose the Transfer Materials marked “D” in Schedule 2 to an ADC Program Member pursuant to the
exercise of the have designed rights granted in Clause 2.1 under an NDA containing substantially similar terms to this Clause 14, the confidentiality period for each deliverable shall be at a minimum equivalent to that set out in Clause 14.1 for the
relevant deliverable, and solely for the purposes of having ARM Compliant Products designed for LICENSEE by such third party. 

  

	14.5	Notwithstanding the foregoing, LICENSEE shall have the right to disclose the Transfer Materials marked “T” in Schedule 2 to a Test House pursuant to the exercise of
the have tested rights granted in Clause 2.1 under an NDA containing substantially similar terms to this Clause 14, except that the confidentiality period for each deliverable shall be at a minimum of five (5) years from the date of disclosure.

  

	14.6	The provisions of this Clause 14 shall not apply to information which; (i) was known to the receiving party prior to disclosure by the other party; or
(ii) is published or otherwise made available to the public other than by a breach of this Agreement by a party hereto; or (iii) is disclosed to the receiving party by a third party having the lawful right to make such
disclosure; or (iv) is independently conceived by the receiving party provided that the receiving party is able to provide evidence of such independent conception in the form of written records; or (v) is released to the
receiving party for disclosure to any third party, other than on a confidential basis, by the disclosing party in writing; or (vi) is marked (N) in the Schedules of this Agreement; or (vii) is required to be disclosed by
applicable laws, subject to the receiving party agreeing to make representations to any relevant court or other entity to preserve the confidentiality of the other party’s information. 

  

	14.7	For the avoidance of doubt, LICENSEE royalty reports may only be disclosed in confidence to ARM’s financial and legal advisors, provided that such advisers shall keep
confidential of the information of the LICENSEE. ARM may disclose the total unit sales of ARM processor based products on an annual basis provided that the unit sales of such products by LICENSEE are not separately identifiable or deducible
therefrom. 

  

 Page 11 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	15.	Warranties and Disclaimers 

  

	15.1	ARM warrants that the Transfer Materials and Design Sign-Off Models delivered to LICENSEE, by ARM, are complete and sufficient for LICENSEE to design an integrated circuit with a
physical interface that will completely and accurately interface to the layout for the relevant Qualified ARM Core translated to the nominated Program Design Rules. LICENSEE’S sole and exclusive remedy for any breach of such warranty shall be
for ARM, at ARM’S discretion, to correct any errors in the materials and deliver such corrected materials to LICENSEE or replace the materials. 

  

	15.2	ARM shall not be liable for any; (i) recoverable or non-recoverable costs incurred, directly or indirectly, in the processing, or manufacture of masks or manufacture and
characterisation of prototypes or production quality silicon in whatever quantity; (ii) any defect caused by a fault in the Authorised Foundry’s agent’s manufacturing process; or (iii) any defect in the Authorised
Product which does not directly result form the use by LICENSEE of the Transfer Materials or Design Sign-Off Models. 

  

	15.3	ARM warrants that to ARM’s knowledge and belief, but expressly without having undertaken any searches for prior art, that; 

  

	 	(i)	the Transfer Materials and Design Sign-Off Models do not infringe any third party copyright, maskwork right or trade secret; and 

  

	 	(ii)	there are no pending Claims that have been made, or actions commenced, against ARM for breach of any third party copyright, maskwork right, patent or trade secret.

  

	15.4	Except as expressly provided in this Agreement, ARM makes no warranties express, implied or statutory, including, without limitation, the implied warranties of satisfactory quality
or fitness for a particular purpose with respect to the Qualified ARM Core, Transfer Materials or Design Sign-Off Models. 

  

	16.	Infringement 

  

	16.1	Subject to the provisions of Clause 17, in the event of a suit against LICENSEE based upon a claim that any portion of the materials delivered by ARM to LICENSEE under this
Agreement (the “Delivered Materials”), when used in accordance with this Agreement, infringe any third party Intellectual Property, ARM agrees to defend and indemnify LICENSEE, at ARM’s expense, and to pay costs and damages finally
awarded in any such suit, provided that ARM is notified promptly in writing of the suit and at ARM’s request and at its expense is given control of the suit and all requested reasonable assistance to defend the same. If the use or sale of any
product incorporating, embodying or based upon the Delivered Materials is enjoined as a result of such suit, ARM, at its sole option and at no expense to LICENSEE, shall (a) obtain for LICENSEE the right to use and sell the Delivered Materials;
(b) make a modification of the Delivered Materials so that the Delivered Materials are no longer subject to such injunction, or (c) replace the unmodified Delivered Materials, or infringing portions thereof, with reasonably equivalent
non-infringing products. If (a), (b) and (c) are not available or commercially practical, then ARM shall pay to LICENSEE compensatory damages subject to the limitations of Clause 17. The provisions of this Clause 16.1 do not extend to any
suit based upon an infringement or alleged infringement of any patent, copyright, trade secret, mask work, trademark or other property right by: (a) the LICENSEE manufacturing process; (b) any modification of the Delivered Materials not
made by ARM; or (c) the use of the Delivered Materials in combination with other equipment, technology or software not purchased or licensed from ARM, provided that such claim would not have occurred but for such combination, modification or
enhancement. THE FOREGOING STATES THE ENTIRE LIABILITY OF ARM WITH RESPECT TO INTELLECTUAL PROPERTY INFRINGEMENT. In the event that there is a final adjudication of infringement, the liability of ARM for such infringement shall terminate with
respect to all damages regarding the infringing Intellectual Property arising after the date of such final adjudication. 

  

	16.2	 In the event of a suit against ARM based in whole or in part upon a claim that (a) the process used by or on behalf of LICENSEE in manufacturing products
incorporating, embodying or based upon the Delivered Materials (as defined in Clause 16.1); (b) any Qualified ARM Core made by LICENSEE as a result of modification of the Delivered Materials by or on behalf of LICENSEE; or (c) the use of
the Delivered Materials by LICENSEE in combination with other equipment, technology or software not purchased or licensed from ARM (provided that such claim would not have occurred but for such combination, modification or enhancement), has
infringed any patent, copyright, mask work, trademark, trade secret or other property right, LICENSEE agrees to defend and indemnify ARM, at LICENSEE expense, and to pay costs and damages finally awarded in any such suit, provided 

  

 Page 12 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	 	 
that LICENSEE is notified promptly in writing of the suit, and at LICENSEE request and at its expense is given control of the suit and all requested
reasonable assistance to defend the same. THE FOREGOING STATES THE ENTIRE LIABILITY OF LICENSEE WITH RESPECT TO INTELLECTUAL PROPERTY INFRINGEMENT. 

  

	17.	Limitation of Liability 

  

	17.1	EXCEPT IN RESPECT OF ANY BREACH OF THE PROVISIONS OF CLAUSE 14 (CONFIDENTIALITY), IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL
DAMAGES WHETHER SUCH DAMAGES ARE ALLEGED AS A RESULT OF TORTIOUS CONDUCT OR BREACH OF CONTRACT OR OTHERWISE EVEN IF THE OTHER PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. SUCH DAMAGES SHALL INCLUDE BUT SHALL NOT BE LIMITED TO THE COST
OF REMOVAL AND REINSTALLATION OF GOODS, LOSS OF GOODWILL, LOSS OF PROFITS, LOSS OF USE OF DATA, INTERRUPTION OF BUSINESS OR OTHER ECONOMIC LOSS. 

  

	17.2	NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED IN THIS AGREEMENT, IN RESPECT OF ALL CLAIMS ARISING OUT OF OR IN CONNECTION WITH THE PROVISIONS OF THIS AGREEMENT, ARM SHALL NOT
BE LIABLE TO LICENSEE FOR ANY AMOUNTS IN EXCESS OF THE SUM OF FEES PAID BY LICENSEE, TO ARM, UNDER THIS AGREEMENT AS AT THE DATE OF FIRST NOTIFICATION OF ANY CLAIM TO ARM. THE EXISTENCE OF MORE THAN ONE CLAIM OR SUIT WILL NOT ENLARGE OR EXTEND THE
LIMIT. LICENSEE RELEASES ARM FROM ALL OBLIGATIONS, LIABILITY, CLAIMS OR DEMANDS IN EXCESS OF THIS LIMITATION. 

  

	17.3	NOTHING IN THIS CLAUSE SHALL OPERATE TO EXCLUDE LIABILITY FOR DEATH OR PERSONAL INJURY RESULTING FROM EITHER PARTY’S NEGLIGENCE. 

  

	18.	Term and Termination 

  

	18.1	This Agreement shall commence on the Effective Date and [***], unless terminated in accordance with the provisions of Clause 18.2. 

  

	18.2	Without prejudice to any other right or remedy which may be available to it, either party shall be entitled summarily to terminate this Agreement by giving written notice to the
other, if the other party; 

  

	 	(i)	has committed a material breach of any of its obligations hereunder which is not capable of remedy; or 

  

	 	(ii)	has committed a material breach of any of its obligations hereunder which is capable of remedy but which has not been remedied within a period of sixty (60) days following
receipt of written notice from ARM to do so; or 

  

	 	(iii)	makes any voluntary arrangement with its creditors for the general settlement of its debts or becomes subject to an administration order; or 

  

	 	(iv)	has an order made against it, or passes a resolution, for its winding-up (except for the purposes of amalgamation or reconstruction) or has an encumbrancer take possession or has a
receiver or similar officer appointed over all or substantially all of its property or assets. 

  

	19.	Effect of Termination 

  

	19.1	Upon termination of this Agreement by ARM in accordance with Clause 18.2; (i) the licences granted to LICENCEE under Clauses 2 and 6 shall cease; and (ii) LICENSEE
shall immediately discontinue any use and distribution of all ARM Compliant Products, Transfer Materials and ARM Confidential Information. LICENSEE shall, at ARM’s option, either destroy or return to ARM any Confidential Information, including
any copies thereof in its possession, together with the Transfer Materials and all copies thereof in its possession. Within one (1) month after termination of this Agreement LICENSEE will furnish to ARM a certificate signed by a duly authorised
representative of LICENSEE that to the best of his or her knowledge, information and belief, after due enquiry, LICENSEE has complied with provisions of this Clause 19.1. 

  

 Page 13 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	19.2	Upon termination of this Agreement by LICENSEE pursuant to Clauses 18.2 (i) or (ii), subject to LICENSEE complying and continuing to comply with the provisions of this
Agreement (including the payment of Royalties in accordance with the provisions of Clause 8.7), LICENSEE may continue, in perpetuity, to have manufactured ARM Compliant Products in production at the date of such termination. For the purposes of
satisfying the provisions of this Clause 19.2 the license rights contained in Clauses 2 and 5 (solely to the extent necessary to enable LICENSEE to continue to have manufactured ARM Compliant Products) shall survive such termination.

  

	19.3	Upon termination of this Agreement by ARM the provisions of Clauses 1, 8 (to the extent that any obligation under this Clause remains outstanding), 9, 14, 16.2, 17, 19 and 20 shall
survive termination. 

  

	20.	General 

  

	20.1	All notices which are required to be given hereunder shall be in writing and shall be sent to the address of the recipient set out in this Agreement or such other address as the
recipient may designate by notice given in accordance with the provisions of this Clause. Any such notice may be delivered personally, by commercial overnight courier or facsimile transmission which shall be followed by a hard copy and shall be
deemed to have been served if by hand when delivered, if by commercial overnight courier 48 hours after deposit with such courier, and if by facsimile transmission when dispatched. 

  

	20.2	Neither party shall assign or otherwise transfer this Agreement or any of its rights and obligations hereunder whether in whole or in part without the prior written consent of the
other. If LICENSEE wishes to assign this Agreement to a party that is a successor-in-interest as a result of a merger or reorganization of LICENSEE or the sale by LICENSEE of all or substantially all of LICENSEE’s assets or equity, then
LICENSEE may do so provided that such party is not a competitor to ARM and LICENSEE obtains ARM’s prior written consent, such consent not to be unreasonably withheld. 

  

	20.3	Failure by either party to enforce any provision of this Agreement shall not be deemed a waiver of future enforcement of that or any other provision. 

  

	20.4	If any provision of this Agreement, or portion thereof, is determined to be invalid or unenforceable the same will be enforced to the maximum extent permissible so as to effect the
intent of the parties, and the remainder of this Agreement will continue in full force and effect. 

  

	20.5	This Agreement, including all Schedules and documents referenced herein, constitutes the entire agreement between the parties with respect to the subject matter hereof, and
supersedes and replaces all prior or contemporaneous understandings or agreements, written or oral, regarding the subject matter. Except as is provided in Clause 7.2 of this Agreement, no amendment to, or modification of, this Agreement shall be
binding unless in writing and signed by a duly authorised representative of both parties. 

  

	20.6	This Agreement shall be governed by and construed in accordance with the laws of England, without reference to conflicts of laws principles. In the event that ARM commences
proceedings against LICENSEE under this Agreement, the parties agree to submit to the jurisdiction of California, for the purpose of hearing and determining any disputes arising out of this Agreement. In the event that LICENSEE commences proceedings
against ARM under this Agreement, the parties agree to submit to the jurisdiction of the High Court of Justice, London, England, for the purpose of hearing and determining any disputes arising out of this Agreement. 

  

	20.7	Neither party shall make any press release or similar public announcement relating to the existence of this Agreement without obtaining the other party’s prior confirmation on
the contents thereof. 

  

	20.8	The Delivered Materials (as defined in Clause 16.1) provided under this Agreement are subject to U.S. export control laws, including the U.S. Export Administration Act and its
associated regulations, and may be subject to export or import regulations in other countries. LICENSEE agrees to comply fully with all laws and regulations of the United States and other countries (“Export Laws”) to assure that neither
the Delivered Materials, nor any direct products thereof are (1) exported, directly or indirectly, in violation of Export Laws, either to any countries that are subject to U.S export restrictions or to any end user who has been prohibited from
participating in the U.S. export transactions by any federal agency of the U.S. government; or (2) intended to be used for any purpose prohibited by Export Laws, including, without limitation, nuclear, chemical, or biological weapons
proliferation. 

  

 Page 14 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 IN
WITNESS WHEREOF the parties have caused this Agreement to be executed by their duly Authorised representative: 
  

									
	ARM LIMITED	  		  	LICENSEE:
					
	 SIGNED
	  	 

	  		  	SIGNED	  	 

	 NAME:
	  	TUDOR BROWN	  		  	NAME:	  	Ping Wu
	 TITLE:
	  	COO	  		  	TITLE:	  	President
	 DATE:
	  	18 Oct 2001	  		  	DATE:	  	10/12/2001

  

 Page 15 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 1 
 Design ID Request 
 (To be completed in duplicate) 
 Section 1 
 ***[Delete as appropriate]*** 
 ARM7TDMI Core: 
 As specified in ARM7TDMI Technical Reference Manual [***]. 
 ARM922T Core: 
 As specified in the ARM922T Core Technical Reference Manual ARM DDI-0184. 
 ARM946E Core: 
 As specified in the ARM946E Core Technical Reference Manual ARM DDI-0155. 
 Section 2 
 Part A 
 Program Design Rules 
 Process: 
 Version: 
 Agreed Waivers (if any): 
 Part B 
 Details of Authorised Design/Authorised Product:

 Part C 
 Authorised Foundry:

 Part D 
 Design ID: 

(To be filled in by ARM) 
  

 Page 16 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 2 
  

							
	 Item
	  	 Part Number
	  	 Description
	  	 Status

 Note: The last column of the deliverable lists show the confidentiality status of the deliverable. 

	          C	- confidential and N - non-confidential. 

 ARM7TDMI Core
Transfer Material 
 [***] 
  

 Page 17 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
  

 Page 18 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 3 
 Royalties and Royalty Reports 
 Part A 
 Royalty Payment Terms 
  

			
	Currency:	  	US Dollars
	Frequency:	  	At the end of each Quarter of each year in which Royalties are payable.
	Payment:	  	Payment by telegraphic transfer to National Westminster Bank PLC of 56 St Andrews
		  	Street, Cambridge, CB2 3DA, UK
	Account name:	  	ARM Ltd
	Account Number:	  	08086796
	Sort code:	  	52-10-46
	SWIFT code:	  	NWBKGB2L

 Part B 
 Royalty Rates 
  

					
	 Cumulative Volume of Authorised Product
	  	 ARM7TDMI Core
 Per Unit Royalty Rate
 ($US)
	 	 ARM9 Core
 Per Unit Royalty Rate
 ($US)

	 [ *** ]
	  	[ *** ]	 	[ *** ]
	 [ *** ]
	  	[ *** ]	 	[ *** ]
	 [ *** ]
	  	[ *** ]	 	[ *** ]
	 [ *** ]
	  	[ *** ]	 	[ *** ]

 [***] 
 In an ARM
Compliant Product with more than one Qualified ARM Core embedded into the same piece of silicon, the following multiplying factors shall be applied to the applicable Royalty Rates determined from the above table. N x M x Max. 
  

					
	Where	  	N =	 	the number of Qualified ARM Cores embedded on the same piece of silicon;
		  	M =	 	the applicable multiplier from the table below; and
		  	Max =	 	Prevailing Royalty Rate or [ *** ], whichever is the greater.

  

			
	 Number of Qualified ARM Cores Embedded on Same
Piece of Silicon
	  	 Multiplier

	 1
	  	 [ *** ]

	 2
	  	 [ *** ]

	 3
	  	 [ *** ]

	 4
	  	 [ *** ]

	 >5
	  	 [ *** ]

 Exhibit 1 
 Form of Royalty Report 
 FOR EACH DESIGN ID ISSUED FOR AN AUTHORISED PRODUCT 
  

							
	 DESIGN ID
	  	 	  	 
	 Cumulative number of UNITS of Authorised Product distributed by LICENSEE
	  	Applicable
Rate	  	Royalty
Due
		  	$	X	  	$	XXX
		  	$	X	  	$	XXX
	 Total
	  			  	$	XXX

  

 Page 19 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 During
the term of this Agreement, LICENSEE shall, upon ARM’S request, discuss with ARM details of LICENSEE’s product lines and product plans for the following Quarter. Such information shall be non-binding, supplied in good faith and treated as
Confidential Information. 
  

 Page 20 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 4 
 Trademarks 
  

					
		  	Trademark	  	Registered/ Unregistered
			
	Part A	  		  	
			
		  	ARM [logo] Exhibit A	  	Registered
			
	Part B	  		  	
			
		  	ARM Powered [logo] Exhibit B	  	Registered
			
	Part C	  		  	
			
		  	ARM [logo] Exhibit C	  	Registered
			
	Part D	  		  	
			
		  	ARM	  	Registered
		  	AMBA	  	Unregistered
		  	ARM7TDMI	  	Registered

 Rules for Trademark Usage 
  

	1.	On Die Encapsulation 

  

	1.1	Except as set out in Clause 1.2, if Licensee is distributing [ARM Compliant Products] Licensee shall apply the Trademark identified in Part A of this Schedule to the
die encapsulation of each unit of [ARM Compliant Product]. 

  

	1.2	Licensee shall not be obliged to apply the Trademark identified in Part A of this Schedule to the die encapsulation of each unit of [ARM Compliant Product] if;

  

	 	1.2.1	Licensee provides written evidence to ARM that Licensee’s customer has requested that the die encapsulation of each unit of [ARM Compliant Product] is to bear no trademarks
whatsoever; or 

  

	 	1.2.2	Licensee provides written evidence to ARM that Licensee’s customer has requested that the die encapsulation of each unit of [ARM Compliant Product] is to bear only the
trademark of such customer; or 

  

	 	1.2.3	the size of the die encapsulation physically prohibits the application of both Licensee’s trademark and the Trademark identified in Part A of this Schedule when such marks are
scaled to occupy the same area. 

  

	1.3	Where Licensee distributes ARM Compliant Products to an Intermediary, the packaging of each unit of such ARM Compliant Product so distributed must bear a mark which unambiguously
identifies Licensee as the manufacturing source of the ARM Product. If the packaging of the ARM Compliant Product cannot accommodate Licensee’s mark because of size limitations, then Licensee shall include a prominent statement indicating that
Licensee is the manufacturing source of the ARM Compliant Product (e.g. “Manufactured by [Licensee identity] under licence from ARM Limited”) in substantially all advertising material and promotional, technical or other documentation,
including press releases, associated with the ARM Compliant Product and Licensee shall oblige any Intermediary to do the same. 

  

	 	Where;	“Intermediary” means any third party to whom Licensee distributes an ARM Product and who is not an End User and “End User” means any person or
other legal entity which licenses an ARM Compliant Product for its own personal use or for use in the ordinary course of its business but not for onward sale, distribution or sublicensing. 

  

	1.4	Except as agreed in writing by ARM, any application by Licensee of the Trademark identified in Part A of this Schedule shall be in accordance with the Trademark Use Guide set out in
Exhibit A of this Schedule. 

  

	2.	On Product Packaging, Documentation, and Copy 

 ARM Powered Logo

  

 Page 21 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	2.1	Licensee shall apply the Trademark identified in Part B of this Schedule, in a prominent place, to any product packaging, advertising material or promotional,
technical or other documentation for, or relating to, any [ARM Compliant Product] distributed under licence from ARM. 

  

	2.2	**[Subject to the payment of an appropriate fee agreed between ARM and Licensee]**, Licensee may apply the Trademark identified in Part B of this Schedule,
to (i) any product which incorporates or takes into use any ARM technology or intellectual property; and (ii) any product packaging, advertising material or promotional, technical or other documentation for, or relating to, such
product, distributed by Licensee under licence from ARM. 

  

	2.3	Any use or application by Licensee of the Trademark identified in Part B of this Schedule shall be in accordance with; (i) the Trademark Use Guide set out in Exhibit B
of this Schedule; and (ii) with accepted trademark use standards. 

 ARM Logo (Exhibit C); Corporate Signature 
  

	2.4	Subject to the restriction in Clause 2.6, Licensee may apply the Trademark identified in Part C of this Schedule to any product packaging, advertising material or
promotional, technical or other documentation for, or relating to, any product distributed by Licensee under licence from ARM which incorporates or takes into use any ARM technology or intellectual property. 

  

	2.5	Any application of the Trademark identified in Part C of this Schedule by Licensee shall be in accordance with; (i) the Trademark Use Guide in Exhibit C of this
Schedule; and (ii) with accepted trademark use standards. 

  

	2.6	The Trademark identified in Part C of this Schedule may only be used separately and only to identify ARM (including ARM Holdings plc, its operating company ARM
Limited, and the regional subsidiaries, ARM, Inc.; ARM KK; and ARM Korea Limited) and may not be incorporated into a body of text. 

 Other
Trademarks 
  

	2.7	Licensee shall apply the appropriate Trademark from those identified in Part D of this Schedule to any product packaging, advertising material or promotional,
technical or other documentation relating to the respective product distributed by Licensee under licence from ARM. 

  

	2.8	Any use of the Trademarks identified in Part D of this Schedule by Licensee shall be in accordance with accepted trademark use standards including but not limited to the
following; 

  

	2.8.1	use of the Trademarks only in conjunction with a generic term for the respective product (e.g. ARM processor, where processor is the generic term); and 

  

	2.8.2	avoiding use of the Trademark, ARM, in the possessive (e.g. ARM’s processor). 

  

	3.	On Website 

  

	3.1	Licensee shall apply the Trademark identified in Part B of this Schedule to the page(s) of Licensee’s web site relating to any [ARM Compliant Product] distributed
under license from ARM. 

  

	3.2	Licensee may use the Trademark identified in Part C of this Schedule to create a hyperlink between the primary page of Licensee’s website and the primary page of
ARM’s website. Any use or application by Licensee on its Website of the Trademarks identified in Part C of this Schedule shall be in accordance with; (i) the Trademark Use Guides set out in Exhibit C of this Schedule;
(ii) accepted trademark use standards; and (iii) the restriction in Clause 2.6 above. 

 Licensee may apply the
Trademarks identified in Part D of this Schedule to the page(s) of Licensee’s website relating to any [ARM Compliant Product] distributed under licence from ARM. Any use or application by Licensee on its Website of the Trademarks
identified in Part D of this Schedule shall be in accordance with; (i) the restrictions set out in Clause 2.8 above; and (ii) accepted trademark use standards. 
  

	4.	Where any registered Trademark is applied to any product packaging, advertising material or promotional, technical or other documentation relating to any product distributed under
licence from ARM, then for each prominent use and the first use in any text of any such mark the mark must appear with the symbol “®” at the upper right corner of the mark. 

  

	5.	Where any unregistered Trademark is applied to any product packaging, advertising material and promotional, technical or other documentation relating to the any product distributed
under licence from ARM, then for each prominent use and the first use in any text of any such mark the mark must appear with the symbol “TM” at the upper right corner of the mark. 

  

 Page 22 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	6.	Licensee shall include appropriate notices in substantially the following form on any product packaging, advertising material and promotional, technical or other documentation
relating to any product distributed under licence from ARM; 

 For registered Trademarks 
 “[Cite Trademark(s)] is [are] the registered trademark(s) of ARM Limited. 
 For unregistered Trademarks 
 “[Cite
Trademark(s)] is [are] the trademark(s) of ARM Limited. 
  

	7.	ARM will provide its Licensees with camera ready and electronic artwork of the Trademarks together with specific Pantone colour references. The Trademarks must not be altered or
modified in any way. The Trademarks may be used in black and white or the exact colour reference identified in the relevant Exhibit. 

  

	8.	In addition to the rules set out above ARM may provide Licensees with additional instructions relating to the use of the Trademarks from time to time which Licensee shall follow in
its use of the Trademarks. 

  

 Page 23 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Trademark Use Guide 
 Exhibit A 
 

 
 Exhibit B 
 

 
 Exhibit C 
 

 
 The marks must appear exactly as shown in this guide; the elements, proportions and relationships must not change.
The marks are available in stat repro form and in .eps for Macintosh or .WMF for PC platforms. These formats ensure the highest possible reproduction quality. However, should you need another format for a specific project, please contact your local
ARM office for advice. 
 When produced in colour, the mark should be printed in Pantone 314 blue. Process colour reproduction may not match
Pantone-identified solid colour standards. 
 When specifying the colour of the mark with process inks, the correct mix is: 
  

			
	 Cyan
	  	100
	 Magenta
	  	0
	 Yellow
	  	8.5
	 Black
	  	34

  

	 	•	 	 Do not alter or deform the shape of the marks. 

  

	 	•	 	 Do not replace the logotype with a different typeface or attempt to mimic the logotype typeface. 

  

	 	•	 	 Do not place competing visual elements (including but not limited to other Trademarks) close to the marks. 

  

	 	•	 	 Do not set type near to the marks that could be construed as a corporate slogan or motto. 

  

 Page 24 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 5 
 Payment Schedule 
 Part A 
  

							
	 Design Fee
	  	 US$
 Due
	 	US$
Payable	 	 Payment Due Date

	          [ *** ]
	  	[ *** ]	 	[ *** ]	 	 [ *** ]

		  		 	[ *** ]	 	 [ *** ]

		  		 	[ *** ]	 	 [ *** ]

	          [ *** ]
	  		 		 	
				
	          [ *** ]
	  	[ *** ]	 	[ *** ]	 	 [ *** ]
 [ *** ]

		  		 	[ *** ]	 	 [ *** ]

				
	          [ *** ]
	  	[ *** ]	 	[ *** ]	 	 [ *** ]
 [ *** ]

		  		 	[ *** ]	 	 [ *** ] 
 [ *** ]

		  		 	[ *** ]	 	 [ *** ]

				
		  		 		 	 [ *** ] 
 [ *** ]

 Part B 
  

					
	 Maintenance Update Fees
	  	US$	 	 Payment Due Date

	 [ *** ]
 [ *** ]
	  	[ *** ]	 	 [ *** ]
 [ *** ]

 Part C 
  

					
	 Second Source Fee
	  	US$	 	 Payment Due Date

	 [ *** ]
	  	[ *** ]	 	 [ *** ]
 [ *** ]
 [ *** ]

 Part D 
  

					
	 Design Sign-Off Model Option Fee
	  	US$	 	 Payment Due Date

	 [ *** ]
	  	[ *** ]	 	 [ *** ]
 [ *** ]
 [ *** ]

  

 Page 25 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Part
E 
  

					
	 Additional Support Fees
	  	US$	 	 Payment Due Date

	 [ *** ]
	  	[ *** ]	 	 [ *** ]
 [ *** ]
 [ *** ]

 Part F 
  

					
	 Process Migration Fee
	  	US$	 	 Payment Due Date

	 [ *** ]
	  	[ *** ]	 	 [ *** ]
 [ *** ]
 [ *** ]

  

 Page 26 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 6 
 End User Licence 
 Spreadtrum Communications, Inc. (“LICENSOR”) hereby grants and the LICENSEE hereby accepts a non transferable and non-exclusive licence to use the Software under the following terms and conditions:

  

	1.	Ownership. The Software is the property of ARMLIMITED and/or its licensors. The LICENSEE acquires no title, right or interest in the Software other than the licence rights
granted herein. 

  

	2.	Use. The LICENSEE may use the Software on any one computer at one time except that the Software may be executed from a common disc shared by multiple CPUs provided that one
authorised copy of the Software has been licensed from LICENSOR for each CPU executing the Software. LICENSEE shall not reverse engineer, decompile or disassemble the Software, in whole or in part. 

  

	3.	Copies. The LICENSEE may make copies of the Software for back-up and archival purposes only. All copies of the Software must bear the same notice(s) contained on the original
copies supplied by LICENSOR. 

  

	4.	Software Limited Warranty. LICENSOR warrants that the disks containing the Software shall be free from defects and workmanship under normal use and the programs will perform
in accordance with the accompanying documentation for a period of ninety (90) days from the date of delivery. Any written or oral information or advice given by LICENSOR distributors, agents or employees will in no way increase the scope of this
warranty. LICENSOR’s entire liability and the LICENSEE’s exclusive remedy will be, at LICENSOR’s sole option, to replace the disk or to use LICENSOR’s reasonable efforts to make the Software meet the warranty set out above. Any
replacement Software will be warranted for the remainder of the original warranty period or thirty (30) days, whichever is the longer. The LICENSEE agrees that the supply of the Software does not include updates and upgrades, which may be
available from LICENSOR under a separate support agreement. 

 THE ABOVE WARRANTIES ARE EXCLUSIVE AND IN LIEU OF ALL OTHER
WARRANTIES, WHETHER EXPRESS OR IMPLIED INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT. 
 IN NO EVENT SHALL LICENSOR BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES RESULTING FROM ITS PERFORMANCE OR FAILURE TO PERFORM UNDER THIS AGREEMENT OR THE FURNISHING, PERFORMANCE, OR USE OF
ANY SOFTWARE LICENSED HERETO, WHETHER DUE TO BREACH OF CONTRACT, BREACH OF WARRANTY, OR NEGLIGENCE EVEN IF LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 
 THE MAXIMUM LIABILITY OF LICENSOR SHALL BE LIMITED TO REFUND TO THE LICENSEE THE FEE PAID BY THE LICENSEE FOR THE SOFTWARE. 
 Assignment of the Agreement. This Agreement and any licence granted hereunder to the LICENSEE may not be assigned, sub-licensed or otherwise transferred by the LICENSEE to any third party without the prior
written consent of LICENSOR. Transfer to a U.S. government department or agency or to a prime or lower tier contractor in connection with a U.S government contract shall be made only upon the prior written agreement to terms agreed by LICENSOR.

 Terms and Termination. This Agreement and licences granted hereunder may be terminated forthwith by LICENSOR by written notice to
the LICENSEE in case of (i) breach by the LICENSEE of any provisions of this Agreement, and (ii) non-payment by the LICENSEE in due time of any sum due from the LICENSEE in consideration of delivery and licence of this Software.

 Upon termination of this Agreement and of the licence granted hereunder, the LICENSEE shall refrain from any further use of the Software,
and LICENSOR may request either the destruction of any copy of the Software, in any form, in the possession of the LICENSEE or the return of the same to LICENSOR. 
 Applicability. The limitations and exclusions above may not apply in certain countries or states where they conflict with local law. In cases where such a conflict exists the local law shall prevail and the
remaining provisions of the Agreement shall remain in full force and effect. 
  

 Page 27 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 7 
 MicroPack 
 Section 1 
 PartA 
 AMBA
Specification 
 Product Specification CPDF Format) 
  

							
	A1	  	BU010-DA-03002	  	AMBA Specification ARM IHI 0011A	  	N
		
	Part B	  	
	Documentation	  	
	Example AMBA System Product Information (PDF Format)	  	
				
	Bl	  	BU010-DA-03003	  	Reference Peripherals Specification ARM DDI 0062	  	N
	B2	  	BU010-DA-03004	  	Example AMBA System User Guide ARM DUI 0092	  	N
	B3	  	BU010-DA-03019	  	ASB Example AMBA System Technical Reference ARM DDI 0138	  	N
	B4	  	BU010-DA-03019	  	AHB Example AMBA ‘System Technical Reference ARM DDI 0170	  	N
		
	Section 2  
	  	
	Part A	  	
	EASY Test Vectors	  	
				
	Al	  	BU010-VE-01005	  	EASY Test Vectors TIC/TIF	  	C
		
	Part B	  	
	Software Examples	  	
				
	Bl	  	BU010-SW-02001	  	EASY Software. Examples	  	N
		
	Part C	  	
	Test Infrastructure	  	
				
	C1	  	BU010-SW-02002	  	TIC Vector Generation Environment	  	C
		
	Part D	  	
	EASY Module Test	  	
				
	Dl	  	BU010-MN-23002	  	EASY Module Test VHDL	  	C
	D2	  	BU010-VE-09001	  	EASY Module Vectors	  	C
		
	Part E	  	
	AMBA Module Test Benches	  	
				
	El	  	BU010-DA-03020	  	AMBA Module Testbench Documentation	  	C
	E2	  	BU010-MN-23003	  	AMBA Module Testbench VHDL	  	C
	E3	  	BU010-SW-02003	  	AMBA Module Testbench Vector Generation Environments	  	C
		
	Part F	  	
	CPU AHB Wrappers	  	
	TBD	  	
		
	Part G	  	
	EASY Models	  	
				
	Al	  	BU010-MN-23001	  	EASY Synthesisable VHDL	  	C
	A2	  	BU010-MN-01001	  	EASY Synthesis Scripts	  	C

  

 Page 28 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 8 
 Form of Subsidiary’s Undertaking 
  

			
	 Name of Subsidiary
	 	 
                                        
                                        
    

		
	 Address of Subsidiary
	 	 
                                        
                                        
    

		
		 	 
                                        
                                        
    

		
		 	 
                                        
                                        
    

		
		 	 
                                        
                                        
    

 Percentage of Subsidiary’s shares owned or controlled by LICENSEE (or a Subsidiary of LICENSEE)
     % 
 The undersigned has read and understood the terms and conditions of the Technology Licence Agreement between ARM and
LICENSEE dated                      (the “Agreement”). The Subsidiary hereby agrees to be bound by each and every term and condition
of the Agreement. The undersigned is duly authorized to execute this undertaking for and on behalf of the Subsidiary. 
  

			
	 Signed
	 	 
                                        
                                        
    

		
	 Name
	 	 
                                        
                                        
    

		
	 Title
	 	 
                                        
                                        
    

		
	 Date
	 	 
                                        
                                        
    

  

 Page 29 of 29 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 AMENDMENT ONE 
 TO THE 
 DESIGN LICENSE AGREEMENT 
 BETWEEN 
 ARM LIMITED 
 AND 
 SPREADTRUM COMMUNICATIONS, INC. 
 This
amendment (“Amendment One”) amends the Design License Agreement between ARM Limited (“ARM”) and Spreadtrum Communications, Inc. (“Spreadtrum”), and dated the 15th October 2001 (“Agreement”). The Effective Date of this Amendment One shall be 11/6, 2001. 
 The Parties hereby agree to make the following amendments to the Agreement: 
  

	1.	Delete Clause 1.19 and add a new Clause 1.19 as follows: 

  

	 	1.19	“EASY Models” means the verilog models identified in Schedule 7 Section 2 Part G. 

  

	2.	Delete Schedule 7 in its entirety and replace it with the Schedule 7 attached hereto to this Amendment One. 

  

	3.	Add a new Clause 1.35 as follows: 

  

	 	1.35	“AMBA Design Kit” means together; (i) the VC Release Note; (ii) the VC Bundle; and (iii) the CPU AHB Wrappers set forth in Schedule 8 Part C.

  

	4.	Delete Clause 1.14 and replace it with a new Clause 1.14 as follows: 

  

	 	1.14	“CPU AHB Wrappers” means such of the wrappers identified in Schedule 7 Section 2 Part F and Schedule 8 Part C as are delivered to LICENSEE from time to time by
ARM pursuant to a request from LICENSEE in accordance with the provisions of Clause 10.2. 

  

	5.	Delete Clause 1.33 in its entirety and replace it with a new Clause 1.33 as follows: 

  

	 	1.33	“Transfer Materials” means together; (i) the Layout Design Data; (ii) the Functional Test Vectors; (iii) ARM MicroPack;
(iv) the AMBA Design Kit; (v) the Documentation; and (vi) the ARM Developers Kit identified in Schedule 2 Part A Section 4, for each Qualified ARM Core, together with any Updates thereto delivered to LICENSEE
by ARM from time to time. 

  

	6.	Add a new Clause 1.36 as follows: 

  

	 	1.36	“VC Bundle” means the deliverables identified in Schedule 8 Part A 

  

	7.	Add a new Clause 1.37 as follows: 

  

	 	1.30	“VC Release Note” means the documentation identified in Schedule 8 Part B. 

  

 1 of 2 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	8.	Delete Clause 2.1(iii) and replace it with a new Clause 2.1(iii) as follows: 

  

	 	(iii)	use, copy and modify; (a) the Software Examples; (b) the EASY Test Vectors; (c) the EASY Models; (d) the Test Infrastructure; (e) the AMBA Module Test
Benches; (f) the EASY Module Test; (g) the CPU AHB Wrappers, (h) the VC Bundle; and (i) the VC Release Note, only for the purposes of designing, having designed (subject to the provisions of Clause 2.2) ARM Compliant Products;

  

	9.	Add the Schedule 8 attached hereto to this Amendment One. 

 Any provision
of the Agreement that is not hereby amended shall remain in full force and effect. 
  

									
	ARM LIMITED	 	 	 	SPREADTRUM COMMUNICATIONS, INC.
					
	BY:	 	

	 		 	BY:	 	

					
	NAME:	 	PHILIP DAVID	 		 	NAME:	 	Ping Wu
					
	TITLE:	 	VP UK LEGAL	 		 	TITLE:	 	President
					
	DATE:	 	03/10/02	 		 	DATE:	 	1/9/2002

  

 2 of 2 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 AMENDMENT TWO 
 TO THE 
 DESIGN LICENSE AGREEMENT 
 BETWEEN 
 ARM LIMITED 
 AND 
 SPREADTRUM COMMUNICATIONS, INC. 
 This
amendment (“Amendment Two”) amends the Design License Agreement between ARM Limited (“ARM”) and Spreadtrum Communications, Inc. (“LICENSEE”), and dated the 15th October 2001 (“Agreement”). The Effective Date of this Amendment One shall be the 30th day of June, 2003. 
 Whereas LICENSEE wishes to exercise the
options granted to it by ARM for a second, third and fourth Authorised Products (as defined in the Agreement) under Clause 2.8 of the Agreement, such Authorised Products to be based on the ARM7TDMI Core. 
 In consideration for the mutual representations, covenants, and other terms and conditions contained herein, ARM and LICENSEE hereby agree to amend the Agreement as
follows: 
  

	1.	Add the following new Clause 1.38: 

  

	 	1.38	“LICENSEE” means Spreadtrum Communications, Inc. (“Spreadtrum”) and any Subsidiaries of Spreadtrum. 

  

	2.	Add the following new Clause 1.39: 

  

	 	1.39	“Subsidiary” means any company 100% of whose voting shares is now or hereafter owned or controlled, directly or indirectly, by a party hereto. A company shall be a
Subsidiary only so long as such control exists and any rights granted to any Subsidiary hereunder shall automatically terminate upon such Subsidiary of Spreadtrum ceasing to be a Subsidiary of Spreadtrum. 

  

	3.	Delete Clause 2.7 in its entirety and replace it with the following new Clause 2.7: 

  

	 	2.7	Under this Agreement LICENSEE shall be permitted to have manufactured and ARM shall only be obliged to issue Design ID(s) in respect of Authorised Designs and four
(4) Authorised Products. The first Authorised Product shall be based on the ARM7TDMI Core identified in Section 1 of Schedule 1. The second, third and fourth Authorised Products shall be based on the ARM7TDMI Core identified in
Section 1 of Schedule 1. For the avoidance of doubt, LICENSEE shall be required to pay [***] Design Fees (as defined in Clause 8.1), one Design Fee for the first Authorised Product and one Design Fee for the second, third, and fourth Authorised
Products. 

  

	4.	Delete Clause 2.8 in its entirety and replace it with the following new Clause 2.8: 

  

	 	2.8	LICENSEE shall base the second, third and fourth Authorised Products on the ARM7TDMI Core identified in Section 1 of Schedule 1 for which LICENSEE shall give written notice to
ARM in the form of a Design ID request as set out in Schedule 1 Section 1. Upon receipt of such notice in accordance with the provisions of this Clause 2.8, ARM shall invoice LICENSEE for the relevant Design Fee (defined in Clause 8.1).

  

 1 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	5.	Add the following new 2.13: 

 Intercompany Matters

  

	 	2.13	Any breach of this Agreement by a Subsidiary of Spreadtrum shall entitle ARM to terminate this Agreement in accordance with the provisions of Clause 18.2 as if Spreadtrum were the
party in breach. Any termination of this Agreement in accordance with the provisions of Clause 18.2 shall be effective in respect of Spreadtrum and all Subsidiaries. 

 Any rights granted to any Subsidiary of Spreatrum hereunder shall automatically terminate upon such Subsidiary of Spreadtrum ceasing to be a Subsidiary of
Spreadtrum. 
 In the event that a Subsidiary of Spreadtrum is in breach of any of the terms of this Agreement, Spreadtrum shall hold harmless
and indemnify ARM against all and any loss, liability, costs, damages, expenses (including the reasonable fees of lawyers and other professionals) suffered, as a result of or in connection with such breach. 
  

	6.	Add the following new Clause 7.5A: 

  

	 	7.5A	Within a mutually agreeable time period following the Effective Date of this Amendment Two, LICENSEE and ARM shall mutually agree a press release relating to the commercial
relationship established under this Agreement. 

  

	7.	Delete Clause 8.4 in its entirety and replace it with the following new Clause 8.4: 

  

	 	8.4	Upon exercise of the option granted in Clause 6.2, for each Design Sign-Off Model Option delivered to LICENSEE, LICENSEE shall pay, to ARM, a fee (“Design Sign-Off
Model Option Fee”) as set out in and in accordance with Schedule 5 Part D and a maintenance fee (“Design Sign-Off Model Option Maintenance Fee”) as set out in and in accordance with Schedule 5 Part G.

  

	8.	Add the following new Clause 13.2: 

  

	 	13.2	In the period of twelve (12) months after the payment of the first installment of the second Design Fee, in consideration for the payment of such Design Fee, LICENSEE may
request and ARM shall provide places for a maximum of three (3) of LICENSEE’S personnel on one of ARM’s standard ARM open training courses and places for a maximum of four (4) of LICENSEE’S personnel on one of ARM’s
foundry program training courses. 

  

	9.	Delete Schedule 1 in its entirety and replace it with the new Schedule 1 attached to this Amendment Two. 

  

	10.	A copy of the existing Schedule 2 setting forth the Transfer Materials for the ARM7TDMI Core is attached to this Amendment Two for convenience. 

  

 2 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	11.	Delete Schedule 3 in its entirety and replace it with the new Schedule 3 attached to this Amendment Two. 

  

	12.	Delete Schedule 5 in its entirety and replace it with the new Schedule 5 attached to this Amendment Two. 

 Any provision of the Agreement that is not hereby amended shall remain in full force and effect. 
  

							
	ARM LIMITED	 	SPREADTRUM COMMUNICATIONS, INC.
				
	BY	 	

	 	BY	 	

				
	NAME	 	Tudor Brown	 	NAME	 	Ping Wu
				
	TITLE	 	Chief Operating Officer	 	TITLE	 	President
				
	DATE	 	30 June 03	 	DATE	 	6/30/03

  

 3 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 1 
 Design ID Request 
 (To be completed in duplicate) 
 ***[Delete as appropriate]*** 
 ARM7TDMI Core: 
 As specified in ARM7TDMI Technical
Reference Manual [***]. 
 Program Design Rules 
 Process: 
 Version: 
 Agreed Waivers
(if any): 
 Details of Authorised Design/Authorised Product: 
 Authorised Foundry: 
 Design ID: 
 (To be filled in by ARM) 
  

 4 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 2 
  

							
	Item	 	 Part Number
	  	 Description
	  	Status
	 Note:
	 	The last column of the deliverable lists show the confidentiality status of the deliverable.	  	
		 	C—confidential and N—non-confidential.	  	

 ARM7TDMI Core Transfer Material 
 [***] 
  

 5 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
  

 6 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 3 
 Royalties and Royalty Reports 
 Royalty Payment Terms 
  

			
	 Currency:
	 	US Dollars
	 Frequency:
	 	At the end of each Quarter of each year in which Royalties are payable.
	 Payment:
	 	Payment by telegraphic transfer to National Westminster Bank PLC of 56 St Andrews Street, Cambridge, CB2 3DA, UK.
	 Account name:
	 	        ARM Ltd
	 Account Number:
	 	        08086796
	 Sort code:
	 	        52-10-46
	 SWIFT code:
	 	        NWBKGB2L

 Royalty Rates 
  

			
	 Cumulative Volume of Authorised Product
	  	 Qualified ARM Core Per Unit Royalty Rate
($US)

	 [ *** ]
	  	 [ *** ]

	 [ *** ]
	  	 [ *** ]

	 [ *** ]
	  	 [ *** ]

	 [ *** ]
	  	 [ *** ]

 In an ARM Compliant Product with more than one Qualified ARM Core embedded into the same piece of silicon, the
following multiplying factors shall be applied to the applicable Royalty Rates determined from the above table. 
 N x M x Max. 
  

			
	 Where
	  	N = the number of Qualified ARM Cores embedded on the same piece of silicon;
		  	M = the applicable multiplier from the table below; and
		  	Max = Prevailing Royalty Rate or [***], whichever is the greater.

  

			
	 Number of Qualified ARM Cores Embedded on Same Piece of Silicon
	  	 Multiplier

	 1
	  	 [ *** ]

	 2
	  	 [ *** ]

	 3
	  	 [ *** ]

	 >4
	  	 [ *** ]

  

 7 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Form of Royalty Report 
 FOR EACH DESIGN ID ISSUED FOR AN AUTHORISED PRODUCT 
  

							
	 DESIGN ID
	  	 	  	 
	 Cumulative number of UNITS of Authorised Product distributed by LICENSEE
	  	 	Applicable Rate	  	 	Royalty Due
		  	$	X	  	$	XXX
		  	$	X	  	$	XXX
	 Total
	  			  	$	XXX

 During the term of this Agreement, LICENSEE shall, upon ARM’s request, discuss with ARM details of
LICENSEE’S product lines and product plans for the following Quarter. Such information shall be non-binding, supplied in good faith and treated as Confidential Information. 
  

 8 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 5 
 Payment Schedule 
 Part A 
  

							
	 Design Fee
	  	US$	 	US$	 	 Payment Due Date

		  	Due	 	Payable	 	
	 [ *** ]
	  	[ *** ]	 	[ *** ]
[ *** ]
[ *** ]	 	 [ *** ]
 [ *** ]
 [ *** ]

				
	 [ *** ]
 [ *** ]
	  	[ *** ]	 	[ *** ]	 	 [ *** ]
 [ *** ]

 Part B 
  

					
	 Maintenance Update Fees
	  	US$	 	 Payment Due Date

	 [ *** ]
 [ *** ]
	  	[ *** ]
[ *** ]	 	 [ *** ]
 [ *** ]

 Part C 
  

					
	 Second Source Fee
	  	US$	 	 Payment Due Date

	 [ *** ]
	  	[ *** ]	 	 [ *** ]
 [ *** ]
 [ *** ]

 Part D 
  

					
	 Design Sign-Off Model Option Fee
	  	US$	 	 Payment Due Date

	 [ *** ]
	  	[ *** ]	 	 [ *** ]
 [ *** ]
 [ *** ]

 Part E 
  

					
	 Additional Support Fees
	  	US$	 	 Payment Due Date

	 [ *** ]
	  	[ *** ]	 	 [ *** ]
 [ *** ]
 [ *** ]

  

 9 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Part
F 
  

					
	 Process Migration Fee
	  	US$	  	 Payment Due Date

	 [ *** ]
	  	[ *** ]	  	 [ *** ]
 [ *** ]
 [ *** ]

 Part G 
  

					
	 Design Sign-Off Model Option Maintenance Fee
	  	US$	  	 Payment Due Date

	 [ *** ]
	  	[ *** ]
[ *** ]	  	 [ *** ]
 [ *** ]
 [ *** ]

  

 10 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 AMENDMENT THREE 
 TO THE 
 DESIGN LICENSE AGREEMENT 
 BETWEEN 
 ARM LIMITED 
 AND 
 SPREADTRUM COMMUNICATIONS, INC. 
 This
amendment (“Amendment Three”) amends the Design License Agreement between ARM Limited (“ARM”) and Spreadtrum Communications. Inc. (“LICENSEE”), and dated the 15th October 2001 (“Agreement”). The Effective Date of this Amendment One shall be the 20th day of November, 2003. 
 Whereas in Amendment Two to the
Agreement, LICENSEE exercised the options granted to it by ARM for a second, third and fourth Authorised Products (as defined in the Agreement) under Clause 2.8 of the Agreement, such Authorised Products to be based on the ARM7TDMI Core. Whereas in
Amendment Three, LICENSEE wishes to license ARM[***] Core for use in the second, third and fourth Authorised Products referred to in Amendment Two to be based on the ARM[***] Core (as defined below), as well as the ARM7TDMI Core. 
 In consideration for the mutual representations, covenants, and other terms and conditions contained herein, ARM and LICENSEE hereby agree to amend the Agreement as
follows: 
  

	1.	Delete Clause 1.7 in its entirety and replace it with the following new Clause 1.7: 

  

	 	1.7	“ARM[***] Core” means the ARM[***] Core as described and identified in the relevant technical reference manual in Schedule 1 Section 1.

  

	2.	Delete Clause 1.8 in its entirety. 

  

	3.	Delete Clause 1.9 in its entirety. 

  

	4.	Add the following new Clause 1.40: 

  

	 	1.40	“Sun SCSL License Agreement” means any of: (i) a Sun Community Source License entered into between LICENSEE and Sun Microsystems Inc for the Sun CLDC
technology: or (ii) any license agreement entered into between LICENSEE and Sun Microsystems Inc which expressly permits LICENSEE to share source code for the Sun CLDC technology with ARM for the Sun CLDC technology.

  

	5.	Add the following new Clause 1.41: 

  

	 	1.41	“Jazelle” means the extension to the ARM architecture that enables the execution of a subset of Java byte codes by an ARM core as accessed through the BXJ
instruction. 

  

	6.	Delete Clause 2.7 in its entirety and replace it with the following new Clause 2.7: 

  

	 	2.7	 Under this Agreement LICENSEE shall be permitted to have manufactured and ARM shall only be obliged to issue Design ID(s) in respect of Authorised 

  

 1 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	 	 
Designs and [***] Authorised Products. The [***] Authorised Product shall be based on the ARM7TDMI Core. The [***] Authorised Product shall be based on
both the ARM7TDMI Core and the ARM[***] Core. The [***] and [***] Authorised Products shall be based on: (i) the ARM[***] Core or (ii) both the ARM7TDMI Core and the ARM[***] Core. The [***] or [***] Authorised Product shall
also include one (1) use of the ARM [***] Wireless Platform, licensed to LICENSEE by ARM under the ARM [***] Wireless Platform license agreement dated the 20th of November, 2003, Document Number LEC-TLA-00233. 

  

	7.	Delete Clause 2.8 in its entirety and replace it with the following new Clause 2.8: 

  

	 	2.8	ARM shall deliver to LICENSEE the Transfer Materials for the ARM[***] Core within thirty (30) days after the Effective Date of this Amendment Three. Subsequent to delivery of
the Transfer Materials for the ARM[***] Core, LICENSEE shall submit a Design ID request as set out in Schedule 1 Section 1. 

  

	8.	Add the following new Clause 2.14: 

  

	 	2.14	LICENSEE acknowledges that the ARM[***] Core incorporates hardware acceleration for Sun Microsystems Inc.’s (“Sun”) Java technology. Without prejudice to any
limitations or restrictions set out in the license grants in Clause 2.1 above, LICENSEE agrees that unless LICENSEE has entered into and continues to enjoy the benefit of a Sun SCSL License Agreement. LICENSEE shall be subject to the following
licensing restrictions; 

  

	 	    A.	LICENSEE shall not; (i) carry out or procure any functional modification of any part of the ARM[***] Core to the extent that it includes, incorporates or implements
Jazelle: or (ii) reverse engineer or use the Transfer Materials licensed under this Agreement for the purpose of implementing the whole or any part of a Java specification (where a Java specification means any “Final Release”
of a “JSR” developed as part of the Java Community Process) without first entering into a Sun SCSL License Agreement; 

  

	 	    B.	LICENSEE agrees that Sun Microsystems Inc. shall be an intended third party beneficiary of the terms and conditions of this Agreement solely for the purpose of enforcing the
restrictions contained in A above; and 

  

	 	    C.	If LICENSEE discloses or distributes any Transfer Materials which includes, incorporates or implements Jazelle to a third party, except as ARM Compliant Products in the form of
silicon, then such third party shall be made subject to the same restrictions as LICENSEE in A and B above. 

  

	9.	Delete Clause 10.3 in its entirety. 

  

	10.	Add the following new Clause 15.5: 

  

	 	15.5	ARM hereby discloses the following against the warranty provided in Clause 15.3(ii) of the Agreement: 

 On the 28th May 2002, ARM received notice that Nazomi Communications. Inc. (“Nazomi”) has filed a patent infringement suit against ARM alleging that the Transfer Materials for the ARM926EJ licensed
this Agreement infringes Nazomi’s United States patent #6.332.215. 
  

 2 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	11.	Delete Schedule 1 in its entirety and replace it with the new Schedule 1 attached to this Amendment Three. 

  

	12.	Add the new Schedule 2A attached to this Amendment Three. 

  

	13.	Delete Schedule 5 Part A in its entirety and replace it with the new Schedule 5 Part A attached to this Amendment Three. 

 Any provision of the Agreement that is not hereby amended shall remain in full force and effect. 
  

											
	 ARM LIMITED
	 		 	SPREADTRUM COMMUNICATIONS, INC.	 	
						
	BY	 	 

	 		 	BY	 	 

	 	
	NAME	 	

	 		 	NAME	 	Ping Wu	 	
	TITLE	 	

	 		 	TITLE	 	CEO/President	 	
	DATE	 	11/20/03	 		 	DATE	 	11/20/03	 	

  

 3 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 1 
 Design ID Request 
 (To be completed in duplicate) 
 Section 1 
 ***[Delete as appropriate]*** 
 ARM7TDMI Core: 
 As specified in ARM7TDMI Technical Reference Manual. 
 ARM[***] Core: 
 As specified in the ARM[***] Technical Reference Manual 
 Section 2

 Part A 
 Program Design Rules 
 Process: 
 Version: 
 Agreed Waivers (if any): 
 Part B 
 Details of Authorised Design/Authorised Product: 
 Part C

 Authorised Foundry: 
 Part D 
 Design ID: 
 (To be filled in by ARM) 
  

 4 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 2A 
  

							
	 Item
	  	Part Number	  	Description	  	Status

  

	Note:	The last column of the deliverable lists show the confidentiality status of the deliverable. 

 C—confidential and N—non-confidential. 
 ARM[***] Core Transfer Materials 
 [***] 
 Key to Disclosure Rights 
  

			
	C	 	Confidential material
	D	 	Confidential material, with disclosure permitted to Designers
	M	 	Confidential material, with disclosure permitted to Manufacturers
	T	 	Confidential material, with disclosure permitted to Test Houses
	N	 	Non-confidential material but disclosure may be subject to license restrictions

 [***] 
  

 5 of 10 

  
 Confidential Treatment
Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and
Exchange Commission. Confidential treatment has been requested by Spreadtrum Communications, Inc. with respect to the omitted portions. 

 Page 6 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
  

 7 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
  

 8 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 5 
 Payment Schedule 
 Part A 
 Note: This schedule takes into account amounts already paid by LICENSEE to ARM under the
original Agreement and Amendment Two. 
  

							
	 Design Fee
	  	US$	  	US$	  	 Payment Due Date

	 	  	Due	  	Payable	  	 
	   [ *** ]
	  	[ *** ]	  	[ *** ]	  	 [ *** ]

				
		  		  	[ *** ]	  	 [ *** ]

				
		  		  	[ *** ]	  	 [ *** ]

				
	   [ *** ]
	  		  		  	
				
	   [ *** ]
	  	[ *** ]	  	[ *** ]	  	 [ *** ]

				
	   [ *** ]
	  	[ *** ]	  	[ *** ]	  	 [ *** ]

  

 9 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Part A (continued) 
  

							
	 Design Fee
	  	US$	  	US$	  	 Payment Due Date

	 	  	Due	  	Payable	  	 
	   [ *** ]
	  		  		  	
				
	   [ *** ]
	  	[ *** ]	  	[ *** ]	  	 [ *** ]

				
	   [ *** ]
	  	[ *** ]	  	[ *** ]	  	 [ *** ]

		  		  		  	 [ *** ]

		  		  		  	 [ *** ]

		  		  		  	 [ *** ]

				
	   [ *** ]
	  		  		  	
				
	   [ *** ]
	  	[ *** ]	  	[ *** ]	  	 [ *** ]

				
	   [ *** ]
	  	[ *** ]	  	[ *** ]	  	 [ *** ]

  

 10 of 10 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 AMENDMENT FOUR 
 TO THE 
 DESIGN LICENSE AGREEMENT 
 BETWEEN 
 ARM LIMITED 
 AND 
 SPREADTRUM COMMUNICATIONS, INC. 
 This
amendment (“Amendment Four”) amends the Design License Agreement between ARM Limited (“ARM”) and Spreadtrum Communications, Inc. (“LICENSEE”), and dated the 15th October 2001 (“Agreement”). The Effective Date of this Amendment Four shall be the 21st day of September, 2004. 
 Background 
 LICENSEE wishes to migrate to an [***] for their design containing and ARM7TDMI
Core. 
 In consideration for the mutual representations, covenants, and other terms and conditions contained herein, ARM and LICENSEE hereby agree to amend
the Agreement as follows: 
  

	1.	Add the attached new Schedule 2 to Schedule 2 of the Agreement. 

  

	2.	LICENSEE agrees to pay to ARM the Process Migration Fee as set forth in Clause 2.6 of the Agreement upon the Effective Date of this Amendment Four. 

 Any provision of the Agreement that is not hereby amended shall remain in full force and effect. 
  

							
	ARM LIMITED	 	SPREADTRUM COMMUNICATIONS, INC.
				
	BY	  	

	 	BY	  	

	NAME	  	WT PARSONS	 	NAME	  	Renyong Fan
	TITLE	  	EVP.	 	TITLE	  	VP. of Operation
	DATE	  	Oct 1, 2004	 	DATE	  	9/27/04

  

 1 of 2 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 2—ARM7TDMI [***] 
 Key to Disclosure Rights 
  

			
	 C
	  	CONFIDENTIAL
	 D
	  	CONFIDENTIAL except disclosure permitted to “ADC Program Member”
	 M
	  	CONFIDENTIAL except disclosure permitted to “Manufacturers”
	 T
	  	CONFIDENTIAL except disclosure permitted to “Test Houses”
	 N
	  	NON-CONFIDENTIAL but disclosure may be subject to license restrictions

 [***] 
  

 2 of 2 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 AMENDMENT FIVE 
 TO THE 
 DESIGN LICENSE AGREEMENT 
 BETWEEN 
 ARM LIMITED 
 AND 
 SPREADTRUM COMMUNICATIONS, INC. 
 This amendment (“Amendment Five”) amends the Design
License Agreement between ARM Limited (“ARM”) and Spreadtrum Communications, Inc. (“LICENSEE”) dated the 15th day of October 2001 (the “Agreement” contract number LEC-DLA-00022-V6.0), as amended. The Effective Date of
this Amendment Five is the 25th day of July 2005. 
 ARM and LICENSEE hereby agree to the following: 
 1. Add the following to Schedule 2 Part B Section 1 Design Sign-Off Models for the ARM7TDMI Core: 
 LF054 ARM7TDMI [***] 
 [***] 
 3. Except as expressly provided in this Amendment Five all of the terms and conditions of the Agreement are hereby ratified by the parties and remain in full force and effect. 
 IN WITNESS WHEREOF the parties have caused this Amendment Five to be signed by their duly authorized representative: 
  

					
	ARM LIMITED	 	SPREADTRUM COMMUNICATIONS, INC.
			
	 BY:
	 	BY:	  	

	 NAME:
	 	NAME:	  	Renyong Fan
	 TITLE:
	 	TITLE:	  	General Manager

  

 Page 1 of 1 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 AMENDMENT SIX 
 TO THE 
 DESIGN LICENSE AGREEMENT 
 BETWEEN 
 ARM LIMITED 
 AND 
 SPREADTRUM COMMUNICATIONS, INC. 
 This
amendment (“Amendment Six”) amends the Design License Agreement between ARM Limited (“ARM”) and Spreadtrum Communications, Inc. (“LICENSEE”), and dated the 15th October 2001, ARM contract number LEC-DLA-00022-V6.0 (“Agreement”). The Effective Date of this Amendment Six shall be the 30th day of September 2006. 
 In
consideration for the mutual representations, covenants, and other terms and conditions contained herein, ARM and LICENSEE hereby agree to amend the Agreement as follows: 
  

	1.	Delete Clause 2.7 in its entirety and replace it with the following new Clause 2.7: 

  

	 	2.7	Under this Agreement LICENSEE shall be permitted to have manufactured and ARM shall only be obliged to issue Design ID(s) in respect of Authorised Designs and [***] Authorised
Products. The [***] Authorised Product shall be based on the ARM7TDMI Core. The [***] and [***] Authorised Product shall be based on either the ARM7TDMI Core and/or the ARM[***] Core. 

 For the avoidance of doubt the fourth Authorised Product previously licensed to LICENSEE under the DLA shall be replaced by the license to one Authorised
Product for the ARM7TDMI-S core under the separate Annex 1 to the DLA, ARM contract number LEC-ANX-00590. 
  

	2.	Delete Schedule 3 in its entirety and replace it with the new Schedule 3 attached to this Amendment Six. 

  

	3.	Except as modified by this Amendment Six, the Agreement shall remain in full force and effect. 

  

	4.	If there is any conflict between the terms of the Agreement and the terms of this Amendment Six, the terms of this Amendment Six shall prevail. 

 The terms-contained herein are agreed and accepted by the authorised signatories of the respective parties: 
  

							
	ARM LIMITED	 	SPREADTRUM COMMUNICATIONS, INC.
				
	BY	 	

	 	BY	 	

	NAME	 	Philip David	 	NAME	 	HARRY QIN
	TITLE	 	General Counsel	 	TITLE	 	VP. BD
	DATE	 	30/09/06	 	DATE	 	09/30/2006

  

 1 of 3 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Schedule 3 
 Royalties and Royalty Reports 
 Part A 
 Royalty Payment Terms 
  

			
	 Currency:
	  	US Dollars
	 Frequency:
	  	At the end of each Quarter of each year in which Royalties are payable.
	 Payment:
	  	Payment by telegraphic transfer to National Westminster Bank PLC of
		  	56 St Andrews Street, Cambridge, CB2 3DA, UK.
	 Account name:
	  	ARM Ltd
	 Account Number:
	  	08086796
	 Sort code:
	  	52-10-46
	 SWIFT code:
	  	NWBKGB2L

 Part B 
 Royalty Rates 
  

							
	 Cumulative Volume of Authorised Product
	  	 ARM7TDMI Core and
ARM7TDMI-S Core
Per Unit Royalty
Rate
 ($US)
	  	 ARM926EJ Core and
ARM926EJ-S
Core
Per Unit Royalty Rate
 ($US)
	  	 ARM1176JZ-S Core
Per Unit Royalty Rate
 ($US)

	 [ *** ]
	  	[ *** ]	  	[ *** ]	  	[ *** ]
	 [ *** ]
	  	[ *** ]	  	[ *** ]	  	[ *** ]
	 [ *** ]
	  	[ *** ]	  	[ *** ]	  	[ *** ]
	 [ *** ]
	  	[ *** ]	  	[ *** ]	  	[ *** ]
	 [ *** ]
	  	[ *** ]	  	[ *** ]	  	[ *** ]
	 [ *** ]
	  	[ *** ]	  	[ *** ]	  	[ *** ]
	 [ *** ]
	  	[ *** ]	  	[ *** ]	  	[ *** ]

 “ARM 7 Family Core” means ARM7TDMI Core and ARM7TDMI-S Core. 
 “ARM9 Family Core” means ARM[***] Core and ARM[***] Core. 
 [***]

 In an ARM Compliant Product with more than one Qualified ARM Core or ARM Compliant Core, as the case may be, embedded into the same piece of silicon, the
following multiplying factors shall be applied to the applicable Royalty Rates determined from the above table. 
 N x M x Max. 
 Where N = the number of Qualified ARM Cores or ARM Compliant Cores, as the case may be, embedded on the same piece of silicon; 
 M = the applicable multiplier from the table below; and 
 Max = Prevailing
Royalty Rate or [ *** ], whichever is the greater. 
  

 2 of 3 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

			
	 Number of Qualified ARM Cores or ARM Compliant
Cores, as the case may
be, Embedded on Same Piece of Silicon
	 	 Multiplier

	 1
	 	 [ *** ]

	 2
	 	 [ *** ]

	 3
	 	 [ *** ]

	 4
	 	 [ *** ]

	 35
	 	 [ *** ]

 Form of Royalty Report 
 FOR EACH DESIGN ID ISSUED FOR AN AUTHORISED PRODUCT 
  

							
	 DESIGN ID
	  	 	  	 
	 Cumulative number of UNITS of Authorised Product distributed by LICENSEE
	  	Applicable Rate	  	Royalty Due
		  	$	X	  	$	XXX
		  	$	X	  	$	XXX
	 Total
	  			  	$	XXX

 During the term of this Agreement, LICENSEE shall, upon ARM’s request, discuss with ARM details of
LICENSEE’S product lines and product plans for the following Quarter. Such information shall be non-binding, supplied in good faith and treated as Confidential Information. 
  

 3 of 3 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 ANNEX
1 
 SPREADTRUM COMMUNICATIONS, INC. 
 ARM[***] CORE

  

			
	 DLA Number
	    	LEC-DLA-00022
	 Legal Counsel
	    	EF
	 Annex Effective Date
	    	March 22, 2006

 This Annex, when signed by both parties, shall form part of and be incorporated into the Technology Licence
Agreement (“DLA”) between the parties (document reference as identified in the table above). Solely for the purposes of interpretation of the DLA with respect to this Annex, to the extent that the provisions contained in this Annex
conflict with any of the provisions of the DLA the provisions contained in this Annex shall prevail over and shall supersede the conflicting provisions in the DLA. 
  

 Page 1 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 1—ARM TECHNOLOGY 
 Key to Disclosure Rights 
  

			
	 D
	  	CONFIDENTIAL except disclosure permitted to “Designers” in accordance with Clause 3 of the TLA
	 M
	  	CONFIDENTIAL except disclosure permitted to “Manufacturers” in accordance with Clause 3 of the
	 T
	  	CONFIDENTIAL except disclosure permitted to “Test Houses” in accordance with Clause 3 of ‘the”
	 CS
	  	CONFIDENTIAL except disclosure permitted to “Customers” in accordance with Clause 3 of the TLA
	 N
	  	NON-CONFIDENTIAL but disclosure may be subject to license restrictions

 AT230 ARM926EJ-S 
 [***] 
  

 Page 2 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
  

 Page 3 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
  
  

 Page 4 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 2—LICENCE AND SPECIAL CONDITIONS 
  

	A.	Definitions 

  

	A.1	“Architecture” means the architecture identified in Section 1 Part I of this Annex 1. 

  

	A.2	“ARM[***] Instruction Set” means the ARM[***] instruction sets as described and identified in the ARM Architecture Reference Manual ARM [***].

  

	A.3	“ARM Instruction Set” means the instruction set identified in Section 1 Part I of this Annex 1. 

  

	A.4	“ARM Technology” means any or all, as the context admits, of the technology identified in Section 1 of this Annex 

  

	A.5	“Authorised Product” means: 

  

	 	(i)	an unlimited number of units of a single design for an ARM Compliant Product which has been taped out and given a unique part number; and 

  

	 	(ii)	an unlimited number of units of any derivatives of the ARM Compliant Products referred to in Clause A.5(i), provided that: 

  

	 	(a)	such derivatives result only from any or all of the following modifications; (1) the implementation by LICENSEE of an Update delivered by ARM to some or all of the Arm
Compliant Product; (2) the correction of errors in such ARM Compliant Products to achieve conformance with the original specification for such design; and (3) a version of such ARM Compliant Product that has been ported to a
different set of process design rules but is otherwise functionally unmodified (except to the extent accommodated by this definition); and 

  

	 	(b)	except as provided below, no more than one such derivative for the ARM Compliant Product referred to in Clause A.5(i) is being manufactured for LICENSEE at any time. LICENSEE shall
be permitted to concurrently manufacture the derivative and the design from which such derivative was derived; (i) indefinitely if the derivative is a result of Clause A.5(ii)(a)(1) or Clause A.5(ii)(a)(2); and (ii) if the
derivative is a result of Clause A. 5(ii)(a)(3), then for a period of twelve (12) months from the date of first manufacture of the new derivative 

  

	A.6	“AVS” means the ARM architectural validation suite identified in Section 1 Part E of this Annex 1. 

  

	A.7	“End User Licence” means a license agreement substantially in the form set out in Section 10 of this Annex 1. 

  

	A.8	“Functional Test Vectors” means the functional test vectors identified in Section 1 Part F of this Annex 1. 

  

	A.9	“Harvard Architecture” means a microprocessor architecture which dictates that the address and data buses for instruction fetches and for data load/store operations
are separate and access separate memories for program instructions and program data. 

  

	A.10	“Implementation and Integration Documentation” means the documentation identified in Section 1 Part B of this Annex 1. 

  

	A.11	“Implementation Scripts” means the deliverables identified in Section 1 Part C Section 2 of this Annex 1. 

  

	A.12	“Models” means; (i) the design simulation models identified in Section 1 Part H; and (ii) any other design simulation model for the
ARM[***] microprocessor core which is generally available from ARM subject to; (a) receipt by ARM of a purchase order from LICENSEE requesting such design simulation model expressly subject to the terms and conditions of this Agreement;
and (b) the payment by LICENSEE to ARM of the then current fee for such design simulation model as quoted by ARM from time to time. 

  

 Page 5 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	A.13	“Pipeline Length” means the number of clocked stages through which each single-cycle instruction must pass to complete the execution of such instruction and
identified in Section 1 Part I of this Annex 1. 

  

	A.14	“Qualified ARM Core” means the ARM[***] microprocessor core as described and identified in the Technical Reference Manual and which; 

  

	 	(i)	executes each and every instruction in the ARM Instruction Set; 

  

	 	(ii)	executes no additional instructions to those contained in the ARM Instruction Set; 

  

	 	(iii)	exhibits the Architecture; 

  

	 	(iv)	exhibits the Pipeline Length; 

  

	 	(v)	is Single Issue; 

  

	 	(vi)	executes all instructions at an identical rate of cycles per instruction (“CPI”) to that specified in the Technical Reference Manual; 

  

	 	(vii)	implements the programmer’s model as identified in the “Architecture Reference Manual” (Published by Addison-Wesley); 

  

	 	(viii)	runs and passes the Functional Test Vectors; 

  

	 	(ix)	runs and passes the AVS; and 

  

	 	(x)	has been verified in accordance with the provisions of Section 3 of this Annex 1. 

  

	A.15	“Single Issue” means that only one instruction is issued for execution within the integer unit in any single clock cycle (where for the purposes of this definition
clock means the clock that advances the pipeline). 

  

	A.16	“Synthesisable RTL” means the deliverables identified in Section 1 Part C Section 1 of this Annex 1. 

  

	A.17	“Synthesisable Core” means the ARM[***] Core licensed under this Annex 1. 

  

	A.18	“Technical Reference Manual” means the relevant technical reference manuals identified in Section 1 Part A Section 1 of this Annex 1

  

	A.19	“Functional and Integration Test” means the relevant test files identified in Section 1 Part G of this Annex 1. 

  

	A.20	“Test Chip” means for each ARM Compliant Core a device which complies with the relevant Test Chip Documentation. 

  

	A.21	“Test Chip Documentation” means the relevant test chip specification identified in Section 1 Part J of this Annex 1. 

  

	A.22	“Test Chip Functional Test Vectors” means the test chip functional test vectors identified in Section 1 Part L of this Annex 1. 

  

	A.23	“Test Chip Synthesisable RTL” means the deliverables identified in Section 1 Part K Section 1 of this Annex 1. 

  

	A.24	“Test Chip Synthesis Scripts” means the deliverables identified in Section 1 Part K Section 2 of this Annex 1. 

  

	A.25	“Use” means in respect of the object code of the Models, the use of (including copying the object code of the Models to the extent that such copying is incidental
to such use, including installation, backup and execution) the object code of the Models, or any part thereof. Use shall specifically exclude: (i) the translation, adaptation, arrangement or other alteration of the object code of the Models
except as allowed by local legislation implementing Article 6 of the EC Directive on the legal protection of computer programs (91/250/EEC) and then only to the extent necessary to achieve interoperability of an independently created program
with other programs; and (ii) the adapting or reverse compiling of the object code of the Models for the purpose of error correction 

  

 Page 6 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	A.26	“Validation and Verification Environment” means the program files identified in Section 1 Part D of this Annex 1. 

  

	B.	Licence 

  

	B.1	Subject to the provisions of Clause 14 (Confidentiality) of the DLA and the provisions of this Section 2, ARM hereby grants, to LICENSEE, a non-transferable (subject to Clause
20.2 of the DLA), non-exclusive, worldwide licence for the Term to; 

 Technical Reference Documentation 
  

	 	(i)	use, copy, modify (solely to the extent necessary to reflect any permitted modifications in accordance with the provisions of this Clause B.1 or for incorporation into
LICENSEE’s documentation), distribute and have distributed the Technical Reference Manuals; 

 ARM Compliant Core

  

	 	(ii)	use and copy the Implementation and Integration Documentation for the sole purpose of design migration as further set forth in Clause C.1 (subject to the provisions of Clause 2.2 of
the DLA) for the ARM Compliant Products; 

  

	 	(iii)	use and copy the AVS only for the purposes of designing, having designed (subject to the provisions of Clause 2.2 of the DLA) ARM Compliant Products and Test Chips;

  

	 	(iv)	use, copy and modify the Synthesisable RTL (solely for the purposes of scan insertion, buffer insertion, timing closure, targeting standard cell libraries, direct instantiations of
cells for speed and power optimisation, and use of LICENSEE specified BIST), only for the purposes of designing, having designed (subject to the provisions of Clause 2.2 of the DLA) ARM Compliant Products; 

  

	 	(v)	use, copy and modify the Implementation Scripts only for the purposes of designing, having designed (subject to the provisions of Clause 2.2 of the DLA), ARM Compliant Products;

  

	 	(vi)	use, copy and modify the Functional and Integration Test only for the purposes of designing, having designed (subject to the provisions of Clauses 2.2), ARM Compliant Products

  

	 	(vii)	use, copy and modify (solely for the purpose of and to the extent necessary to run the vectors on a simulator or tester) the Functional Test Vectors, only for the purposes of
designing and having designed (subject to the provisions of Clauses 2.2), manufacturing and having manufactured (subject to the provisions of Clause 2.3 of the DLA), testing and having tested (subject to the provisions of Clause 2.5 of the DLA) ARM
Compliant Products; 

  

	 	(viii)	use, copy and modify the Validation and Verification Environment only for the purposes of designing and having designed (subject to the provisions of Clause 2.2 of the DLA) ARM
Compliant Products and Test Chips; 

  

	 	(ix)	manufacture and have manufactured (subject to the provisions of Clause 2.3 of the DLA) the Authorised Products created under the licences granted in Clauses B.1(i) to B.1
(viii) inclusive; 

  

	 	(x)	package and have packaged (subject to the provisions of Clause 2.4 of the DLA), Authorised Products manufactured under the licences granted in Clause B.1(ix);

  

	 	(xi)	sell, supply and distribute encapsulated die of the Authorised Products which have been manufactured under the licences granted in Clause B.1(ix); 

  

 Page 7 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Models 
  

	 	(xii)	copy and use, internally and for third party support purposes, the Models and related documentation; 

  

	 	(xiii)	use, reproduce and distribute, and sub-license (subject to the terms of an End User Licence) the Use of the object code of the Models, solely for the purpose of developing the ARM
Compliant Products; and 

  

	 	(xiv)	modify, reproduce, use and distribute, in connection with the Models, the documentation related thereto. 

  

	 	(xv)	use, copy and modify; (a) the Test Chip Functional Test Vectors (solely for the purposes of and to the extent necessary to run the vectors on a simulator or tester;
(b) the Test Chip Synthesisable RTL (solely for the purposes of scan insertion, buffer insertion, timing closure, targeting standard cell libraries, direct instantiations of cells for speed and power optimisation, and use of LICENSEE
specified BIST and (c) the Test Chip Synthesis Scripts, only for the purposes of designing, having designed (subject to the provisions of Clause 2.2) Test Chips; 

  

	 	(xvi)	use and copy the Test Chip Documentation, only for the purposes of designing and having designed (subject to the provisions of Clauses 2.2 and 2.3 of the DLA) Test Chips;

  

	 	(xvii)	manufacture and have manufactured (subject to the provisions of Clause 2.3 of the DLA) the Test Chips created under the licences granted in Clauses B.1(i) to B.1(viii).

  

	C.	License Limitation 

  

	C.1	The purpose of this Annex is to allow LICENSEE to migrate its second Authorised Product (as defined in Clause 1.12 of the DLA) which is part number [***], from [***] technology to
[***] technology. ARM hereby acknowledges that the [***] may at LICENSEE’s discretion have a different part number but shall be functionality unmodified from part [***] as per Clause A5(ii)(a)(3). 

 The license granted hereunder is granted solely to enable LICENSEE to exercise its rights under Clause 2.6, paragraph 2 of the DLA. [***] shall be due on
the Annex Effective Date and payable in accordance with Clause 8.11 of the DLA by LICENSEE. 
  

	D.	Amendments to the OLA 

  

	D.1	LICENSEE hereby agrees that if; (a) an Authorised Foundry breaches the confidentiality provisions in Clause 2.3(i)(a) and 2.3(ii); or (b) a Designer breaches the
confidentiality provisions in Clause 2.2(ii) and 2.2(iii), then LICENSEE shall hold ARM harmless from and keep ARM indemnified against all and any loss, liability, costs, damages, expenses (including reasonable attorneys fees), suffered, incurred or
sustained by ARM as a result of such breach. 

  

	D.2	For the purposes of this Annex 1 the provisions of Clauses 14.2—14.5 of the DLA shall be replaced with the following provisions: 

 Permitted Disclosure to Authorised Foundry 
  

	 	3.2	LICENSEE may disclose the (i) the ARM Technology marked “M” and any translation, modification, compilation, abridgement or other form in which the ARM Technology
marked “M” has been recast, transformed or adapted; (ii) any GDSII created by or for LICENSEE from the synthesizable RTL licensed under this Annex 1 and (iii) any masks created from the GDSII by or for LICENSEE, to an
Authorised Foundry pursuant to the exercise of any have manufactured rights (if granted in Section 2 of this Annex 1) solely for the purposes of having ARM Compliant Products or other devices which contain royalty bearing ARM Technology
licensed in accordance with the terms of this DLA, as the case may be, manufactured for LICENSEE by such third party and under a nondisclosure agreement containing substantially similar terms to this Clause 3, except that the confidentiality period
for each deliverable shall be, at a minimum, of five (5) years from the date of disclosure. 

  

 Page 8 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Permitted Disclosure to Designers 
  

	 	3.3	LICENSEE may disclose the ARM Technology marked “D” in this Annex 1 and any translation, modification, compilation, abridgement or other form in which the ARM Technology
marked “D” has been recast, transformed or adapted, to a Designer pursuant to the exercise of the have designed rights (if granted in Section 2 of this Annex 1) solely for the purposes of having ARM Compliant Products or other
devices which contain royalty bearing ARM Technology licensed in accordance with the terms of this DLA, as the case may be, designed for LICENSEE by such third party and under a non-disclosure agreement containing substantially similar terms to this
Clause 3, including the confidentiality period for each deliverable determined in accordance with the provisions of Clause 3.1. 

 Permitted Disclosure to Test Houses 
  

	 	3.4	LICENSEE may disclose (i) the ARM Technology marked “T” in this Annex 1 and any translation, modification, compilation, abridgement or other form in which the ARM
Technology marked T” has been recast, transformed or adapted; and (ii) any ATPG test vectors created by or for LICENSEE from the Synthesizable RTL (defined in this Annex 1), to a Test House pursuant to the exercise of the have
tested rights (if granted in Section 2 of this Annex 1) solely for the purposes of having ARM Compliant Products or other devices which contain royalty bearing ARM Technology licensed in accordance with the terms of this Annex, as the case may
be, tested for LICENSEE by such third party and under a non-disclosure agreement containing substantially similar terms to this Clause 3, except that the confidentiality period for each deliverable shall be, at a minimum, five (5) years from
the date of disclosure. 

  

	D.3	The parties hereby agree that the provisions of Clauses 3, 4 and 5 of the DLA are not applicable in respect of the Qualified ARM Core licensed under this Annex 1, and accordingly
shall not apply to this Annex 1. 

  

	D.4	For the purposes of this Annex 1 the provisions of Clause 15.1 of the DLA shall be replaced with the following provision: 

  

	 	15.1	ARM warrants to LICENSEE that the ARM Technology will be consistent with allowing a competent semiconductor manufacturer to manufacture products which substantially conform to the
functionality described in the relevant technical reference manual. LICENSEE acknowledges that the process for converting the ARM Technology delivered to LICENSEE in to silicon necessarily involves the introduction and use of technology not
delivered by ARM and accordingly ARM’s liability and LICENSEE’S sole remedy for breach of the warranty provided under this Clause 15.1 shall be as follows; if LICENSEE can demonstrate to ARM that any defect in the silicon developed using
any ARM Technology is exclusively caused by a defect in the ARM Technology as delivered to LICENSEE then ARM shall use commercially reasonable efforts to correct any errors in the ARM Technology and deliver corrected ARM Technology to LICENSEE. THE
FOREGOING STATES THE ENTIRE LIABILITY OF ARM WITH RESPECT TO BREACH OF THE WARRANTY PROVIDED IN THIS CLAUSE 15.1. 

  

	D.5	For the purposes of this Annex 1 the provisions of Clause 17.2 of the DLA shall be replaced with the following provision: 

  

	 	17.2	NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED IN THE DLA, THE MAXIMUM LIABILITY OF ARM TO LICENSEE IN AGGREGATE FOR ALL CLAIMS MADE AGAINST ARM IN CONTRACT TORT OR OTHERWISE
UNDER OR IN CONNECTION WITH THE SUBJECT MATTER OF THIS ANNEX SHALL NOT EXCEED [***]. THE EXISTENCE OF MORE THAN ONE CLAIM OR SUIT WILL NOT ENLARGE OR EXTEND THE LIMIT. LICENSEE RELEASES ARM FROM ALL OBLIGATIONS, LIABILITY, CLAIMS OR DEMANDS IN
EXCESS OF THIS LIMITATION. 

  

	D.7	Prior to the distribution of any ARM Compliant Product the ARM Technology manufactured by or for LICENSEE under the licences granted in Section 2 of this Annex 1, LICENSEE
shall verify such ARM Technology in accordance with the verification procedure set out in Section 3 of this Annex 1. 

  

 Page 9 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	E.	Special Conditions 

 Sun Java Hardware
Acceleration 
 “Sun SCSL License Agreement” means any of; (i) a Sun Community Source License entered into
between LICENSEE and Sun Microsystems Inc. for the Sun CLDC technology; or (ii) any license agreement entered into between LICENSEE and Sun Microsystems Inc. which expressly permits LICENSEE to share source code for the Sun CLDC
technology with ARM for the Sun CLDC technology. 
 “Jazelle” means the extension to the ARM architecture that enables the
execution of a subset of Java byte codes by an ARM core as accessed through the BXJ instruction. 
  

	E.1	LICENSEE acknowledges that the ARM Compliant Core incorporates hardware acceleration for Sun Microsystems Inc.’s (“Sun”) Java technology. Without prejudice to any
limitations or restrictions set out in the licence grants in Clause B.1 above, LICENSEE agrees that unless LICENSEE has entered into and continues to enjoy the benefit of a Sun SCSL License Agreement, LICENSEE shall be subject to the following
licensing restrictions; 

  

	 	A.	LICENSEE shall not; (i) carry out or procure any functional modification of any part of the ARM[***] Core to the extent that it includes, incorporates or implements
Jazelle; or (ii) reverse engineer or use the ARM Technology licensed under this Annex for the purpose of implementing the whole or any part of a Java specification (where a Java specification means any “Final Release” of a
“JSR” developed as part of the Java Community Process without first entering into a Sun SCSL License Agreement); 

  

	 	B.	LICENSEE agrees that Sun Microsystems Inc. shall be an intended third party beneficiary of the terms and conditions of this DLA solely for the purpose of enforcing the restrictions
contained in A above; and 

  

	 	C.	If LICENSEE discloses or distributes any ARM Technology which includes, incorporates or implements Jazelle to a third party, except as ARM Compliant Products in the form of silicon,
then such third party shall be made subject to the same restrictions as LICENSEE in A and B above. 

  

	F.	Disclosures 

  

	F.1	ARM hereby discloses the following against the warranty provided in Clause 15.3(iii) of the DLA; 

 On the 28th May 2002 ARM received notice that Nazomi Communications, Inc. (“Nazomi”) has filed a patent infringement suit against ARM alleging that the ARM Technology licensed under this Annex 1
infringes Nazomi’s United States patent #6,332,215. 
 G. Test Chip Restrictions - 
  

	G.1	No right is granted to LICENSEE to distribute or commercially exploit the Test Chips, or any technology contained therein (excluding the ARM Compliant Core) without obtaining a
separate licence from ARM. 

  

 Page 10 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 3—DESIGN ID REQUEST FORM; VERIFICATION 
 DESIGN ID REQUEST FORM: 
 Not Applicable 
 VERIFICATION 
 V.1 Definitions 
  

	V.1.1	“Implementation” means, in respect of a microprocessor core, a unique physical layout for such microprocessor core. 

  

	V.1.2	“Post Layout Synthesized Netlist” means a post layout synthesized netlist incorporating the ARM Compliant Core which; (i) obeys the Timing Constraints
File in respect of such synthesis; and (ii) includes back annotated delays derived from the physical layout. 

  

	V.1.3	“Timing Constraints File” means the timing constraints file determined by LICENSEE prior to final synthesis. 

  

	V.1.4	“Validation and Verification Confirmation” means the completed document in the form set out in Part D of Section 3 of this Annex 1. 

 

	V1.5	“Validation Deliverables” means together the AVS and the Verification and Validation Environment 

 V.2 Validation and Verification of ARM Compliant Core Implementation 
  

	V.2.1	For each Implementation of an ARM Compliant Core intended for incorporation in integrated circuits which will be distributed by or for LICENSEE, LICENSEE shall verify such
Implementation by at least one of the following methods; 

  

	 	1.	Validation and verification by Equivalence Checking of RTL and Synthesized Netlist (See Part A) 

  

	 	2.	LICENSEE Specified validation and verification (See Part B) 

  

	 	3.	Validation and verification by Test Chip (See Part C) 

  

 Page 11 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Part
A 
 Validation and Verification by Equivalence Checking of RTL and Synthesized Netlist 
 Methodology 
 Validation 
  

	V.A.1	Validate the configured Synthesisable RTL using the Validation Deliverables in accordance with the Implementation Guide and generate the validation log report (“Validation
Logs”). 

 Verification 
  

	V.A.2	(i) use an equivalence checker to compare the Synthesisable RTL with the Post-Layout Synthesized Netlist and generate equivalence check log results (“RTL-Post
Layout Equivalence Log Results”); (ii) simulate the Functional Test Vectors on the Post-Layout Synthesized Netlist and generate log results (“Post Layout Log Results”); and (iii) run static timing
analysis on the Post-Layout Synthesized Netlist and generate log results (“STA Log Results”). 

 Delivery of Validation and
Verification Confirmation 
  

	V.A.3	If the Validation Logs, RTL-Post Layout Equivalence Log Results, Post Layout Log Results and the STA Log Results (together the “Equivalence Log Results”) indicate
that no errors have been detected (or the parties have jointly agreed a waiver in respect of any detected errors), LICENSEE shall deliver a Verification Confirmation to ARM and ARM shall acknowledge, in writing, the receipt by ARM of the
Verification Confirmation within ten (10) working days of its receipt by ARM. 

 Validation and Verification Criteria 

 

	V.A.4	The Implementation of the ARM Compliant Core shall be validated and verified when; (i) the Equivalence Log Results indicate that no errors have been detected (or the parties
have jointly agreed a waiver in respect of any detected errors); and (ii) LICENSEE has received confirmation of receipt of the relevant Validation and Verification Confirmation from ARM in accordance with the provisions of Clause V.A.3.

 Records and Delivery of Equivalence Log Results 
  

	V.A.5	For each ARM Compliant Product incorporating an Implementation of the ARM Compliant Core, LICENSEE shall keep a copy of the Equivalence Log Results for such ARM Compliant Product
and shall deliver, as soon as reasonably possible, copies of such records to ARM upon request from ARM. If ARM concludes that the Implementation of the ARM Compliant Core has not been validated and verified in accordance with the provisions of
Clause V.A.4, then ARM shall indicate to LICENSEE the errors which ARM has detected and LICENSEE shall repeat the process prescribed in Clauses V.A.1- V.A.3. 

 Part B 
 LICENSEE Specified Validation and Verification 
 Methodology 
  

	V.B.1	Subject to V.B.4, use LICENSEE’S custom validation and verification flow. 

  

	V.B.2	 If LICENSEE elects such validation and verification, LICENSEE shall, inform ARM in writing at least ninety (90) days prior to tape out of an ARM Compliant
Product that LICENSEE wishes to use LICENSEE’S specified validation and verification flow and supply to ARM a copy of the proposed validation and verification flow (each a “Validation and Verification Flow”). Within 30 days of
the receipt of the Validation 

  

 Page 12 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 
and Verification Flow ARM shall notify LICENSEE in writing whether the Validation and Verification Flow has been accepted by ARM. If accepted by ARM,
LICENSEE shall validate and verify such ARM Compliant Products using the Validation and Verification Flow. If after acceptance of the Validation and Verification Flow by ARM, LICENSEE wishes to modify the Validation and Verification Flow LICENSEE
shall submit the modified Validation and Verification Flow to ARM for re-acceptance prior to validating and verifying the relevant Synthesisable ARM Compliant Core. 
  

	V.B.3	If ARM rejects either the Validation and Verification Flow or any modified Validation and Verification Flows, ARM shall provide LICENSEE with written reasons for such rejection
together with any required, changes LICENSEE may resubmit the Validation and Verification Flow or any modified versions thereof to ARM for acceptance. 

 Default 
  

	V.B.4	If ARM fails to accept the Validation and Verification Flow LICENSEE shall validate and verify the Post Layout Synthesized Netlist in accordance with one of the other methods set
out in Clause V.2.1. 

 Part C 
 Validation and Verification by Test Chip 
 Methodology 
 Validation 
  

	V.C.1	Validate the configured RTL using the Validation Deliverables in accordance with the Implementation Guide and generate the validation log report (“Validation
Logs”). 

 Verification 
  

	V.C.2	Design (or have designed) and manufacture (or have manufactured) a Test Chip and run on such test chip; (i) the Test Chip Functional Test Vectors to generate a results
log (“Test Chip Test Vector Log Results”). 

 Delivery of Test Chips 
  

	V.C.3	After the Test Chip Test Vector Log Results indicate that no errors have been detected (or the parties have jointly agreed in good faith, a waiver in respect of any errors,
LICENSEE shall deliver the Test Chip Test Vector Log Results and five (5) tested samples of the Test Chip to ARM. As soon as reasonably possible following receipt by ARM of the five (5) Test Chip samples, ARM shall run the Test Chip
silicon validation software to generate a results log (“Test Chip Validation Log Results”) and provide to licensee (i) notice of verification of the Implementation in accordance with the provisions of Clause V.C.4 or
(ii) error logs of any verification failures. 

 Validation and Verification Criteria 
  

	V.C.4	The ARM Compliant Core shall be verified when; (i) the Validation Logs indicate that no errors have been detected (or the parties have jointly agreed a waiver in respect
of any detected errors); and (ii) the Test Chip Test Vector Log Results for the Implementation indicate that no errors have been detected (or the parties have jointly agreed a waiver in respect of any detected errors); and
(iii) LICENSEE has received notice of verification of the Implementation from ARM in accordance with the provisions of Clause V.C.5. 

 Notice of Validation and Verification 
  

	V.C.5	ARM shall notify LICENSEE, in writing, within thirty (30) days of delivery by LICENSEE of the Test Chip samples to ARM, whether such Test Chip has been verified or has failed
the validation and verification process. In the event that any Test Chip fails the process, ARM shall provide details of the errors that cause the failure to LICENSEE and LICENSEE shall endeavour to correct the errors. The parties shall repeat the
above process until either; (i) the Test Chip is validated and verified; or (ii) LICENSEE withdraws the Test Chip from the validation and verification process. In the event that ARM fails to report the result of the
validation and verification process within the Verification Period, the Test Chip subject to the verification process shall be deemed verified. 

  

 Page 13 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Part D 
 Validation and Verification Confirmation 
 Validation and Verification in accordance with Section 3 Part A 
  

	1.	Equivalence checking 

  

					
	 Description of process applied
	  	 Tool(s) used
	  	 Completed
 (Tick)

	ARM Compliant Core RTL to post-layout netlist *	  		  	
	
 *  Process can be
performed in one step or using several intermediate steps

	
	 2.      STA on Post-Layout Synthesized Netlist

			
	 Description of process applied
	  	 Tool(s) used
	  	 Completed
(Tick)

	 Post-layout netlist
	  		  	
	
	 3.      Test Vector Simulations on Post-Layout Synthesized Netlist

	 Description of process applied
	  	 Tool(s) used
	  	 Completed
(Tick)

	 Functional Test Vectors (file names)
	  		  	

 Verification in accordance with Section 3 Part B 
 Depending upon agreed verification methodology. 
  

			
	 Partner
	 	
	 Partner Contact
	 	
	 Core Name and Revision
	 	
	 Date
	 	
	 Signature
	 	

  

 Page 14 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 4—SUPPORT AND MAINTENANCE PERIODS AND LIMITATION 
 SUPPORT AND MAINTENANCE PERIOD 
 In respect of the Authorised Product licensed under this Annex, ARM shall provide Support (as defined in Clause 11 of the DLA) and Maintenance (as defined in Clause 10 of
the DLA) for the period ending two years from payment to ARM of the Design Fee (set out in Schedule 5 of the DLA)for the ARM[***]. 
 SUPPORT LIMITATIONS

 In respect of the Authorised Product licensed under this Annex, ARM shall provide a maximum
number of 8 Man Days support during the Support and Maintenance Period. 1 Man Day shall mean 7  1/2 hours.

  

 Page 15 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 5—TRAINING REQUIREMENT AND CONSULTING SERVICES 
 TRAINING—NOT APPLICABLE 
 CONSULTING SERVICES 
 ARM shall provide to LICENSEE two consecutive weeks of on-site consulting services at a facility located within the San Francisco Bay area for a fee of [ *** ] (the “Consulting Fee”). The Consulting Fee shall cover of
the cost of having on-site one ARM engineer to assist LICENSEE with the harding of the ARM Technology who shall work 5 business days per week, 7  1/2 hours per day. The Consulting Fee also includes the consultants travel and living expenses. LICENSEE and ARM shall mutually agree the
start date of such consulting services. 
  

 Page 16 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 6—TRADEMARKS 
  

			
	Trademark	  	Registered/ Unregistered

 Part A 
  

			
	 ARM w/bar [logo] Exhibit A
	  	Registered

 Part B 
  

			
	 ARM Powered [logo] Exhibit B
	  	Registered

 Part C 
  

			
	 ARM [logo] Exhibit C
	  	Registered

 Part D 
  

			
	 ARM Connect Community
 Partner [logo] Exhibit D
	  	Unregistered

 Part E 
  

			
	ARM	  	Registered
	ARM926EJ-S	  	Unregistered

  

 Page 17 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 7—TERM 
 Unless terminated earlier in accordance with the provisions of Clause 18 of the DLA, this Annex 1 shall continue in
force for a period of [***] from the Annex Effective Date. 
  

 Page 18 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 8—FEES AND ROYALTIES 
 FEES 
 Licence Fees 
 NOT APPLICABLE 
 Support and Maintenance Fees 
 NOT APPLICABLE 
 ROYALTIES 
  

			
	 Currency:
	 	US Dollars
		
	 Currency Conversion:
	 	ASP in any currency other than US$ shall be converted to ASP in US$ using the average local currency/US$ exchange rate over the Quarter as published by the US Federal Reserve [see
http://www.federalreserve.gov/releases/g5/]
		
	 Due:
	 	At the end of each Quarter
		
	 Payable:
	 	In accordance with the provisions of Clause 8.11 of the DLA.

 Calculation: 
 For each unit of ARM Compliant Product distributed by LICENSEE, LICENSEE shall pay a Royalty determined from the following table: 
 Royalty Rate

  

			
	 Cumulative Number of ARM Based Products distributed
	  	 Royalty per unit of ARM
 Based Product
 ($U.S)

	 [ *** ]
	  	[ *** ]
	 [ *** ]
	  	[ *** ]
	 [ *** ]
	  	[ *** ]
	 [ *** ]
	  	[ *** ]

 In an ARM Compliant Product with more than one ARM core embedded into the same piece of silicon, a royalty
multiplying factor shall be applied as shown in the table below. 
  

			
	 Number of ARM cores Embedded on Same Piece of Silicon
	  	Multiplier
	 1
	  	[ *** ]
	 2
	  	[ *** ]
	 3
	  	[ *** ]
	 4
	  	[ *** ]
	 >4
	  	[ *** ]

  

 Page 19 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 To
calculate the royalty payable, the total royalty for all of the cores on the ARM Compliant Product must be added together and then multiplied by the Royalty Multiplier. 
 If there are multiple cores of different ARM families on the same ARM compliant product then those cores which have the highest royalty are added up until a maximum number of five cores, and the royalty multiplier is
then applied. 
 Example 1: 
 [***] 
 [***] 
 Example 2: 
 [***] 
 [***] 
 ROYALTY REPORT 
 Form of Royalty Report 
  

			
	 Send to:
	 	The address for ARM set out in the DLA via first class mail and to royaltyreports@arm.com via email.

 Table 1 
  

											
	 Part Number
	  	 Intended Application
	  	Number of Units of
ARM Compliant
Product distributed
by LICENSEE in
Quarter	  	ASP(US$)	  	Applicable Royalty
Rate	  	Royalty Due
						
		  		  		  	$XXX	  	X%	  	$XXX
						
		  		  		  	$XXX	  	X%	  	$XXX

 Table 2 
  

											
	 Part Number
	  	 Intended Application
	  	Estimated Number
of Units of ARM
Compliant Product
distributed by
LICENSEE in Next
Calendar
Quarter	  	ASP (US$)	  	Applicable Royalty
Rate	  	Royalty Due
						
		  		  		  	$XXX	  	X%	  	$XXX
						
		  		  		  	$XXX	  	X%	  	$XXX

 The information provided in Table 2 shall be non-binding, supplied in good faith and treated as LICENSEE’S
Confidential Information. 
  

 Page 20 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 9—MARKETING 
 Not Applicable 
  

 Page 21 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 10—END USER LICENCE 
 Spreadtrum Communications, Inc. (“LICENSOR”) hereby grants and the LICENSEE hereby
accepts a non transferable and nonexclusive licence to use the Model solely for the purpose of developing a product which incorporates a CPU manufactured under LICENSOR’s licence from ARM (“Purpose”), under the following terms and
conditions: 
  

	1.	Ownership. The Model is the property of ARM LIMITED and/or its licensors. The LICENSEE acquires no title, right or . . . . interest in the Model other than the licence rights
granted herein. 

  

	2.	Use. The LICENSEE may use the Model on any one computer at one time except that the Model may be executed from a common disc shared by multiple CPUs provided that one
authorised copy of the Model has been licensed from LICENSOR for each CPU concurrently executing the Model. 

 LICENSEE shall
not reverse engineer, decompile or disassemble the Model, in whole or in part. 
 LICENSEE shall only be permitted to use the Model for the
Purpose. 
 LICESENSOR hereby authorises LICENSEE to concurrently use up to a maximum number of
[            ] copies of the Model 
  

	3.	Copies. Except as provided in Clause 2, LICENSEE may make copies of the Model for back-up and archival purposes only. All copies of the Model must bear the same notice(s)
contained on the original copies supplied by LICENSOR. 

  

	4.	Model Limited Warranty. LICENSOR warrants that the disks containing the Model shall be free from defects and workmanship under normal use and the programs will perform in
accordance with the accompanying documentation for a period of ninety (90) days from the date of delivery. Any written or oral information or advice given by LICENSOR distributors, agents or employees will in no way increase the scope of this
warranty. LICENSOR’s entire liability and the LICENSEE’s exclusive remedy will be, at LICENSOR’s sole option, to replace the disk or to use LICENSOR’s reasonable efforts to make the Model meet the warranty set forth above. Any
replacement Model will be warranted for the remainder of the original warranty period or thirty (30) days, whichever is the longer. The LICENSEE agrees that the supply of the Model does not include updates and upgrades, which may be available
from LICENSOR under a separate support agreement. 

 THE ABOVE WARRANTIES ARE EXCLUSIVE AND IN LIEU OF ALL OTHER WARRANTIES,
WHETHER EXPRESS OR IMPLIED INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. 
 IN
NO EVENT SHALL LICENSOR BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES RESULTING FROM ITS PERFORMANCE OR FAILURE TO PERFORM UNDER THIS AGREEMENT OR THE FURNISHING, PERFORMANCE, OR USE OF ANY MODEL LICENSED HERETO, WHETHER
DUE TO BREACH OF CONTRACT, BREACH OF WARRANTY, OR NEGLIGENCE EVEN IF LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 
 THE
MAXIMUM LIABILITY OF LICENSOR SHALL BE LIMITED TO REFUND OF THE FEES PAID BY LICENSEE (IF ANY) FOR THE MODEL. 
  

	5.	Assignment of the Agreement. This Agreement and any license granted hereunder to the LICENSEE may not be assigned, sub-licensed or otherwise transferred by the LICENSEE to
any third party 

  

	6.	Term and Termination. Unless terminated in accordance with the provisions of this Clause 6, this Agreement and licenses granted hereunder shall continue in force until
completion of the Purpose. LICENSOR may terminated this Agreement by written notice to the LICENSEE in the event of a breach by LICENSEE of any provisions of this Agreement. 

 Upon expiration or termination of this Agreement, the LICENSEE shall refrain from any further use of the Model, and LICENSEE shall either return or
destroy and copies of the Model in it’s possession at the date of expiration of termination as applicable. 
  

	7.	Applicability. The limitations and exclusions above may not apply in certain countries or states where they conflict with local law. In cases where such a conflict exists the
local law shall prevail and the remaining provisions of the Agreement shall remain in full force and effect. 

  

 Page 22 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 IN
WITNESS WHEREOF the parties have caused this Annex 1 to be signed by their duly authorised representative: 
  

											
	 ARM LIMITED
	 		 	SPREADTRUM COMMUNICATIONS, INC.	 	
						
	BY:	 	 

	 		 	BY:	 	 

	 	
						
	NAME:	 	Paul Elbro	 		 	NAME:	 	HARRY QIN	 	
	TITLE:	 	Director, ARM Services Division	 		 	TITLE:	 	VP, Marketing	 	
	DATE:	 	22/3/06	 		 	DATE:	 	03/11/2006	 	

  

 Page 23 of 23 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 AMENDMENT TO ANNEX 1 OF 
 THE DESIGN LICENCE AGREEMENT 
 BETWEEN ARM LIMITED 
 AND SPREADTRUM COMMUNICATIONS, INC. 
 This Amendment (“Amendment”) serves to amend the Annex 1 for the ARM[***] Core
dated 22nd March 2006 (“Annex 1” contract no: LEC-ANX-00279) to the Design License Agreement
between ARM Limited (“ARM”) and Spreadtrum Communications, Inc. (“Spreadtrum”) dated 15th October 2001 (the “DLA” contract no: LEC-DLA-00022). The effective date of this Amendment shall be the 9 of June 2006. 
 Whereas, the parties wish to add deliverables to Annex 1 for the ARM[***]. 
 Now, Therefore,
for good and valuable consideration, the parties hereby agree to amend the Annex 1 as follows: 
  

	1.	The following new deliverables are hereby added to Section 1, Part H: 

  

											
	 Part number
	  	 Description
	  	Disclosure	  	Simulator	  	Platform	  	Delivery Date
	 [***]
	  	 [***]
	  	[***]	  	[***]	  	Solaris	  	Effective Date+ 10 Days
	 [***]
	  	 [***]
	  	[***]	  	[***]	  	Linux	  	Effective Date + 10 Days

 In Witness Whereof, the parties have caused this Amendment to Annex 1 to be executed by
their duly authorized representatives: 
  

											
	Accepted and Agreed to:	 		 		 	
				
	ARM LIMITED:	 		 	SPREADTRUM COMMUNICATIONS, INC.:	 	
						
	 By:
	 	

	 		 	 By:
	 	

	 	
	 Name:
	 	 Warren East
	 		 	 Name:
	 	HARRY QIN	 	
	 Title:
	 	 Chief Executive Officer
	 		 	 Title:
	 	VP, MKT LBO	 	
	 Date:
	 		 		 	 Date:
	 	06/05/2006	 	

  

 1 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 ANNEX
1 
 SPREADTRUM COMMUNICATIONS, INC. 
 ARM[***] CORE

  

  

							
	 DLA Number
	  	LEC-DLA-00022-V6.0	 		  	
	Legal Counsel	  	AP	 		  	
	Annex Effective Date	  	September 30, 2006	 		  	

 This Annex, when signed by both parties, shall form part of and be incorporated into the Design License Agreement
(“DLA”) between the parties (document reference as identified in the table above). Solely for the purposes of interpretation of the DLA with respect to this Annex, to the extent that the provisions contained in this Annex conflict with any
of the provisions of the DLA the provisions contained in this Annex shall prevail over and shall supersede the conflicting provisions in the DLA. 
  

 Page 1 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 1 - ARM TECHNOLOGY 
 Key to Disclosure Rights 
  

			
	 D
	  	CONFIDENTIAL except disclosure permitted to “Designers” in accordance with Clause 14 of the DLA
	 M
	  	CONFIDENTIAL except disclosure permitted to “Manufacturers” in accordance with Clause 14 of the DLA
	 T
	  	CONFIDENTIAL except disclosure permitted to “Test Houses” in accordance with Clause 14 of the DLA
	 N
	  	NON-CONFIDENTIAL but disclosure may be subject to license restrictions

 [***] 
  
  

 Page 2 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
  

 Page 3 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 2 - LICENCE AND SPECIAL CONDITIONS 
  

	A.	Definitions 

  

	A.1	“Architecture” means the architecture identified in Section 1 Part I of this Annex 1. 

  

	A.2	“ARM Compliant Core” means the ARM[***] microprocessor core as described and identified in the Technical Reference Manual and which; 

  

	 	(i)	executes each and every instruction in the ARM Instruction Set; 

  

	 	(ii)	executes no additional instructions to those contained in the ARM Instruction Set; 

  

	 	(iii)	exhibits the Architecture; 

  

	 	(iv)	exhibits the Pipeline Length; 

  

	 	(v)	is Single Issue; 

  

	 	(vi)	executes all instructions at an identical rate of cycles per instruction (“CPI”) to that specified in the Technical Reference Manual; 

  

	 	(vii)	implements the programmer’s model as identified in the Architecture Documentation listed in Section 1 Part A; 

  

	 	(viii)	runs and passes the Functional Test Vectors; 

  

	 	(ix)	runs and passes the AVS; and 

  

	 	(x)	has been verified in accordance with the provisions of Section 3 of this Annex 1. 

  

	A.3	“ARM Compliant Product” means an integrated circuit incorporating an ARM Compliant Core. 

  

	A.4	“ARM[***] Instruction Set” means the ARM[***] instruction sets as described and identified in the ARM Architecture Reference Manual ARM [***].

  

	A.5	“ARM Instruction Set” means the instruction set identified in Section 1 Part I of this Annex 1. 

  

	A.6	“ARM Technology” means any or all, as the context admits, of the technology identified in Section 1 of this Annex 

  

	A.7	“Authorised Product” means: 

  

	 	(i)	an unlimited number of units of a single design for an ARM Compliant Product which has been taped out and given a unique part number; and 

  

	 	(ii)	an unlimited number of units of any derivatives of the ARM Compliant Products referred to in Clause A.7(i), provided that: 

  

	 	(a)	such derivatives result only from any or all of the following modifications; (1) the implementation by LICENSEE of an Update delivered by ARM to some or all of the Arm
Compliant Product; (2) the correction of errors in such ARM Compliant Products to achieve conformance with the original specification for such design; and (3) a version of such ARM Compliant Product that has been ported to a different set
of process design rules but is otherwise functionally unmodified (except to the extent accommodated by this definition); and 

  

 Page 4 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	 	(b)	except as provided below, no more than one such derivative for the ARM Compliant Product referred to in Clause A.7(i) is being manufactured for LICENSEE at any time. LICENSEE shall
be permitted to concurrently manufacture the derivative and the design from which such derivative was derived; (i) indefinitely if the derivative is a result of Clause A.7(ii)(a)(1) or Clause A.7(ii)(a)(2); and (ii) if the
derivative is a result of Clause A. 7(ii)(a)(3), then for a period of twelve (12) months from the date of first manufacture of the new derivative 

  

	A.8	“AVS” means the ARM architectural validation suite identified in Section 1 Part E of this Annex 1. 

  

	A.9	“Designer” means any entity sub-contracted by LICENSEE to provide design resource to LICENSEE. 

  

	A.10	“End User Licence” means a license agreement substantially in the form set out in Section 10 of this Annex 1. 

  

	A.11	“Functional and Integration Test” means the relevant test files identified in Section 1 Part G of this Annex 1. 

  

	A.12	“Functional Test Vectors” means the functional test vectors identified in Section 1 Part F of this Annex 1. 

  

	A.13	“Harvard Architecture” means a microprocessor architecture which dictates that the address and data buses for instruction fetches and for data load/store operations
are separate and access separate memories for program instructions and program data. 

  

	A.14	“Implementation and Integration Documentation” means the documentation identified in Section 1 Part B of this Annex 1. 

  

	A.15	“Implementation Scripts” means the deliverables identified in Section 1 Part C Section 2 of this Annex 1. 

  

	A.16	“Models” means; (i) the design simulation models identified in Section 1 Part H; and (ii) any other design simulation model for the ARM[***]
microprocessor core which is generally available from ARM subject to; (a) receipt by ARM of a purchase order from LICENSEE requesting such design simulation model expressly subject to the terms and conditions of this Agreement; and (b) the
payment by LICENSEE to ARM of the then current fee for such design simulation model as quoted by ARM from time to time. 

  

	A.17	“Pipeline Length” means the number of clocked stages through which each single-cycle instruction must pass to complete the execution of such instruction and
identified in Section 1 Part I of this Annex 1. 

  

	A.18	“RTL Test Benches” means the program files identified in Section 1 Part D of this Annex 1. 

  

	A.19	“Single Issue” means that only one instruction is issued for execution within the integer unit in any single clock cycle (where for the purposes of this definition
clock means the clock that advances the pipeline). 

  

	A.20	“Synthesisable RTL” means the deliverables identified in Section 1 Part C Section 1 of this Annex 1. 

  

	A.21	“Technical Reference Manual” means the relevant technical reference manuals identified in Section 1 Part A Section 1 of this Annex 1

  

	A.22	“Use” means in respect of the object code of the Models, the use of (including copying the object code of the Models to the extent that such copying is incidental
to such use, including installation, backup and execution) the object code of the Models, or any part thereof. Use shall specifically exclude: (i) the translation, adaptation, arrangement or other alteration of the object code of the Models
except as allowed by local legislation implementing Article 6 of the EC Directive on the legal protection of computer programs (91/250/EEC) and then only to the extent necessary to achieve interoperability of an independently created program
with other programs; and (ii) the adapting or reverse compiling of the object code of the Models for the purpose of error correction 

  

	B.	Licence 

  

	B.1	Subject to the provisions of Clause 14 (Confidentiality) of the DLA and the provisions of this Section 2, ARM hereby grants, to LICENSEE, a non-transferable (subject to Clause
20.2 of the DLA), non-exclusive, worldwide licence for the Term to; 

  

 Page 5 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Technical Reference Documentation 
  

	 	(i)	use, copy, modify (solely to the extent necessary to reflect any permitted modifications in accordance with the provisions of this Clause B.1 or for incorporation into
LICENSEE’s documentation), distribute and have distributed the Technical Reference Manuals; 

 ARM Compliant Core

  

	 	(ii)	use and copy the Implementation and Integration Documentation for the sole purpose of designing and having designed (subject to the provisions of Clause 2.2 of the DLA) for the ARM
Compliant Products; 

  

	 	(iii)	use and copy the AVS only for the purposes of designing and having designed (subject to the provisions of Clause 2.2 of the DLA) ARM Compliant Products and Test Chips;

  

	 	(iv)	use, copy and modify the Synthesisable RTL (solely for the purposes of scan insertion, buffer insertion, timing closure, targeting standard cell libraries, direct instantiations of
cells for speed and power optimisation, and use of LICENSEE specified BIST), only for the purposes of designing and having designed (subject to the provisions of Clause 2.2 of the DLA) ARM Compliant Products; 

  

	 	(v)	use, copy and modify the Implementation Scripts only for the. purposes of designing and having designed (subject to the provisions of Clause 2.2 of the DLA), ARM Compliant Products;

  

	 	(vi)	use, copy and modify the Functional and Integration Test only for the purposes of designing and having designed (subject to the provisions of Clauses 2.2), ARM Compliant Products

  

	 	(vii)	use, copy and modify (solely for the purpose of and to the extent necessary to run the vectors on a simulator or tester) the Functional Test Vectors, only for the purposes of
designing and having designed (subject to the provisions of Clauses 2.2), manufacturing and having manufactured (subject to the provisions of Clause 2.3 of the DLA), testing and having tested (subject to the provisions of Clause 2.5 of the DLA) ARM
Compliant Products; 

  

	 	(viii)	use, copy and modify the RTL Test Benches only for the purposes of designing and having designed (subject to the provisions of Clause 2.2 of the DLA) ARM Compliant Products and Test
Chips; 

  

	 	(ix)	manufacture and have manufactured (subject to the provisions of Clause 2.3 of the DLA) one (1) Authorised Product created under the licences granted in Clauses B.1(i) to B.1
(viii) inclusive; 

  

	 	(x)	package and have packaged (subject to the provisions of Clause 2.4 of the DLA), one (1) Authorised Product manufactured under the licences granted in Clause B.1(ix);

  

	 	(xi)	sell, supply and distribute encapsulated die of one (1) Authorised Product which has been manufactured under the licences granted in Clause B.1(ix); 

Models 
  

	 	(xii)	copy and use, internally and for third party support purposes, the Models and related documentation; 

  

	 	(xiii)	use, reproduce and distribute, and sub-license (subject to the terms of an End User Licence) the Use of the object code of the Models, solely for the purpose of developing the ARM
Compliant Products; and 

  

	 	(xiv)	modify, reproduce, use and distribute, in connection with the Models, the documentation related thereto. 

  

	C.	Special Conditions 

 Sun Java Hardware
Acceleration 
 “Sun SCSL License Agreement” means any of; (i) a Sun Community Source License entered into between LICENSEE
and Sun Microsystems Inc for the Sun CLDC technology; or (ii) any license agreement entered into between LICENSEE and Sun Microsystems Inc which expressly permits LICENSEE to share source code for the Sun CLDC technology with ARM for the Sun
CLDC technology. 
  

 Page 6 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 “Jazelle” means the extension to the ARM architecture that enables the execution of a subset of Java byte codes by an ARM core as accessed through the BXJ instruction. 
  

	C.1	LICENSEE acknowledges that the ARM Compliant Core incorporates hardware acceleration for Sun Microsystems Inc.’s (“Sun”) Java technology. Without prejudice to any
limitations or restrictions set out in the licence grants in Clause B.1 above, LICENSEE agrees that unless LICENSEE has entered into and continues to enjoy the benefit of a Sun SCSL License Agreement, LICENSEE shall be subject to the following
licensing restrictions; 

  

	 	A.	LICENSEE shall not; (i) carry out or procure any functional modification of any part of the ARM[***] Core to the extent that it includes, incorporates or implements Jazelle; or
(ii) reverse engineer or use the ARM Technology licensed under this Annex for the purpose of implementing the whole or any part of a Java specification (where a Java specification means any “Final Release” of a “JSR”
developed as part of the Java Community Process without first entering into a Sun SCSL License Agreement; 

  

	 	B.	LICENSEE agrees that Sun Microsystems Inc. shall be an intended third party beneficiary of the terms and conditions of this DLA solely for the purpose of enforcing the restrictions
contained in A above; and 

  

	 	C.	If LICENSEE discloses or distributes any ARM Technology which includes, incorporates or implements Jazelle to a third party, except as ARM Compliant Products in the form of silicon,
then such third party shall be made subject to the same restrictions as LICENSEE in A and B above. 

 Disclosures

  

	C.2	ARM hereby discloses the following against the warranty provided in Clause 15.3(ii) of the DLA; 

 On the 28th May 2002 ARM received notice that Nazomi Communications, Inc. (“Nazomi”) has filed a patent infringement suit against ARM alleging that the ARM Technology licensed under this Annex 1
infringes Nazomi’s United States patent #6,332,215. 
  

	D.	Amendments to the DLA 

  

	D.1	For the purposes of this Annex 1, Clause 1.11 of the DLA shall be replaced with the following: 

  

	 	“1.11	Authorised Foundry” means the entity sub-contracted by LICENSEE to manufacture integrated circuits for LICENSEE.” 

  

	D.2	LICENSEE hereby agrees that if; (a) an Authorised Foundry breaches the confidentiality provisions in Clause 2.3(i)(a) and 2.3(ii); or (b) a Designer breaches the
confidentiality provisions in Clause 2.2(ii) and 2.2(iii), then LICENSEE shall hold ARM harmless from and keep ARM indemnified against all and any loss, liability, costs, damages, expenses (including reasonable attorneys fees), suffered, incurred or
sustained by ARM as a result of such breach. 

  

	D.3	For the purposes of this Annex 1 the provisions of Clauses 14.3 -14.5 of the DLA shall be replaced with the following provisions and new Clause 14.8 shall be added:

 Permitted Disclosure to Authorised Foundry 
  

	 	14.3	LICENSEE may disclose the (i) the ARM Technology marked “M” and any translation, modification, compilation, abridgement or other form in which the ARM Technology
marked “M” has been recast, transformed or adapted; (ii) any GDSII created by or for LICENSEE from the synthesizable RTL licensed under this Annex 1 and (iii) any masks created from the GDSII by or for LICENSEE, to an
Authorised Foundry pursuant to the exercise of any have manufactured rights (if granted in Section 2 of this Annex 1) solely for the purposes of having ARM Compliant Products or other devices which contain royalty bearing ARM Technology
licensed in accordance with the terms of this DLA, as the case may be, manufactured for LICENSEE by such third party and under a non-disclosure agreement containing substantially similar terms to this Clause 14, except that the confidentiality
period for each deliverable shall be, at a minimum, of five (5) years from the date of disclosure. 

  

 Page 7 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Permitted Disclosure to Designers 
  

	 	14.4	LICENSEE may disclose the ARM Technology marked “D” in this Annex 1 and any translation, modification, compilation, abridgement or other form in which the ARM Technology
marked “D” has been recast, transformed or adapted, to a Designer pursuant to the exercise of the have designed rights (if granted in Section 2 of this Annex 1) solely for the purposes of having ARM Compliant Products or other
devices which contain royalty bearing ARM Technology licensed in accordance with the terms of this DLA, as the case may be, designed for LICENSEE by such third party and under a non-disclosure agreement containing substantially similar terms to this
Clause 14, including the confidentiality period for each deliverable determined in accordance with the provisions of Clause 14.1. 

 Permitted Disclosure to Test Houses 
  

	 	14.5	LICENSEE may disclose (i) the ARM Technology marked “T” in this Annex 1 and any translation, modification, compilation, abridgement or other form in which the ARM
Technology marked “T” has been recast, transformed or adapted; and (ii) any ATPG test vectors created by or for LICENSEE from the Synthesizable RTL (defined in this Annex 1), to a Test House pursuant to the exercise of the have
tested rights (if granted in Section 2 of this Annex 1) solely for the purposes of having ARM Compliant Products or other devices which contain royalty bearing ARM Technology licensed in accordance with the terms of this Annex, as the case may
be, tested for LICENSEE by such third party and under a non-disclosure agreement containing substantially similar terms to this Clause 14, except that the confidentiality period for each deliverable shall be, at a minimum, five (5) years from
the date of disclosure. 

  

	D.4	The parties hereby agree that the provisions of Clauses 3, 4 and 5 of the DLA are not applicable in respect of the Qualified ARM Core licensed under this Annex 1, and accordingly
shall not apply to this Annex 1. 

  

	D.5	For the purposes of this Annex 1 the provisions of Clause 15.1 of the DLA shall be replaced with the following provision: 

  

	 	15.1	ARM warrants to LICENSEE that the ARM Technology will be consistent with allowing a competent semiconductor manufacturer to manufacture products which substantially conform to the
functionality described in the relevant technical reference manual. LICENSEE acknowledges that the process for converting the ARM Technology delivered to LICENSEE in to silicon necessarily involves the introduction and use of technology not
delivered by ARM and accordingly ARM’s liability and LICENSEE’s sole remedy for breach of the warranty provided under this Clause 15.1 shall be as follows; if LICENSEE can demonstrate to ARM that any defect in the silicon developed using
any ARM Technology is exclusively caused by a defect in the ARM Technology as delivered to LICENSEE then ARM shall use commercially reasonable efforts to correct any errors in the ARM Technology and deliver corrected ARM Technology to LICENSEE. THE
FOREGOING STATES THE ENTIRE LIABILITY OF ARM WITH RESPECT TO BREACH OF THE WARRANTY PROVIDED IN THIS CLAUSE 15.1. 

  

	D.6	For the purposes of this Annex 1 the provisions of Clause 17.2 of the DLA shall be replaced with the following provision: 

  

	 	17.2.	NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED IN THE DLA, THE MAXIMUM LIABILITY OF ARM TO LICENSEE IN AGGREGATE FOR ALL CLAIMS MADE AGAINST ARM IN CONTRACT TORT OR OTHERWISE
UNDER OR IN CONNECTION WITH THE SUBJECT MATTER OF THIS ANNEX SHALL NOT EXCEED $750,000. THE EXISTENCE OF MORE THAN ONE CLAIM OR SUIT WILL NOT ENLARGE OR EXTEND THE LIMIT. LICENSEE RELEASES ARM FROM ALL OBLIGATIONS, LIABILITY, CLAIMS OR DEMANDS IN
EXCESS OF THIS LIMITATION. 

  

	D.7	Prior to the distribution of any ARM Compliant Product manufactured by or for LICENSEE under the licences granted in Section 2 of this Annex 1, LICENSEE shall verify such ARM
Technology in accordance with the verification procedure set out in Section 3 of this Annex 1. 

  

 Page 8 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 3 – DESIGN ID REQUEST FORM; VERIFICATION 
 DESIGN ID REQUEST FORM: 
 Not Applicable 
 VERIFICATION 
  

	V.1	Definitions 

  

	V.1.1	“Implementation” means, in respect of a microprocessor core, a unique physical layout for such microprocessor core. 

  

	V.1.2	“Post Layout Synthesized Netlist” means a post layout synthesized netlist incorporating the ARM Compliant Core which; (i) obeys the Timing Constraints File in
respect of such synthesis; and (ii) includes back annotated delays derived from the physical layout. 

  

	V.1.3	“Timing Constraints File” means the timing constraints file determined by LICENSEE prior to final synthesis. 

  

	V.1.4	“Validation and Verification Confirmation” means the completed document in the form set out in Part C of Section 3 of this Annex 1. 

 

	V1.5	“Validation Deliverables” means together the AVS and the RTL Test Benches. 

  

	V.2	Validation and Verification of ARM Compliant Core Implementation 

  

	V.2.1	For each Implementation of an ARM Compliant Core intended for incorporation in integrated circuits which will be distributed by or for LICENSEE, LICENSEE shall verify such
Implementation by at least one of the following methods; 

  

	 	1.	Validation and verification by Equivalence Checking of RTL and Synthesized Netlist (See Part A) 

  

	 	2.	LICENSEE Specified validation and verification (See Part B) 

  

 Page 9 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Part
A 
 Validation and Verification by Equivalence Checking of RTL and Synthesized Netlist 
 Methodology 
 Validation 
  

	V.A.1	Validate the configured Synthesisable RTL using the Validation Deliverables in accordance with the Implementation Guide and generate the validation log report
(“Validation Logs”). 

 Verification 
  

	V.A.2	(i) use an equivalence checker to compare the Synthesisable RTL with the Post-Layout Synthesized Netlist and generate equivalence check log results (“RTL-Post Layout
Equivalence Log Results”); (ii) simulate the Functional Test Vectors on the Post-Layout Synthesized Netlist and generate log results (“Post Layout Log Results”); and (iii) run static timing analysis on the Post-Layout
Synthesized Netlist and generate log results (“STA Log Results”). 

 Delivery of Validation and
Verification Confirmation 
  

	V.A.3	If the Validation Logs, RTL-Post Layout Equivalence Log Results, Post Layout Log Results and the STA Log Results (together the “Equivalence Log Results”) indicate
that no errors have been detected (or the parties have jointly agreed a waiver in respect of any detected errors), LICENSEE shall deliver a Verification Confirmation to ARM and ARM shall acknowledge, in writing, the receipt by ARM of the
Verification Confirmation within ten (10) working days of its receipt by ARM. 

 Validation and Verification Criteria 

 

	V.A.4	The Implementation of the ARM Compliant Core shall be validated and verified when; (i) the Equivalence Log Results indicate that no errors have been detected (or the parties
have jointly agreed a waiver in respect of any detected errors); and (ii) LICENSEE has received confirmation of receipt of the relevant Validation and Verification Confirmation from ARM in accordance with the provisions of Clause V.A.3.

 Records and Delivery of Equivalence Log Results 
  

	V.A.5	For each ARM Compliant Product incorporating an Implementation of the ARM Compliant Core, LICENSEE shall keep a copy of the Equivalence Log Results for such ARM Compliant Product
and shall deliver, as soon as reasonably possible, copies of such records to ARM upon request from ARM. If ARM concludes that the Implementation of the ARM Compliant Core has not been validated and verified in accordance with the provisions of
Clause V.A.4, then ARM shall indicate to LICENSEE the errors which ARM has detected and LICENSEE shall repeat the process prescribed in Clauses V.A.1- V.A.3. 

 Part B 
 LICENSEE Specified Validation and Verification 
 Methodology 
  

	V.B.1	Subject to V.B.4, use LICENSEE’s custom validation and verification flow. 

  

	V.B.2	 If LICENSEE elects such validation and verification, LICENSEE shall, inform ARM in writing at least ninety (90) days prior to tape out of an ARM Compliant
Product that LICENSEE wishes to use LICENSEE’s specified validation and verification flow and supply to ARM a copy of the proposed validation and verification flow (each a “Validation and Verification Flow”). Within 30 days of
the receipt of the Validation 

  

 Page 10 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	 	 
and Verification Flow ARM shall notify LICENSEE in writing whether the Validation and Verification Flow has been accepted by ARM. If accepted by ARM,
LICENSEE shall validate and verify such ARM Compliant Products using the Validation and Verification Flow. If after acceptance of the Validation and Verification Flow by ARM, LICENSEE wishes to modify the Validation and Verification Flow LICENSEE
shall submit the modified Validation and Verification Flow to ARM for re-acceptance prior to validating and verifying the relevant Synthesisable ARM Compliant Core. 

  

	V.B.3	If ARM rejects either the Validation and Verification Flow or any modified Validation and Verification Flows, ARM shall provide LICENSEE with written reasons for such rejection
together with any required changes. LICENSEE may resubmit the Validation and Verification Flow or any modified versions thereof to ARM for acceptance. 

 Default 
  

	V.B.4	If ARM fails to accept the Validation and Verification Flow LICENSEE shall validate and verify the Post Layout Synthesized Netlist in accordance with one of the other methods set
out in Clause V.2.1. 

  

 Page 11 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Part C 
 Validation and Verification Confirmation 
 Validation and Verification in accordance with Section 3 Part A 
  

	1.	Equivalence checking 

  

							
	 Description of process applied
	  	 Tool(s) used
	  	 Completed
(Tick)
	  	 
	 ARM Compliant Core RTL to post-layout netlist *
	  		  		  	

	*	Process can be performed in one step or using several intermediate steps 

  

	2.	STA on Post-Layout Synthesized Netlist 

  

							
	 Description of process applied
	  	 Tool(s) used
	  	 Completed
(Tick)
	  	 
	 Post-layout netlist
	  		  		  	

  

	3.	Test Vector Simulations on Post-Layout Synthesized Netlist 

  

							
	 Description of process applied
	  	 Tool(s) used
	  	 Completed
(Tick)
	  	 
	 Functional Test Vectors (file names)
	  		  		  	

 Verification in accordance with Section 3 Part B 
 Depending upon agreed verification methodology. 
  

			
	 Partner
	 	
	 Partner Contact
	 	
	 Core Name and Revision
	 	
	 Date
	 	
	 Signature
	 	

  

 Page 12 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 4 - SUPPORT AND MAINTENANCE PERIODS AND LIMITATION 
 Support and Maintenance Period 
 In consideration for the payment of each annual Support and Maintenance Fee set out in Section 8, ARM shall provide one (1) year of Support and Maintenance for
the ARM Technology licensed under this Annex 1. 
 Support Limitations 
 ARM shall provide a maximum of seventeen (17) person days of Support per annum. 
  

 Page 13 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 5 - TRAINING 
 NOT APPLICABLE. 
  

 Page 14 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 6 - TRADEMARKS 
  

							
		 	 Trademark
	  	Registered/ Unregistered	  	

 Part A 
  

							
		 	 ARM w/bar [logo] Exhibit A
	  	Registered	  	

 Part B 
  

							
		 	 ARM Powered [logo] Exhibit B
	  	Registered	  	

 Part C 
  

							
		 	 ARM [logo] Exhibit C
	  	Registered	  	

 Part D 
  

							
		 	ARM Connect Community Partner [logo] Exhibit D	  	 Unregistered
	  	

 Part E 
  

							
		 	 ARM
	  	Registered	  	
		 	 ARM[***]
	  	Unregistered	  	

  

 Page 15 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 7 - TERM 
 Unless terminated earlier in accordance with the provisions of Clause 17 of the DLA, this Annex 1 shall continue in force
for the continuance of the DLA. 
  

 Page 16 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 8 - FEES AND ROYALTIES 
 FEES 
 Licence Fees 
 Licence Fees 
  

							
	 Fee (Descriptor)
	  	US$	  	 
	  	  	Due	  	Payable	  	 Due Date (Invoice Date)

	 [***]
	  	[***]	  	[***]	  	 [***]

 Support and Maintenance Fees 
  

					
	 Support and Maintenance Period
	  	Fee (US$) (*)	  	 Invoice Date

	 [***]
	  	[***]	  	 [***]

			
	 [***]
	  	[***]	  	 [***]

			
	 [***]
	  	[***]	  	 [***]

	[***]	

 ROYALTIES 
 AS SET OUT IN SCHEDULE 3 OF THE DLA 
  

 Page 17 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 9 - MARKETING 
 Not Applicable 
  

 Page 18 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 10 – END USER LICENCE 
 Spreadtrum Communications, Inc. (“LICENSOR”) hereby grants and the LICENSEE hereby
accepts a non transferable and non-exclusive licence to use the Model solely for the purpose of developing a product which incorporates a CPU manufactured under LICENSOR’s licence from ARM (“Purpose”), under the following terms and
conditions: 
  

	1.	Ownership. The Model is the property of ARM LIMITED and/or its licensors. The LICENSEE acquires no title, right or interest in the Model other than the licence rights granted
herein. 

  

	2.	Use. The LICENSEE may use the Model on any one computer at one time except that the Model may be executed from a common disc shared by multiple CPUs provided that one
authorised copy of the Model has been licensed from LICENSOR for each CPU concurrently executing the Model. 

 LICENSEE shall
not reverse engineer, decompile or disassemble the Model, in whole or in part. 
 LICENSEE shall only be permitted to use the Model for the
Purpose. 
 LICESENSOR hereby authorises LICENSEE to concurrently use up to a maximum number of
[        ] copies of the Model 
  

	3.	Copies. Except as provided in Clause 2, LICENSEE may make copies of the Model for back-up and archival purposes only. All copies of the Model must bear the same notice(s)
contained on the original copies supplied by LICENSOR. 

  

	4.	Model Limited Warranty. LICENSOR warrants that the disks containing the Model shall be free from defects and workmanship under normal use and the programs will perform in
accordance with the accompanying documentation for a period of ninety (90) days from the date of delivery. Any written or oral information or advice given by LICENSOR distributors, agents or employees will in no way increase the scope of this
warranty. LICENSOR’s entire liability and the LICENSEE’s exclusive remedy will be, at LICENSOR’s sole option, to replace the disk or to use LICENSOR’s reasonable efforts to make the Model meet the warranty set forth above. Any
replacement Model will be warranted for the remainder of the original warranty period or thirty (30) days, whichever is the longer. The LICENSEE agrees that the supply of the Model does not include updates and upgrades, which may be available
from LICENSOR under a separate support agreement. 

 THE ABOVE WARRANTIES ARE EXCLUSIVE AND IN LIEU OF ALL OTHER WARRANTIES,
WHETHER EXPRESS OR IMPLIED INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. 
 IN
NO EVENT SHALL LICENSOR BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES RESULTING FROM ITS PERFORMANCE OR FAILURE TO PERFORM UNDER THIS AGREEMENT OR THE FURNISHING, PERFORMANCE, OR USE OF ANY MODEL LICENSED HERETO, WHETHER
DUE TO BREACH OF CONTRACT, BREACH OF WARRANTY, OR NEGLIGENCE EVEN IF LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 
 THE
MAXIMUM LIABILITY OF LICENSOR SHALL BE LIMITED TO REFUND OF THE FEES PAID BY LICENSEE (IF ANY) FOR THE MODEL. 
  

	5.	Assignment of the Agreement. This Agreement and any license granted hereunder to the LICENSEE may not be assigned, sub-licensed or otherwise transferred by the LICENSEE to
any third party 

  

	6.	Term and Termination. Unless terminated in accordance with the provisions of this Clause 6, this Agreement and licenses granted hereunder shall continue in force until
completion of the Purpose. LICENSOR may terminated this Agreement by written notice to the LICENSEE in the event of a breach by LICENSEE of any provisions of this Agreement. 

 Upon expiration or termination of this Agreement, the LICENSEE shall refrain from any further use of the Model, and LICENSEE shall either return or
destroy and copies of the Model in it’s possession at the date of expiration of termination as applicable. 
  

	7.	Applicability. The limitations and exclusions above may not apply in certain countries or states where they conflict with local law. In cases where such a conflict exists the
local law shall prevail and the remaining provisions of the Agreement shall remain in full force and effect. 

  

 Page 19 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 IN
WITNESS WHEREOF the parties have caused this Annex 1 to be signed by their duly authorised representative: 
  

									
	ARM LIMITED	 		 	SPREADTRUM COMMUNICATIONS, INC.
					
	BY:	 	 

	 		 	BY:	 	 

	NAME:	 	Philip David	 		 	NAME:	 	Harry Qin
	TITLE:	 	General Counsel	 		 	TITLE:	 	VP, BD
	DATE:	 	30/09/06	 		 	DATE:	 	09/30/2006

  

 Page 20 of 20 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 ANNEX
1 
 SPREADTRUM COMMUNICATIONS, INC. 
 ARM7TDMI-S
CORE 
  

							
	DLA Number	 	LEC-DLA-00022-V6.0	 		 	
	Legal Counsel	 	AP	 		 	
	Annex Effective Date	 	September 30, 2006	 		 	

 This Annex, when signed by both parties, shall form part of and be incorporated into the Design License Agreement
(“DLA”) between the parties (document reference as identified in the table above). Solely for the purposes of interpretation of the DLA with respect to this Annex, to the extent that the provisions contained in this Annex conflict with any
of the provisions of the DLA the provisions contained in this Annex shall prevail over and shall supersede the conflicting provisions in the DLA. 
  

 Page 1 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 1 - ARM TECHNOLOGY 
 Key to Disclosure Rights 
  

			
	D	  	CONFIDENTIAL except disclosure permitted to “Designers” in accordance with Clause 14 of the DLA
	M	  	CONFIDENTIAL except disclosure permitted to “Manufacturers” in accordance with Clause 14 of the DLA
	T	  	CONFIDENTIAL except disclosure permitted to “Test Houses” in accordance with Clause 14 of the DLA
	N	  	NON-CONFIDENTIAL but disclosure may be subject to license restrictions

 [***] 
  

 Page 2 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

 Page 3 of 21 

  
 Confidential Treatment
Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and
Exchange Commission. Confidential treatment has been requested by Spreadtrum Communications, Inc. with respect to the omitted portions. 

 Page 4 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 2 - LICENCE AND SPECIAL 
 CONDITIONS 
  

	A.	Definitions 

  

	A.1	“Architecture” means the architecture identified in Section 1 Part I of this Annex 1. 

  

	A.2	“ARM Compliant Core” means the ARM7TDMI-S microprocessor core as described and identified in the Technical Reference Manual and which; 

  

	 	(i)	executes each and every instruction in the ARM Instruction Set; 

  

	 	(ii)	executes no additional instructions to those contained in the ARM Instruction Set; 

  

	 	(iii)	exhibits the Architecture; 

  

	 	(iv)	exhibits the Pipeline Length; 

  

	 	(v)	is Single Issue; 

  

	 	(vi)	executes all instructions at an identical rate of cycles per instruction (“CPI”) to that specified in the Technical Reference Manual; 

  

	 	(vii)	implements the programmer’s model as identified in the “Architecture Reference Manual” (Published by Addison-Wesley); 

  

	 	(viii)	runs and passes the Functional Test Vectors; 

  

	 	(ix)	runs and passes the AVS; and 

  

	 	(x)	has been verified in accordance with the provisions of Section 3 of this Annex 1. 

  

	A.3	“ARM Compliant Product” means an integrated circuit incorporating an ARM Compliant Core. 

  

	A.4	“ARM[***] Instruction Set” means the ARM[***] instruction sets as described and identified in the ARM Architecture Reference Manual ARM [***].

  

	A.5	“ARM Instruction Set” means the instruction set identified in Section 1 Part I of this Annex 1. 

  

	A.6	“ARM Technology” means any or all, as the context admits, of the technology identified in Section 1 of this Annex 

  

	A.7	“Authorised Product” means: 

  

	 	(i)	an unlimited number of units of a single design for an ARM Compliant Product which has been taped out and given a unique part number; and 

  

	 	(ii)	an unlimited number of units of any derivatives of the ARM Compliant Products referred to in Clause A.7(i), provided that: 

  

	 	(a)	such derivatives result only from any or all of the following modifications; (1) the implementation by LICENSEE of an Update delivered by ARM to some or all of the Arm
Compliant Product; (2) the correction of errors in such ARM Compliant Products to achieve conformance with the original specification for such design; and (3) a version of such ARM Compliant Product that has been ported to a different set
of process design rules but is otherwise functionally unmodified (except to the extent accommodated by this definition); and 

  

 Page 5 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	 	(b)	except as provided below, no more than one such derivative for the ARM Compliant Product referred to in Clause A.7(i) is being manufactured for LICENSEE at any time. LICENSEE shall
be permitted to concurrently manufacture the derivative and the design from which such derivative was derived; (i) indefinitely if the derivative is a result of Clause A.7(ii)(a)(1) or Clause A.7(ii)(a)(2); and (ii) if the
derivative is a result of Clause A.7(ii)(a)(3), then for a period of twelve (12) months from the date of first manufacture of the new derivative 

  

	A.8	“AVS” means the ARM architectural validation suite identified in Section 1 Part E of this Annex 1. 

  

	A.9	“Designer” means any entity sub-contracted by LICENSEE to provide design resource to LICENSEE. 

  

	A.10	“End User Licence” means a license agreement substantially in the form set out in Section 10 of this Annex 1. 

  

	A.11	“Functional and Integration Test” means the relevant test files identified in Section 1 Part G of this Annex 1. 

  

	A.12	“Functional Test Vectors” means the functional test vectors identified in Section 1 Part F of this Annex 1. 

  

	A.13	“Implementation and Integration Documentation” means the documentation identified in Section 1 Part B of this Annex 1. 

  

	A.14	“Implementation Scripts” means the deliverables identified in Section 1 Part C Section 2 of this Annex 1. 

  

	A.15	“Models” means; (i) the design simulation models identified in Section 1 Part H; and (ii) any other design simulation model for the
ARM7TDMI-S microprocessor core which is generally available from ARM subject to; (a) receipt by ARM of a purchase order from LICENSEE requesting such design simulation model expressly subject to the terms and conditions of this
Agreement; and (b) the payment by LICENSEE to ARM of the then current fee for such design simulation model as quoted by ARM from time to time. 

  

	A.16	“Pipeline Length” means the number of clocked stages through which each single-cycle instruction must pass to complete the execution of such instruction and
identified in Section 1 Part I of this Annex 1. 

  

	A.17	“RTL Test Benches” means the program files identified in Section 1 Part D of this Annex 1. 

  

	A.18	“Single Issue” means that only one instruction is issued for execution within the integer unit in any single clock cycle (where for the purposes of this definition
clock means the clock that advances the pipeline). 

  

	A.19	“Synthesisable RTL” means the deliverables identified in Section 1 Part C Section 1 of this Annex 1. 

  

	A.20	“Technical Reference Manual” means the relevant technical reference manuals identified in Section 1 Part A Section 1 of this Annex 1

  

	A.21	“Test Chip” means for each ARM Compliant Core a device which complies with the relevant Test Chip Documentation. 

  

	A.22	“Test Chip Documentation” means the relevant test chip specification identified in Section 1 Part J of this Annex 1. 

  

	A.23	“Test Chip Functional Test Vectors” means the test chip functional test vectors identified in Section 1 Part L of this Annex 1. 

  

	A.24	“Test Chip Synthesisable RTL” means the deliverables identified in Section 1 Part K Section 1 of this Annex 1. 

  

	A.25	“Test Chip Synthesis Scripts” means the deliverables identified in Section 1 Part K Section 2 of this Annex 1. 

  

	A.26	 “Use” means in respect of the object code of the Models, the use of (including copying the object code of the Models to the extent that such
copying is incidental to such use, including installation, backup and execution) the object code of the Models, or any part thereof. Use shall specifically exclude: (i) the translation, adaptation, arrangement or other alteration of the object
code of the Models except as allowed by local legislation implementing Article 6 of the EC Directive on the legal protection of computer programs 

  

 Page 6 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	 	 
(91/250/EEC) and then only to the extent necessary to achieve interoperability of an independently created program with other programs; and
(ii) the adapting or reverse compiling of the object code of the Models for the purpose of error correction 

  

	A.27	“Von Neumann Architecture” means a microprocessor architecture which dictates that the instruction stream for the integer unit shares the same port with the data
stream for such integer unit 

  

	B.	Licence 

  

	B.1	Subject to the provisions of Clause 14 (Confidentiality) of the DLA and the provisions of this Section 2, ARM hereby grants, to LICENSEE, a non-transferable (subject to Clause
20.2 of the DLA), non-exclusive, worldwide licence for the Term to; 

 Technical Reference Documentation

 (i) use, copy, modify (solely to the extent necessary to reflect any permitted modifications in accordance with the provisions of this
Clause B.1 or for incorporation into LICENSEE’s documentation), distribute and have distributed the Technical Reference Manuals; 
 ARM Compliant Core 
 (ii) use and copy the Implementation and Integration Documentation for the sole
purpose of designing and having designed (subject to the provisions of Clause 2.2 of the DLA) for the ARM Compliant Products; 
 (iii) use and
copy the AVS only for the purposes of designing and having designed (subject to the provisions of Clause 2.2 of the DLA) ARM Compliant Products and Test Chips; 
 (iv) use, copy and modify the Synthesisable RTL (solely for the purposes of scan insertion, buffer insertion, timing closure, targeting standard cell libraries, direct instantiations of cells for speed and power
optimisation, and use of LICENSEE specified BIST), only for the purposes of designing and having designed (subject to the provisions of Clause 2.2 of the DLA) ARM Compliant Products; 
 (v) use, copy and modify the Implementation Scripts only for the purposes of designing and having designed (subject to the provisions of Clause 2.2 of the
DLA), ARM Compliant Products; 
 (vi) use, copy and modify the Functional and Integration Test only for the purposes of designing and having
designed (subject to the provisions of Clauses 2.2), ARM Compliant Products 
 (vii) use, copy and modify (solely for the purpose of and to
the extent necessary to run the vectors on a simulator or tester) the Functional Test Vectors, only for the purposes of designing and having designed (subject to the provisions of Clauses 2.2), manufacturing and having manufactured (subject to the
provisions of Clause 2.3 of the DLA), testing and having tested (subject to the provisions of Clause 2.5 of the DLA) ARM Compliant Products; 
 (viii) use, copy and modify the RTL Test Benches only for the purposes of designing and having designed (subject to the provisions of Clause 2.2 of the DLA) ARM Compliant Products and Test Chips; 
 (ix) manufacture and have manufactured (subject to the provisions of Clause 2.3 of the DLA) [***] Authorised Product created under the
licences granted in Clauses B.1(i) to B.1(viii) inclusive; 
 (x) package and have packaged (subject to the provisions of Clause 2.4 of the
DLA), [***] Authorised Product manufactured under the licences granted in Clause B.1(ix); 
 (xi) sell, supply and distribute
encapsulated die of [***] Authorised Product which has been manufactured under the licences granted in Clause B.1(ix); 
 Models 
 (xii) copy and use, internally and for third party support purposes, the Models and related documentation;

  

 Page 7 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	 	(xiii)	use, reproduce and distribute, and sub-license (subject to the terms of an End User Licence) the Use of the object code of the Models, solely for the purpose of developing the ARM
Compliant Products; 

  

	 	(xiv)	modify, reproduce, use and distribute, in connection with the Models, the documentation related thereto; and 

 Test Chips 
  

	 	(xv)	use, copy and modify; (a) the Test Chip Functional Test Vectors (solely for the purposes of and to the extent necessary to run the vectors on a simulator or tester;
(b) the Test Chip Synthesisable RTL (solely for the purposes of scan insertion, buffer insertion, timing closure, targeting standard cell libraries, direct instantiations of cells for speed and power optimisation, and use of LICENSEE specified
BIST and (c) the Test Chip Synthesis Scripts, only for the purposes of designing and having designed (subject to the provisions of Clause 2.2 of the DLA) Test Chips; 

  

	 	(xvi)	use and copy the Test Chip Documentation, only for the purposes of designing and having designed (subject to the provisions of Clause 2.2 of the DLA) Test Chips; and

  

	 	(xvii)	manufacture and have manufactured (subject to the provisions of Clause 2.3 of the DLA) the Test Chips created under the licences granted in Clauses B.1(xv) to B.1(xvi).

  

	C.	Process Migration 

  

	C.1	LICENSEE shall have the right to exercise the licenses granted in Clause B.1 of this Annex 1 for the purpose of migrating the Authorised Product based on the ARM7TDMI Core for
Project Name: [***] (the “First Authorised Product”) from the [***] process technology to any other process technology. An Authorised Product that has been migrated to a new process technology shall be functionality unmodified from part
[***] in accordance with Clause A.7(ii)(a)(3)of this Annex 1. For each process migration, LICENSEE shall pay to ARM a Process Migration Fee (defined in Clause 8.6 of the DLA) which shall be due upon tape out of the migrated Authorised Product and
shall be payable in accordance with Clause 8.11 of the DLA. 

  

	D.	Amendments to the DLA 

  

	D.1	For the purposes of this Annex 1, Clause 1.11 of the DLA shall be replaced with the following: 

  

	 	“1.11	Authorised Foundry” means the entity sub-contracted by LICENSEE to manufacture integrated circuits for LICENSEE.” 

  

	D.2	LICENSEE hereby agrees that if; (a) an Authorised Foundry breaches the confidentiality provisions in Clause 2.3(i)(a) and 2.3(ii); or (b) a Designer breaches the
confidentiality provisions in Clause 2.2(ii) and 2.2(iii), then LICENSEE shall hold ARM harmless from and keep ARM indemnified against all and any loss, liability, costs, damages, expenses (including reasonable attorneys fees), suffered, incurred or
sustained by ARM as a result of such breach. 

  

	D.3	For the purposes of this Annex 1 the provisions of Clauses 14.3—14.5 of the DLA shall be replaced with the following provisions and new Clause 14.8 shall be added:

 Permitted Disclosure to Authorised Foundry 
  

	 	14.3	LICENSEE may disclose the (i) the ARM Technology marked “M” and any translation, modification, compilation, abridgement or other form in which the ARM Technology
marked “M” has been recast, transformed or adapted; (ii) any GDSII created by or for LICENSEE from the synthesizable RTL licensed under this Annex 1 and (iii) any masks created from the GDSII by or for LICENSEE, to an
Authorised Foundry pursuant to the exercise of any have manufactured rights (if granted in Section 2 of this Annex 1) solely for the purposes of having ARM Compliant Products or other devices which contain royalty bearing ARM Technology
licensed in accordance with the terms of this DLA, as the case may be, manufactured for LICENSEE by such third party and under a nondisclosure agreement containing substantially similar terms to this Clause 14, except that the confidentiality period
for each deliverable shall be, at a minimum, of five (5) years from the date of disclosure. 

  

 Page 8 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Permitted Disclosure to Designers 
  

	 	14.4	LICENSEE may disclose the ARM Technology marked “D” in this Annex 1 and any translation, modification, compilation, abridgement or other form in which the ARM Technology
marked “D” has been recast, transformed or adapted, to a Designer pursuant to the exercise of the have designed rights (if granted in Section 2 of this Annex 1) solely for the purposes of having ARM Compliant Products or other
devices which contain royalty bearing ARM Technology licensed in accordance with the terms of this DLA, as the case may be, designed for LICENSEE by such third party and under a non-disclosure agreement containing substantially similar terms to this
Clause 14, including the confidentiality period for each deliverable determined in accordance with the provisions of Clause 14.1. 

 Permitted Disclosure to Test Houses 
  

	 	14.5	LICENSEE may disclose (i) the ARM Technology marked “T” in this Annex 1 and any translation, modification, compilation, abridgement or other form in which the ARM
Technology marked “T” has been recast, transformed or adapted; and (ii) any ATPG test vectors created by or for LICENSEE from the Synthesizable RTL (defined in this Annex 1), to a Test House pursuant to the exercise of the have
tested rights (if granted in Section 2 of this Annex 1) solely for the purposes of having ARM Compliant Products or other devices which contain royalty bearing ARM Technology licensed in accordance with the terms of this Annex, as the case may
be, tested for LICENSEE by such third party and under a non-disclosure agreement containing substantially similar terms to this Clause 14, except that the confidentiality period for each deliverable shall be, at a minimum, five (5) years from
the date of disclosure. 

  

	D.4	The parties hereby agree that the provisions of Clauses 3, 4 and 5 of the DLA are not applicable in respect of the Qualified ARM Core licensed under this Annex 1, and accordingly
shall not apply to this Annex 1. 

  

	D.5	For the purposes of this Annex 1 the provisions of Clause 15.1 of the DLA shall be replaced with the following provision: 

  

	 	15.1	ARM warrants to LICENSEE that the ARM Technology will be consistent with allowing a competent semiconductor manufacturer to manufacture products which substantially conform to the
functionality described in the relevant technical reference manual. LICENSEE acknowledges that the process for converting the ARM Technology delivered to LICENSEE in to silicon necessarily involves the introduction and use of technology not
delivered by ARM and accordingly ARM’S liability and LICENSEE’s sole remedy for breach of the warranty provided under this Clause 15.1 shall be as follows; if LICENSEE can demonstrate to ARM that any defect in the silicon developed using
any ARM Technology is exclusively caused by a defect in the ARM Technology as delivered to LICENSEE then ARM shall use commercially reasonable efforts to correct any errors in the ARM Technology and deliver corrected ARM Technology to LICENSEE. THE
FOREGOING STATES THE ENTIRE LIABILITY OF ARM WITH RESPECT TO BREACH OF THE WARRANTY PROVIDED IN THIS CLAUSE 15.1. 

  

	D.6	For the purposes of this Annex 1 the provisions of Clause 17.2 of the DLA shall be replaced with the following provision: 

  

	 	17.2	NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED IN THE DLA, THE MAXIMUM LIABILITY OF ARM TO LICENSEE IN AGGREGATE FOR ALL CLAIMS MADE AGAINST ARM IN CONTRACT TORT OR OTHERWISE
UNDER OR IN CONNECTION WITH THE SUBJECT MATTER OF THIS ANNEX SHALL NOT EXCEED [***]. THE EXISTENCE OF MORE THAN ONE CLAIM OR SUIT WILL NOT ENLARGE OR EXTEND THE LIMIT. LICENSEE RELEASES ARM FROM ALL OBLIGATIONS, LIABILITY, CLAIMS OR DEMANDS IN
EXCESS OF THIS LIMITATION. 

  

	D.7	Prior to the distribution of any ARM Compliant Product manufactured by or for LICENSEE under the licences granted in Section 2 of this Annex 1, LICENSEE shall verify such ARM
Technology in accordance with the verification procedure set out in Section 3 of this Annex 1. 

 E.
Test Chip Restrictions 
  

	E.1	No right is granted to LICENSEE to distribute or commercially exploit the Test Chips, or any technology contained therein (excluding the ARM Compliant Core) without obtaining a
separate licence from ARM. 

  

 Page 9 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 3 – DESIGN ID REQUEST FORM; 
 VERIFICATION 
 DESIGN ID REQUEST FORM: 
 Not Applicable 
 VERIFICATION 
 V.1 Definitions 
  

	V.1.1	“Implementation” means, in respect of a microprocessor core, a unique physical layout for such microprocessor core. 

  

	V.1.2	“Post Layout Synthesized Netlist” means a post layout synthesized netlist incorporating the ARM Compliant Core which; (i) obeys the Timing Constraints File in
respect of such synthesis; and (ii) includes back annotated delays derived from the physical layout. 

  

	V.1.3	“Timing Constraints File” means the timing constraints file determined by LICENSEE prior to final synthesis. 

  

	V.1.4	“Validation and Verification Confirmation” means the completed document in the form set out in Part D of Section 3 of this Annex 1. 

 

	V1.5	“Validation Deliverables” means together the AVS and the RTL Test Benches. 

  

	V.2	Validation and Verification of ARM Compliant Core Implementation 

  

	V.2.1	For each Implementation of an ARM Compliant Core intended for incorporation in integrated circuits which will be distributed by or for LICENSEE, LICENSEE shall verify such
Implementation by at least one of the following methods; 

  

	 	1.	Validation and verification by Equivalence Checking of RTL and Synthesized Netlist (See Part A) 

  

	 	2.	LICENSEE Specified validation and verification (See Part B) 

  

	 	3.	Validation and verification by Test Chip (See Part C) 

  

 Page 10 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Part
A 
 Validation and Verification by Equivalence Checking of RTL and 
 Synthesized Netlist 
 Methodology 
 Validation 
  

	V.A.1	Validate the configured Synthesisable RTL using the Validation Deliverables in accordance with the Implementation Guide and generate the validation log report (“Validation
Logs”). 

 Verification 
  

	V.A.2	(i) use an equivalence checker to compare the Synthesisable RTL with the Post-Layout Synthesized Netlist and generate equivalence check log results (“RTL-Post Layout
Equivalence Log Results”); (ii) simulate the Functional Test Vectors on the Post-Layout Synthesized Netlist and generate log results (“Post Layout Log Results”); and (iii) run static timing analysis on the
Post-Layout Synthesized Netlist and generate log results (“STA Log Results”). 

 Delivery of Validation and Verification
Confirmation 
  

	V.A.3	If the Validation Logs, RTL-Post Layout Equivalence Log Results, Post Layout Log Results and the STA Log Results (together the “Equivalence Log Results”) indicate
that no errors have been detected (or the parties have jointly agreed a waiver in respect of any detected errors), LICENSEE shall deliver a Verification Confirmation to ARM and ARM shall acknowledge, in writing, the receipt by ARM of the
Verification Confirmation within ten (10) working days of its receipt by ARM. 

 Validation and Verification Criteria 

 

	V.A.4	The Implementation of the ARM Compliant Core shall be validated and verified when; (i) the Equivalence Log Results indicate that no errors have been detected (or the
parties have jointly agreed a waiver in respect of any detected errors); and (ii) LICENSEE has received confirmation of receipt of the relevant Validation and Verification Confirmation from ARM in accordance with the provisions of Clause
V.A.3. 

 Records and Delivery of Equivalence Log Results 
  

	V.A.5	For each ARM Compliant Product incorporating an Implementation of the ARM Compliant Core, LICENSEE shall keep a copy of the Equivalence Log Results for such ARM Compliant Product
and shall deliver, as soon as reasonably possible, copies of such records to ARM upon request from ARM. If ARM concludes that the Implementation of the ARM Compliant Core has not been validated and verified in accordance with the provisions of
Clause V.A.4, then ARM shall indicate to LICENSEE the errors which ARM has detected and LICENSEE shall repeat the process prescribed in Clauses V.A.1- V.A.3. 

 Part B 
 LICENSEE Specified Validation and Verification 
 Methodology 
  

	V.B.1	Subject to V.B.4, use LICENSEE’s custom validation and verification flow. 

  

	V.B.2	 If LICENSEE elects such validation and verification, LICENSEE shall, inform ARM in writing at least ninety (90) days prior to tape out of an ARM Compliant
Product that LICENSEE wishes to use LICENSEE’s specified validation and verification flow and supply to ARM a copy of the proposed validation and verification flow (each a “Validation and Verification Flow”). Within 30 days of
the receipt of the Validation 

  

 Page 11 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  

	 	 
and Verification Flow ARM shall notify LICENSEE in writing whether the Validation and Verification Flow has been accepted by ARM. If accepted by ARM,
LICENSEE shall validate and verify such ARM Compliant Products using the Validation and Verification Flow. If after acceptance of the Validation and Verification Flow by ARM, LICENSEE wishes to modify the Validation and Verification Flow LICENSEE
shall submit the modified Validation and Verification Flow to ARM for re-acceptance prior to validating and verifying the relevant Synthesisable ARM Compliant Core. 

  

	V.B.3	If ARM rejects either the Validation and Verification Flow or any modified Validation and Verification Flows, ARM shall provide LICENSEE with written reasons for such rejection
together with any required changes. LICENSEE may resubmit the Validation and Verification Flow or any modified versions thereof to ARM for acceptance. 

 Default 
  

	V.B.4	If ARM fails to accept the Validation and Verification Flow LICENSEE shall validate and verify the Post Layout Synthesized Netlist in accordance with one of the other methods set
out in Clause V.2.1. 

 Part C 
 Validation and Verification by Test Chip 
 Methodology 
 Validation 
  

	V.C.1	Validate the configured RTL using the Validation Deliverables in accordance with the Implementation Guide and generate the validation log report (“Validation
Logs”). 

 Verification 
  

	V.C.2	Design (or have designed) and manufacture (or have manufactured) a Test Chip and run on such test chip; (i) the Test Chip Functional Test Vectors to generate a results log
(“Test Chip Test Vector Log Results”). 

 Delivery of Test Chips 
  

	V.C.3	After the Test Chip Test Vector Log Results indicate that no errors have been detected (or the parties have jointly agreed in good faith, a waiver in respect of any errors,
LICENSEE shall deliver the Test Chip Test Vector Log Results and five (5) tested samples of the Test Chip to ARM. As soon as reasonably possible following receipt by ARM of the five (5) Test Chip samples, ARM shall run the Test Chip
silicon validation software to generate a results log (“Test Chip Validation Log Results”) and provide to licensee (i) notice of verification of the Implementation in accordance with the provisions of Clause V.C.4 or
(ii) error logs of any verification failures. 

 Validation and Verification Criteria 
  

	V.C.4	The ARM Compliant Core shall be verified when; (i) the Validation Logs indicate that no errors have been detected (or the parties have jointly agreed a waiver in respect
of any detected errors); and (ii) the Test Chip Test Vector Log Results for the Implementation indicate that no errors have been detected (or the parties have jointly agreed a waiver in respect of any detected errors); and
(iii) LICENSEE has received notice of verification of the Implementation from ARM in accordance with the provisions of Clause V.C.5. 

 Notice of Validation and Verification 
  

	V.C.5	ARM shall notify LICENSEE, in writing, within thirty (30) days of delivery by LICENSEE of the Test Chip samples to ARM, whether such Test Chip has been verified or has failed
the validation and verification process. In the event that any Test Chip fails the process, ARM shall provide details of the errors that cause the failure to LICENSEE and LICENSEE shall endeavour to correct the errors. The parties shall repeat the
above process until either; (i) the Test Chip is validated and verified; or (ii) LICENSEE withdraws the Test Chip from the validation and verification process. In the event that ARM fails to report the result of the
validation and verification process within the Verification Period, the Test Chip subject to the verification process shall be deemed verified. 

  

 Page 12 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 Part
D 
 Validation and Verification Confirmation 
 Validation and Verification in accordance with Section 3 Part A 
  

	1.	Equivalence checking 

  

					
	 Description of process applied
	  	 Tool(s) used
	  	 Completed
(Tick)

	 ARM Compliant Core RTL to post-layout netlist *
	  		  	

	*	Process can be performed in one step or using several intermediate steps 

  

	2.	STA on Post-Layout Synthesized Netlist 

  

					
	 Description of process applied
	  	 Tool(s) used
	  	 Completed
(Tick)

	 Post-layout netlist
	  		  	

  

	3.	Test Vector Simulations on Post-Layout Synthesized Netlist 

  

					
	 Description of process applied
	  	 Tool(s) used
	  	 Completed
(Tick)

	 Functional Test Vectors (file names)
	  		  	

 Verification in accordance with Section 3 Part B 
 Depending upon agreed verification methodology. 
  

			
	 Partner
	 	
	 Partner Contact
	 	
	 Core Name and Revision
	 	
	 Date
	 	
	 Signature
	 	

  

 Page 13 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 4 – SUPPORT AND MAINTENANCE 
 PERIODS AND LIMITATION 
 Support and Maintenance Period 
 In consideration for the payment of each annual Support and Maintenance Fee set out
in Section 8, ARM shall provide one (1) year of Support and Maintenance for the ARM Technology licensed under this Annex 1. 
 Support
Limitations 
 ARM shall provide a maximum of seventeen (17) person days of Support per annum. 
  

 Page 14 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 5 – TRAINING 
 NOT APPLICABLE. 
  

 Page 15 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 6 – TRADEMARKS 
  

			
	Trademark	  	Registered/ Unregistered

 Part A 
  

			
	ARM w/bar [logo] Exhibit A	  	Registered

 Part B 
  

			
	ARM Powered [logo] Exhibit B	  	Registered

 Part C 
  

			
	ARM [logo] Exhibit C	  	Registered

 Part D 
  

			
	 ARM Connect Community
 Partner [logo]
Exhibit D
	  	Unregistered

 Part E 
  

			
	ARM	  	Registered
	ARM7TDMI-S	  	Unregistered

  

 Page 16 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 7 – TERM 
 Unless terminated earlier in accordance with the provisions of Clause 17 of the DLA, this Annex 1 shall continue in
force for the continuance of the DLA. 
  

 Page 17 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 8 – FEES AND ROYALTIES 
 FEES 
 Licence Fees 
 Not applicable(*) 
 (*) (a credit from the fourth Authorised Product design fee paid under the DLA shall apply as the License Fee hereunder) 
 Support and Maintenance Fees 
  

					
	 Support and Maintenance
Period
	  	Fee (US$) (*)	 	 Invoice Date

	 [***]
	  	[***]	 	 [***]

	 [***]
	  	[***]	 	 [***]

	 [***]
	  	[***]	 	 [***]

	[***]	

 ROYALTIES 
 AS SET OUT IN SCHEDULE 3 OF THE DLA 
  

 Page 18 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 9 – MARKETING 
 Not Applicable 
  

 Page 19 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 SECTION 10 – END USER LICENCE 
 Spreadtrum Communications, Inc. (“LICENSOR”) hereby grants and the LICENSEE hereby
accepts a non transferable and nonexclusive licence to use the Model solely for the purpose of developing a product which incorporates a CPU manufactured under LICENSOR’s licence from ARM (“Purpose”), under the following terms and
conditions: 
  

	1.	Ownership. The Model is the property of ARM LIMITED and/or its licensors. The LICENSEE acquires no title, right or interest in the Model other than the licence rights granted
herein. 

  

	2.	Use. The LICENSEE may use the Model on any one computer at one time except that the Model may be executed from a common disc shared by multiple CPUs provided that one
authorised copy of the Model has been licensed from LICENSOR for each CPU concurrently executing the Model. 

 LICENSEE shall
not reverse engineer, decompile or disassemble the Model, in whole or in part. 
 LICENSEE shall only be permitted to use the Model for the
Purpose. 
 LICESENSOR hereby authorises LICENSEE to concurrently use up to a maximum number of
[            ] copies of the Model 
  

	3.	Copies. Except as provided in Clause 2, LICENSEE may make copies of the Model for back-up and archival purposes only. All copies of the Model must bear the same notice(s)
contained on the original copies supplied by LICENSOR. 

  

	4.	Model Limited Warranty. LICENSOR warrants that the disks containing the Model shall be free from defects and workmanship under normal use and the programs will perform in
accordance with the accompanying documentation for a period of ninety (90) days from the date of delivery. Any written or oral information or advice given by LICENSOR distributors, agents or employees will in no way increase the scope of this
warranty. LICENSOR’s entire liability and the LICENSEE’s exclusive remedy will be, at LICENSOR’s sole option, to replace the disk or to use LICENSOR’s reasonable efforts to make the Model meet the warranty set forth above. Any
replacement Model will be warranted for the remainder of the original warranty period or thirty (30) days, whichever is the longer. The LICENSEE agrees that the supply of the Model does not include updates and upgrades, which may be available
from LICENSOR under a separate support agreement. 

 THE ABOVE WARRANTIES ARE EXCLUSIVE AND IN LIEU OF ALL OTHER WARRANTIES,
WHETHER EXPRESS OR IMPLIED INCLUDING, WITHOUT LIMITATION, THE IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. 
 IN
NO EVENT SHALL LICENSOR BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES RESULTING FROM ITS PERFORMANCE OR FAILURE TO PERFORM UNDER THIS AGREEMENT OR THE FURNISHING, PERFORMANCE, OR USE OF ANY MODEL LICENSED HERETO, WHETHER
DUE TO BREACH OF CONTRACT, BREACH OF WARRANTY, OR NEGLIGENCE EVEN IF LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 
 THE
MAXIMUM LIABILITY OF LICENSOR SHALL BE LIMITED TO REFUND OF THE FEES PAID BY LICENSEE (IF ANY) FOR THE MODEL. 
  

	5.	Assignment of the Agreement. This Agreement and any license granted hereunder to the LICENSEE may not be assigned, sub-licensed or otherwise transferred by the LICENSEE to
any third party 

  

	6.	Term and Termination. Unless terminated in accordance with the provisions of this Clause 6, this Agreement and licenses granted hereunder shall continue in force until
completion of the Purpose. LICENSOR may terminated this Agreement by written notice to the LICENSEE in the event of a breach by LICENSEE of any provisions of this Agreement. 

 Upon expiration or termination of this Agreement, the LICENSEE shall refrain from any further use of the Model, and LICENSEE shall either return or
destroy and copies of the Model in it’s possession at the date of expiration of termination as applicable. 
  

	7.	Applicability. The limitations and exclusions above may not apply in certain countries or states where they conflict with local law. In cases where such a conflict exists the
local law shall prevail and the remaining provisions of the Agreement shall remain in full force and effect. 

  

 Page 20 of 21 

 Confidential Treatment Requested by Spreadtrum Communications, Inc. 
 [***]. Certain information in this letter has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested by
Spreadtrum Communications, Inc. with respect to the omitted portions. 
  
 IN
WITNESS WHEREOF the parties have caused this Annex 1 to be signed by their duly authorised representative: 
  

									
	ARM LIMITED	 		 	SPREADTRUM COMMUNICATIONS, INC.
					
	BY:	 	 

	 		 	BY:	 	 

	NAME:	 	Philip David	 		 	NAME:	 	HARRY QIN
	TITLE:	 	General Counsel	 		 	TITLE:	 	VP, BD
	DATE:	 	30/09/06	 		 	DATE:	 	09/30/2006

  

 Page 21 of 21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00124-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00124-of-00352.parquet"}]]